endolymphatic hydrops: An accumulation of endolymph in the inner ear (labyrinth) leading to buildup of pressure and distortion of intralabyrinthine structures, such as cochlea and semicircular canals. It is characterized by sensorineural hearing loss; tinnitus; and sometimes vertigo.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3995 |
4. Check minimum number of eventsNone |
3995 |
5. Include endpointsNone |
3995 |
6. Filter based on genotype QC (FinnGen only) |
3894 |
Control definitions (FinnGen only)
- Control exclude
- H8_INNER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H81
- Name in latin
- Morbus Ménière
Similar endpoints
↥List of similar endpoints to
Ménière disease
based on the number of shared cases.
Similar with more cases:
- Disorders of vestibular function (Vertigo)
- Diseases of inner ear
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 26706 | 17134 | 9455 |
| Only index persons | 24436 | 15945 | 8491 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.41 | 0.49 | 0.26 |
| Only index persons | 0.50 | 0.59 | 0.32 |
| Median age at first event (years) | |||
| Whole population | 57.15 | 57.45 | 56.61 |
| Only index persons | 56.64 | 56.87 | 56.19 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3894 | 2537 | 1357 |
| Unadjusted period prevalence (%) | 0.80 | 0.90 | 0.62 |
| Median age at first event (years) | 56.08 | 54.87 | 58.34 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3995
- Matched controls
- 39950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H81.0
ICD-10 Finland
Ménière disease
11894.2
307.7
3790
62
R42
ICD-10 Finland
Dizziness and giddiness
7.1
307.7
2250
6110
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
4.4
307.7
1433
4492
N05AB04
ATC
prochlorperazine; systemic, rectal
13.1
307.7
421
356
DFF00
NOMESCO Finland
Pure tone audiometry
6.4
307.7
1169
2431
DFF59
NOMESCO Finland
Other assessment of balance
34.3
307.7
254
79
H81.2
ICD-10 Finland
Vestibular neuronitis
83.6
307.7
176
22
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.9
307.7
1431
4975
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
14.1
307.7
781
678
N07CA01
ATC
betahistine; oral
105.2
307.7
3109
1290
H81.3
ICD-10 Finland
Other peripheral vertigo
37.7
307.7
529
161
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
11.0
307.7
410
412
Z01.1
ICD-10 Finland
Examination of ears and hearing
5.9
307.7
1458
3558
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
7.3
307.7
816
1355
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
16.8
288.8
245
155
C03EA02
ATC
trichlormethiazide and potassium-sparing agents; oral
10.2
269.9
315
334
UDC00
NOMESCO Finland
Ear microscopy
4.8
254.5
643
1525
38599
ICD-8 Finland
Ménière's disease
+∞
222.0
211
*
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
21.5
217.1
163
79
DFF50
NOMESCO Finland
Electronystagmography
88.6
213.0
112
13
DFF15
NOMESCO Finland
Speech audiometry
5.0
205.0
485
1082
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
13.2
188.0
181
143
3860A
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Ménière's disease
+∞
177.4
169
*
H93.1
ICD-10 Finland
Tinnitus
3.9
156.1
513
1461
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.7
153.8
540
1609
Z97.4
ICD-10 Finland
Presence of external hearing-aid
4.2
146.6
423
1095
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
4.0
141.5
441
1207
H02
ICPC
Hearing complaint
2.7
137.8
945
4135
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
30.0
133.1
88
30
H82
ICPC
Vertiginous syndrome
7.1
124.5
191
280
N17
ICPC
Vertigo/dizziness
2.7
116.4
772
3295
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
110.4
1199
6376
DAX08
NOMESCO Finland
Fitting of hearing aid
3.2
96.2
406
1345
DFE00
NOMESCO Finland
Insertion of cochlear implant
23.6
90.3
65
28
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.8
87.8
279
768
Z3229
NOMESCO Finland
Other healthcare associate professional
2.8
87.4
485
1872
DC1AD
NOMESCO Finland
Temporalbone CT
8.8
86.2
109
127
SPAT1043
SPAT
Audiometry
2.4
74.7
573
2580
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
6.3
73.3
124
201
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
71.3
647
3130
R5120
NOMESCO Finland
Preparation of an aid
3.8
68.5
220
609
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
342.9
67.7
68
*
H02AB06
ATC
prednisolone; systemic
1.8
66.5
2077
15156
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
6.2
59.4
103
171
H91.9
ICD-10 Finland
Hearing loss, unspecified
2.8
59.2
314
1176
H29
ICPC
Ear symptom/complaint other
2.1
58.6
618
3157
DFX00
NOMESCO Finland
Connecting cochlear implant
19.8
58.1
45
23
G44.2
ICD-10 Finland
Tension-type headache
2.1
57.1
624
3230
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
3.5
56.5
203
605
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
6.2
55.0
95
157
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
4.6
52.6
127
284
H81.4
ICD-10 Finland
Vertigo of central origin
11.1
52.0
55
50
AA1AD
NOMESCO Finland
CT of head and brain
1.7
51.5
1301
8766
H81
ICD-10 Finland
Disorders of vestibular function
17.6
48.9
40
23
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
5.7
47.3
89
160
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
45.7
493
2526
R51.80
ICD-10 Finland
Headache
1.9
45.6
650
3673
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
44.2
977
6299
DFF16
NOMESCO Finland
Speech-in-noise audiometry
16.8
41.9
35
21
H80.9
ICD-10 Finland
Otosclerosis, unspecified
148.3
41.8
44
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.1
41.4
175
576
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
13.1
40.8
39
30
A02BC05
ATC
esomeprazole; systemic
1.6
40.5
1682
12636
R06AE53
ATC
cyclizine, combinations; systemic
6.3
40.3
68
110
R01AD09
ATC
mometasone; nasal
1.6
39.2
1740
13238
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
37.9
1436
10522
4173
FHL
Surgery on Saccus endolymphaticus
+∞
37.6
36
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
37.4
370
1828
R01AD08
ATC
fluticasone; nasal
1.6
36.6
1105
7662
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
36.1
1185
8376
M03BX02
ATC
tizanidine; oral
1.5
34.1
2354
19456
DDA00
NOMESCO Finland
Stapedotomy
121.1
33.7
36
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
4.5
33.1
80
179
H53.1
ICD-10 Finland
Subjective visual disturbances
2.1
32.6
320
1574
H80.1
ICD-10 Finland
Otosclerosis involving oval window, obliterative
+∞
32.3
31
*
R11
ICD-10 Finland
Nausea and vomiting
2.0
32.2
385
2037
H13
ICPC
Plugged feeling ear
1.6
32.1
831
5522
M54.5
ICD-10 Finland
Low back pain
1.5
31.9
1430
10764
A02BC03
ATC
lansoprazole; oral
1.5
31.6
1174
8485
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
31.6
879
5944
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
4.1
30.6
84
208
M25.5
ICD-10 Finland
Pain in joint
1.5
30.3
1293
9609
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
30.2
378
2030
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
29.3
1202
8843
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
4.5
29.2
71
160
M01AH05
ATC
etoricoxib; oral
1.5
28.7
2376
20020
M79.6
ICD-10 Finland
Pain in limb
1.5
28.4
1736
13806
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
28.2
350
1872
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
28.2
522
3165
UJF32
NOMESCO Finland
Coloscopy
1.5
28.1
1084
7862
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
27.5
1164
8596
A02BC02
ATC
pantoprazole; systemic
1.5
27.5
2744
23863
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
27.1
302
1555
N02BE01
ATC
paracetamol; systemic, rectal
1.8
27.0
3554
32800
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
26.3
1155
8579
H81.8
ICD-10 Finland
Other disorders of vestibular function
23.3
26.1
37
16
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
26.1
427
2495
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
25.8
726
4896
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
25.6
1097
8101
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
25.2
1793
14552
R03AC02
ATC
salbutamol; inhalant
1.4
25.0
2067
17214
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
24.8
1136
8490
R01AD58
ATC
fluticasone, combinations; nasal
1.5
24.7
861
6083
Z97.8
ICD-10 Finland
Presence of other specified devices
6.4
24.3
40
63
N03AX12
ATC
[U] gabapentin; oral
1.6
24.0
645
4293
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
23.8
2605
22695
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
23.8
696
4728
H92.0
ICD-10 Finland
Otalgia
2.1
23.7
248
1248
R06.0
ICD-10 Finland
Dyspnoea
1.5
23.0
1094
8214
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
22.4
868
6253
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
22.4
739
5149
L01
ICPC
Neck symptom/complaint
1.6
22.3
621
4165
R53
ICD-10 Finland
Malaise and fatigue
1.5
22.2
968
7140
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
22.2
985
7291
J01DB01
ATC
cefalexin; oral
1.5
22.2
3148
28546
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
22.1
351
2028
L03
ICPC
Low back symptom/complaint
1.4
22.0
1105
8371
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
22.0
699
4829
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
21.9
336
1923
XF404
NOMESCO Finland
Ambulatory ECG
1.8
21.8
350
2030
G47.3
ICD-10 Finland
Sleep apnoea
1.5
21.7
812
5805
SFA20
NOMESCO Finland
Two-surface restoration
1.4
21.6
2070
17494
N06AX11
ATC
mirtazapine; oral
1.4
21.5
1304
10208
Z01.2
ICD-10 Finland
Dental examination
1.4
21.4
1646
13412
H91.8
ICD-10 Finland
Other specified hearing loss
3.8
21.3
65
174
SFA10
NOMESCO Finland
One-surface restoration
1.4
21.3
1955
16390
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
21.0
1973
16586
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.0
20.7
234
1211
R07.3
ICD-10 Finland
Other chest pain
1.7
20.6
416
2572
A02BC01
ATC
omeprazole; systemic
1.4
20.6
1042
7887
J01AA02
ATC
doxycycline; systemic
1.4
20.4
3017
27271
M01AE02
ATC
naproxen; oral, rectal
1.4
20.2
2044
17349
N06AX21
ATC
duloxetine; oral
1.6
20.1
463
2961
DFA00
NOMESCO Finland
Saccotomy
+∞
19.8
19
*
C07AB07
ATC
bisoprolol; oral
1.4
19.8
1939
16353
J01MA02
ATC
ciprofloxacin; systemic
1.4
19.6
1453
11716
M01AB05
ATC
diclofenac; systemic, rectal
1.4
19.6
2456
21502
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
19.6
1633
13418
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
19.6
2347
20406
A04AA01
ATC
ondansetron; systemic, rectal
1.7
19.4
344
2051
R05
ICD-10 Finland
Cough
1.5
19.3
822
6013
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
19.3
472
3063
K02.1
ICD-10 Finland
Caries of dentine
1.4
19.2
2037
17357
RK520, ,
NOMESCO Finland
6.7
19.1
30
45
R03BA05
ATC
fluticasone; inhalant
1.5
18.8
652
4574
3882A
ICD-9 Finland
Other disorders of ear, Sudden hearing loss, unspecified
15.9
18.8
30
19
J01CA04
ATC
amoxicillin; systemic
1.4
18.7
3049
27750
A02BC04
ATC
rabeprazole; oral
1.7
18.5
340
2048
N02AX02
ATC
tramadol; systemic, rectal
1.4
18.3
1616
13353
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
18.2
1859
15702
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
18.1
568
3901
H28
ICPC
Limited function/disability (H)
3.4
18.1
63
185
SPAT1263
SPAT
Sampling
1.4
18.1
1510
12368
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.9
18.0
84
294
J01FA10
ATC
azithromycin; systemic
1.3
17.6
1998
17108
K30
ICD-10 Finland
Functional dyspepsia
1.6
17.6
437
2845
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
17.5
415
2670
A98
ICPC
Health maint/preventive medicine
1.8
17.5
3759
35868
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
17.4
396
2521
H02AB04
ATC
methylprednisolone; systemic
1.5
17.3
540
3699
J01FA06
ATC
roxithromycin; oral
1.3
17.3
1475
12092
S18
ICPC
Laceration/cut
1.3
17.3
1801
15208
J02AC01
ATC
fluconazole; systemic
1.3
17.2
1437
11745
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
17.1
756
5557
TDA90
NOMESCO Finland
Removal wax from ear
3.3
17.1
65
202
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
17.0
616
4353
R4110, ,
SPAT
1.5
17.0
539
3705
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
17.0
1561
12932
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
17.0
1851
15721
R01AD12
ATC
fluticasone furoate; nasal
1.4
17.0
1050
8180
3891A
ICD-9 Finland
Deafness, Sensorineural deafness
16.0
17.0
27
17
G43.9
ICD-10 Finland
Migraine, unspecified
2.0
17.0
194
1008
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
16.9
310
1865
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
16.7
413
2682
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
16.7
253
1441
N03AE01
ATC
clonazepam; systemic
1.9
16.7
221
1207
N03AX16
ATC
[U] pregabalin
1.4
16.5
858
6486
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
16.5
758
5607
C10AA07
ATC
rosuvastatin; oral
1.4
16.5
1283
10359
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.0
16.4
70
233
M01AX17
ATC
nimesulide; oral
1.4
16.3
912
6980
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
16.2
383
2460
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
16.2
955
7372
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
16.1
905
6932
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
16.0
1514
12565
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
15.9
452
3032
SPAT1260
SPAT
Consultation of another employee
1.5
15.8
640
4617
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
15.8
949
7345
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
15.7
1594
13351
R55
ICD-10 Finland
Syncope and collapse
1.6
15.7
423
2803
M79.1
ICD-10 Finland
Myalgia
1.5
15.7
530
3690
J01DA01
ATC
[U] cefalexin
1.3
15.7
2262
19892
SPAT1153
SPAT
Removal of sutures
1.4
15.6
1178
9445
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
15.6
585
4158
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.9
15.6
204
1110
N06AA09
ATC
amitriptyline; systemic
1.6
15.4
373
2411
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
15.4
1449
12002
R06AE07
ATC
cetirizine; oral
1.3
15.3
1570
13153
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
15.2
234
1338
C07AA05
ATC
propranolol; systemic
1.4
15.2
685
5043
R05
ICPC
Cough
1.4
15.1
907
7013
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
15.1
1911
16473
A02BA02
ATC
ranitidine; systemic
1.4
14.9
724
5399
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
14.7
480
3316
H83.1
ICD-10 Finland
Labyrinthine fistula
+∞
14.6
14
*
3861A
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Other and unspecified peripheral vertigo
+∞
14.6
14
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
14.6
275
1667
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
14.6
710
5294
H81
ICPC
Excessive ear wax
1.4
14.6
672
4962
R03DC03
ATC
montelukast; oral
1.5
14.5
586
4222
SPAT1312
SPAT
General health counselling
1.3
14.4
1083
8661
J35.0
ICD-10 Finland
Chronic tonsillitis
2.1
14.4
141
694
H01
ICPC
Ear pain/earache
1.6
14.3
390
2589
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
14.3
502
3518
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
14.3
1340
11059
H90.8
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unspecified
4.4
14.2
35
80
H03
ICPC
Tinnitus, ringing/buzzing ear
2.4
14.0
91
377
SPAT1097
SPAT
Recording of ECG
1.5
13.9
540
3859
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
13.8
690
5162
SPAT1301
SPAT
No procedures
1.3
13.8
1130
9142
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
3.7
13.8
42
113
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.5
13.8
401
2702
DC1AI
NOMESCO Finland
Cone beam CT of ear
20.1
13.8
20
10
J01EA01
ATC
trimethoprim; systemic
1.3
13.7
988
7844
P01AB01
ATC
metronidazole; oral, rectal
1.3
13.6
1430
11965
XQ800
NOMESCO Finland
Prick test
1.7
13.6
237
1405
P06
ICPC
Sleep disturbance
1.5
13.6
429
2939
R02
ICPC
Shortness of breath/dyspnoea
1.5
13.6
520
3704
SPAT1310
SPAT
Counselling related to known health issue
1.3
13.6
1110
8970
J01FA09
ATC
clarithromycin; systemic
1.3
13.5
1070
8606
UKC02
NOMESCO Finland
Cystoscopy
1.4
13.5
566
4106
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
13.5
212
1222
R21
ICPC
Throat symptom/complaint
1.4
13.4
610
4487
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
13.4
1497
12628
H61.2
ICD-10 Finland
Impacted cerumen
1.7
13.3
262
1608
L08
ICPC
Shoulder symptom/complaint
1.4
13.2
858
6696
N02BF01
ATC
gabapentin; oral
1.5
13.2
390
2636
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
13.1
188
1055
D82
ICPC
Teeth/gum disease
1.3
13.0
1215
9991
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
12.9
2563
23203
R06AX27
ATC
desloratadine; oral
1.3
12.9
941
7471
SFA30
NOMESCO Finland
Three-surface restoration
1.3
12.9
1472
12431
L17
ICPC
Foot/toe symptom/complaint
1.3
12.9
1127
9185
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
12.9
969
7731
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.0
12.8
135
683
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.5
12.8
406
2786
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
12.7
381
2581
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
12.6
1287
10705
R4135
NOMESCO Finland
Rehabilitation for hearing problems
2.4
12.5
84
354
N05BB51
ATC
hydroxyzine, combinations; systemic
13.2
12.4
21
16
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
12.3
290
1860
P01
ICPC
Feeling anxious/nervous/tense
1.6
12.2
323
2128
M48.0
ICD-10 Finland
Spinal stenosis
1.5
12.2
476
3401
R01AD01
ATC
beclometasone; nasal
1.4
12.2
527
3838
H66.9
ICD-10 Finland
Otitis media, unspecified
1.8
12.2
185
1056
TDA90, ,
SPAT
1.6
12.0
260
1633
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
12.0
227
1377
SGA01
NOMESCO Finland
Emergency treatment
1.4
12.0
487
3506
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
12.0
852
6731
L13
ICPC
Hip symptom/complaint
1.4
11.9
762
5922
R74
ICPC
Upper respiratory infection acute
1.3
11.9
989
7990
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
11.8
249
1554
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.6
11.8
291
1887
KMAK, ,
NOMESCO Finland
1.3
11.7
1695
14685
SPAT1325
SPAT
Vaccination
1.3
11.7
1197
9933
M01AG02
ATC
tolfenamic acid; oral, rectal
1.4
11.7
508
3700
XF402
NOMESCO Finland
ECG with work load test
1.5
11.7
378
2602
R00.2
ICD-10 Finland
Palpitations
1.6
11.7
275
1764
XA402
NOMESCO Finland
ENMG
2.2
11.6
94
430
H60.3
ICD-10 Finland
Other infective otitis externa
2.3
11.6
89
399
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
11.5
805
6342
F51.0
ICD-10 Finland
Nonorganic insomnia
1.4
11.5
539
3983
3870A
ICD-9 Finland
Otosclerosis involving oval window, nonobliterative
+∞
11.5
11
*
H53.2
ICD-10 Finland
Diplopia
2.0
11.5
124
634
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.3
11.4
1015
8264
DE2CF
NOMESCO Finland
Acoustic channel extensive MRI examination with median intensity magnet
120.4
11.4
12
*
N06AB04
ATC
citalopram; systemic
1.4
11.4
732
5689
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
2.2
11.4
98
460
L02
ICPC
Back symptom/complaint
1.5
11.4
341
2311
R12
ICD-10 Finland
Heartburn
1.6
11.3
291
1905
K08.80
ICD-10 Finland
Toothache NOS
1.6
11.3
290
1897
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.8
11.3
156
864
C03AA03
ATC
hydrochlorothiazide; oral
1.5
11.3
352
2403
A03
ICPC
Fever
1.4
11.3
509
3732
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
11.3
767
6013
M01AH01
ATC
celecoxib; oral
1.4
11.3
653
4996
C10AA05
ATC
atorvastatin; oral
1.3
11.2
1598
13797
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
11.2
164
925
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
1.9
11.2
138
737
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
11.2
486
3542
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
11.2
1499
12852
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.5
10.9
338
2306
K04.0
ICD-10 Finland
Pulpitis
1.6
10.9
256
1642
K07.60
ICD-10 Finland
Snapping jaw
1.8
10.9
166
949
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
10.9
638
4888
J01CA08
ATC
pivmecillinam; oral
1.3
10.9
1538
13257
M01AH02
ATC
rofecoxib; oral
1.4
10.8
467
3397
M77.1
ICD-10 Finland
Lateral epicondylitis
1.6
10.8
237
1494
RK420, ,
NOMESCO Finland
10.6
10.8
20
19
K80
ICPC
Cardiac arrhythmia NOS
1.5
10.7
321
2174
M54.3
ICD-10 Finland
Sciatica
1.7
10.7
211
1295
34609
ICD-8 Finland
Migraine, Unspecified
3.5
10.7
36
104
R03AC03
ATC
terbutaline; inhalant
1.4
10.7
476
3482
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.7
10.7
217
1343
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.6
10.6
249
1596
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
10.6
359
2494
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
10.6
424
3042
Z71.8
ICD-10 Finland
Other specified counselling
1.3
10.6
1160
9687
G04BD12
ATC
mirabegron; oral
1.4
10.6
467
3410
B37.0
ICD-10 Finland
Candidal stomatitis
3.0
10.6
46
156
RK320, ,
NOMESCO Finland
3.5
10.5
36
105
WZC00, ,
SPAT
1.4
10.5
501
3707
A03CA02
ATC
clidinium and psycholeptics; oral
1.6
10.5
216
1340
A01
ICPC
Pain general/multiple sites
1.5
10.5
373
2617
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
10.5
202
1233
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
10.4
788
6264
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
10.4
1547
13387
H80.8
ICD-10 Finland
Other otosclerosis
+∞
10.4
10
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
10.4
1021
8409
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
10.3
679
5290
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
3.1
10.3
41
132
SPAT1041
SPAT
Comprehensive hearing test
2.7
10.3
54
203
M54.2
ICD-10 Finland
Cervicalgia
1.6
10.2
274
1811
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
10.2
847
6818
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.5
10.2
360
2521
C05AA08
ATC
fluocortolone; rectal, topical
1.4
10.2
468
3440
K07.61
ICD-10 Finland
Cracking jaw joint
2.4
10.2
66
275
A04
ICPC
Weakness/tiredness general
1.4
10.1
567
4308
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.4
10.1
387
2753
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
10.1
1336
11404
N01
ICPC
Headache
1.5
10.0
318
2180
SPAT1216
SPAT
Assessment of functional ability
1.4
10.0
582
4449
H83.3
ICD-10 Finland
Noise effects on inner ear
4.6
10.0
23
50
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
9.9
212
1330
C07AB02
ATC
metoprolol; systemic
1.3
9.9
725
5737
D33.30
ICD-10 Finland
Acoustic neuroma
3.7
9.9
30
81
A01AB09
ATC
miconazole; local oral
1.5
9.8
300
2040
-1, ,
NOMESCO Finland
1.3
9.8
1021
8457
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
9.8
693
5452
C10AA01
ATC
simvastatin; oral
1.2
9.8
1555
13530
R51
ICD-10 Finland
Headache
1.7
9.8
173
1032
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.6
9.8
259
1708
R83
ICPC
Respiratory infection other
1.3
9.8
726
5753
TAB00
NOMESCO Finland
Lumbar puncture
1.8
9.8
142
801
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
2.5
9.8
58
232
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
9.7
694
5467
R50.9
ICD-10 Finland
Fever, unspecified
1.4
9.7
499
3739
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.9
9.7
123
665
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
9.7
587
4514
H03AA01
ATC
levothyroxine sodium; systemic
1.3
9.7
858
6962
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.9
9.7
119
637
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
9.6
1348
11562
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
9.6
1283
10943
M01AC06
ATC
meloxicam; systemic, rectal
1.3
9.6
1308
11181
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.7
9.6
166
985
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
9.5
798
6425
R06AX22
ATC
ebastine; oral
1.4
9.5
564
4324
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
9.5
243
1591
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
9.5
371
2650
RK120, ,
NOMESCO Finland
7.1
9.5
22
31
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
9.5
294
2007
SPAT1104
SPAT
Monitoring of emergency patient
1.6
9.4
226
1457
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
9.4
481
3599
H83.8
ICD-10 Finland
Other specified diseases of inner ear
100.3
9.4
10
*
H80
ICD-10 Finland
Otosclerosis
100.3
9.4
10
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
9.4
3324
31558
H93.2
ICD-10 Finland
Other abnormal auditory perceptions
3.1
9.3
38
124
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
2.5
9.3
57
231
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
3.2
9.3
36
114
RK110, ,
NOMESCO Finland
3.4
9.3
33
99
G04CA02
ATC
tamsulosin; oral
1.3
9.3
691
5475
D11
ICPC
Diarrhoea
1.4
9.3
373
2679
N05CF01
ATC
zopiclone; oral
1.3
9.2
1168
9892
M02AA07
ATC
piroxicam; topical
1.2
9.2
1307
11214
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
9.2
250
1659
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.8
9.1
130
729
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
9.1
441
3271
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
9.1
184
1139
A03FA02
ATC
cisapride; oral, rectal
1.5
9.1
268
1811
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.6
9.0
235
1544
M01AC01
ATC
piroxicam; systemic, rectal
1.4
9.0
461
3449
N03AX11
ATC
topiramate; oral
2.2
9.0
75
349
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.8
8.9
130
734
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.1
8.9
77
363
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
8.9
857
7018
Z45.3
ICD-10 Finland
Adjustment and management of implanted hearing device
18.6
8.9
13
7
L15
ICPC
Knee symptom/complaint
1.3
8.9
909
7500
DFX03
NOMESCO Finland
Review, maintenance and user education for hearing aid
3.4
8.9
31
92
D09
ICPC
Nausea
1.8
8.9
138
795
N30.0
ICD-10 Finland
Acute cystitis
1.3
8.9
635
5002
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
8.8
1007
8418
S06.0
ICD-10 Finland
Concussion
1.4
8.8
348
2489
R03BA02
ATC
budesonide; inhalant
1.3
8.8
599
4681
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.4
8.8
369
2669
G03DB01
ATC
dydrogesterone; oral
1.4
8.8
389
2841
C01CA24
ATC
epinephrine; parenteral
1.6
8.8
189
1188
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
8.8
1396
12112
D01
ICPC
Abdominal pain/cramps general
1.4
8.8
399
2929
D02
ICPC
Abdominal pain epigastric
1.6
8.7
216
1404
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
8.7
941
7816
TQW40, ,
SPAT
1.4
8.7
347
2488
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
8.7
760
6148
EB1VA, ,
NOMESCO Finland
1.3
8.7
575
4477
L86
ICPC
Back syndrome with radiating pain
1.6
8.6
219
1431
L12
ICPC
Hand/finger symptom/complaint
1.3
8.6
574
4472
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
8.6
877
7229
N02CC03
ATC
zolmitriptan; nasal, oral
1.7
8.6
158
954
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
2.2
8.6
66
297
R03BC03
ATC
nedocromil; inhalant
1.5
8.6
229
1514
UDM02
NOMESCO Finland
Sinoscopy
2.1
8.6
77
369
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
16.3
8.5
13
8
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
8.5
486
3700
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
8.5
272
1869
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
8.5
328
2339
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.6
8.5
169
1043
R30.0
ICD-10 Finland
Dysuria
1.7
8.4
145
860
N06AB10
ATC
escitalopram; oral
1.3
8.4
611
4822
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.8
8.4
122
690
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
8.4
366
2668
Z00.0
ICD-10 Finland
General medical examination
1.3
8.3
640
5087
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.1
8.3
77
374
R03BA08
ATC
ciclesonide; inhalant
1.5
8.3
294
2062
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.5
8.2
276
1914
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.8
8.2
115
642
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
8.2
638
5076
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.0
8.2
81
402
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
8.2
851
7025
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
8.2
249
1692
N80.0
ICD-10 Finland
Endometriosis of uterus
2.2
8.2
66
303
H02AB07
ATC
prednisone; oral
1.4
8.2
462
3512
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.7
8.2
138
815
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
8.2
285
1993
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
8.1
1017
8580
J01DA09
ATC
[U] cefadroxil
1.3
8.1
848
7006
R52.2
ICD-10 Finland
Other chronic pain
1.7
8.1
129
749
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.8
8.1
38
135
J05AB11
ATC
valaciclovir; oral
1.3
8.1
494
3799
U02
ICPC
Urinary frequency/urgency
1.3
8.1
538
4190
R06AX13
ATC
loratadine; oral
1.4
8.1
461
3509
M01AB08
ATC
etodolac; oral
1.5
8.0
244
1659
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
8.9
8.0
16
18
SPAT1229
SPAT
Assessment of need for aid
1.5
8.0
277
1935
C01DA14
ATC
isosorbide mononitrate; oral
1.3
7.8
540
4227
R35
ICD-10 Finland
Polyuria
1.5
7.8
227
1530
M02AA10
ATC
ketoprofen; topical
1.3
7.8
552
4337
M79.7
ICD-10 Finland
Fibromyalgia
1.8
7.8
117
669
J01MA06
ATC
norfloxacin; oral
1.3
7.8
457
3495
N06AX16
ATC
venlafaxine; oral
1.4
7.8
439
3337
R06.5
ICD-10 Finland
Mouth breathing
1.5
7.8
265
1846
R52.9
ICD-10 Finland
Pain, unspecified
1.4
7.7
343
2506
M54.8
ICD-10 Finland
Other dorsalgia
1.7
7.7
149
912
4133
FHL
Stapedectomy sampling
45.1
7.7
9
*
C03BB04
ATC
chlortalidone and potassium; oral
45.1
7.7
9
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
7.7
690
5594
N06AB06
ATC
sertraline; oral
1.4
7.7
340
2484
M22.4
ICD-10 Finland
Chondromalacia patellae
2.0
7.7
83
427
D06
ICPC
Abdominal pain localized other
1.4
7.6
286
2027
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.9
7.6
35
123
A02BX02
ATC
sucralfate; oral
1.7
7.6
136
816
N03AF01
ATC
carbamazepine; oral, rectal
1.6
7.6
164
1033
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.3
7.6
871
7270
ZXC10
NOMESCO Finland
Use of laser
2.1
7.6
65
307
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
7.6
442
3377
G50.1
ICD-10 Finland
Atypical facial pain
2.1
7.5
66
315
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
7.5
112
640
ZXA10
NOMESCO Finland
Bilateral
1.3
7.5
634
5102
R01AD59
ATC
mometasone, combinations; nasal
1.6
7.5
185
1205
A02BA04
ATC
nizatidine; systemic
1.5
7.4
256
1786
GD1AA, ,
SPAT
1.3
7.4
473
3659
SFA00
NOMESCO Finland
Small restoration
1.3
7.4
453
3484
R13
ICD-10 Finland
Dysphagia
1.5
7.4
248
1721
L82
ICD-10 Finland
Seborrhoeic keratosis
1.3
7.4
679
5518
6266A
ICD-9 Finland
Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia
1.8
7.4
115
665
C01BC04
ATC
flecainide; systemic
1.7
7.3
118
688
D07AC01
ATC
betamethasone; topical
1.2
7.3
1258
10951
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
7.3
132
794
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
1.9
7.3
94
512
SPAT1081
SPAT
Cardiorespiratory global assessment
1.6
7.3
185
1210
C10AX09
ATC
ezetimibe; oral
1.3
7.3
584
4662
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.8
7.3
103
578
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.5
7.3
204
1364
38699, ,
ICD-8 Finland
+∞
7.3
7
*
SPAT1351
SPAT
Extensive ear examination
3.1
7.3
29
94
L57.0
ICD-10 Finland
Actinic keratosis
1.4
7.2
401
3040
K39
ICPC
Cardiovascular, Physical function test
4.3
7.2
18
42
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
7.2
615
4952
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.5
7.2
221
1508
WZB00, ,
SPAT
1.5
7.2
246
1715
F29
ICPC
Eye symptom/complaint other
1.4
7.2
346
2564
C10AA04
ATC
fluvastatin; oral
1.4
7.2
302
2187
A11
ICPC
Chest pain NOS
1.4
7.2
294
2119
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
4.5
7.2
17
38
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
1.8
7.2
107
611
M45
ICD-10 Finland
Ankylosing spondylitis
2.1
7.2
62
294
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
7.2
672
5475
OAA65, ,
SPAT
1.3
7.2
419
3202
S29
ICPC
Skin symptom/complaint other
1.3
7.1
705
5783
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.9
7.1
91
497
A05
ICPC
Feeling ill
1.6
7.0
160
1022
R06AE03
ATC
cyclizine; systemic, rectal
10.0
7.0
13
13
M54.1
ICD-10 Finland
Radiculopathy
1.7
7.0
132
805
WX290
NOMESCO Finland
Other blockage of nerve
1.2
7.0
1438
12730
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.2
6.9
1158
10043
K59.0
ICD-10 Finland
Constipation
1.5
6.9
188
1250
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
6.9
924
7833
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.6
6.9
153
972
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.5
6.9
213
1456
H60.8
ICD-10 Finland
Other otitis externa
1.8
6.9
97
545
N05BA04
ATC
oxazepam; oral
1.2
6.9
900
7614
J01FA01
ATC
erythromycin; systemic
1.3
6.8
389
2959
D10
ICPC
Vomiting
1.6
6.8
139
864
R31
ICD-10 Finland
Unspecified haematuria
1.4
6.8
319
2352
J02AC02
ATC
itraconazole; systemic
1.3
6.8
579
4656
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.3
6.8
739
6121
H57.1
ICD-10 Finland
Ocular pain
1.7
6.8
120
720
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.5
6.7
183
1217
H90.2
ICD-10 Finland
Conductive hearing loss, unspecified
3.6
6.7
21
58
C03BA04
ATC
chlortalidone; oral
16.7
6.7
10
6
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
6.7
2271
20979
XKD00
NOMESCO Finland
Uroflowmetry
1.3
6.7
456
3560
H60
ICD-10 Finland
Otitis externa
1.6
6.7
154
987
A06AC51
ATC
ispaghula, combinations; oral
1.6
6.7
156
1003
N39.3
ICD-10 Finland
Stress incontinence
1.4
6.7
271
1951
R04
ICPC
Breathing problem other
1.6
6.7
129
792
E0000UV, ,
ATC
1.2
6.7
1431
12699
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.2
6.6
884
7487
N02CC07
ATC
frovatriptan; oral
1.8
6.6
102
588
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.6
6.6
133
824
J01FF01
ATC
clindamycin; systemic
1.2
6.6
890
7547
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.1
6.6
61
297
K29
ICPC
Cardiovascular sympt/complt other
1.6
6.6
153
982
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.5
6.6
195
1321
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.2
6.6
1236
10832
N63
ICD-10 Finland
Unspecified lump in breast
1.5
6.6
217
1504
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.4
6.6
291
2128
P20
ICPC
Memory disturbance
1.3
6.5
535
4282
D01BA02
ATC
terbinafine; oral
1.2
6.5
825
6947
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
2.5
6.5
38
152
R51.81
ICD-10 Finland
Facial pain NOS
1.9
6.5
80
431
G43
ICD-10 Finland
Migraine
1.7
6.5
119
721
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
6.5
879
7460
C03CA01
ATC
furosemide; systemic
1.2
6.5
1130
9833
RK290, ,
NOMESCO Finland
6.2
6.5
16
26
G44.0
ICD-10 Finland
Cluster headache syndrome
2.6
6.4
35
135
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.3
6.4
402
3101
C08CA05
ATC
nifedipine; systemic
1.5
6.4
194
1320
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
6.4
566
4572
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.4
6.4
40
165
R07.0
ICD-10 Finland
Pain in throat
1.5
6.4
196
1337
M01AX05
ATC
glucosamine; oral
1.2
6.4
722
6003
SDA03
NOMESCO Finland
Periodontal treatment
1.2
6.4
1304
11507
H91.0
ICD-10 Finland
Ototoxic hearing loss
14.3
6.4
10
7
C08DA01
ATC
verapamil; systemic
1.6
6.4
141
896
G43.8
ICD-10 Finland
Other migraine
2.3
6.3
45
197
XCK00
NOMESCO Finland
Perimetry
1.5
6.3
209
1450
P25
ICPC
Phase of life problem adult
1.7
6.3
114
689
E03.89
ICD-10 Finland
Other specified hypothyroidism
1.6
6.3
141
899
J05AB01
ATC
aciclovir; systemic
1.2
6.3
729
6082
207
Kela drug reimbursment
Chronic arrhythmias
1.3
6.3
569
4613
K04.1
ICD-10 Finland
Necrosis of pulp
1.4
6.2
318
2379
D12
ICPC
Constipation
1.6
6.2
128
800
K04
ICPC
Palpitations/awareness of heart
1.5
6.2
178
1200
D07AC13
ATC
mometasone; topical
1.2
6.2
942
8085
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
1.9
6.2
74
396
ZXA05
NOMESCO Finland
Left side
1.2
6.1
843
7161
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
1.8
6.1
91
521
C03DA01
ATC
spironolactone; oral
1.3
6.1
425
3330
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
6.1
832
7059
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.7
6.1
104
619
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.6
6.1
148
962
N06AX26
ATC
vortioxetine; oral
1.5
6.1
204
1419
C07AA07
ATC
sotalol; systemic
1.6
6.1
117
719
M50.3
ICD-10 Finland
Other cervical disc degeneration
1.8
6.1
77
420
H04
ICPC
Ear discharge
1.7
6.0
113
689
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.6
6.0
81
1401
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
betahistine; oral
N07CA01 [21604833]
N07CA01 [21604833]
4.1e+00
5.7e+00
6.1e+00
—
6.6e+00
6.1e+00
5.4e+00
cases:23.60%
controls:0.51%
cases:36.30%
controls:0.19%
cases:14.89%
controls:0.04%
—
—
cases:25.33%
controls:0.04%
cases:50.91%
controls:0.22%
cases:49.40%
controls:0.43%
913
195
2955
38313
1404
72
2464
38436
576
15
3292
38493
—
979
17
2886
38449
1939
85
1870
37731
1743
148
1785
34381
Otolaryngology
4 [38004449]
4 [38004449]
1.4e+00
2.4e+00
2.8e+00
9.2e+00
3.2e+00
3.4e+00
2.1e+00
cases:26.14%
controls:8.37%
cases:25.16%
controls:3.02%
cases:7.32%
controls:0.48%
cases:71.87%
controls:0.03%
cases:12.55%
controls:0.56%
cases:50.93%
controls:3.19%
cases:46.23%
controls:9.43%
1011
3223
2857
35285
973
1164
2895
37344
283
183
3585
38325
2780
10
1088
38498
485
215
3380
38251
1940
1208
1869
36608
1631
3257
1897
31272
Dizziness and giddiness
R42 [45568132]
R42 [45568132]
2.0e+00
3.5e+00
4.4e+00
—
4.0e+00
2.7e+00
1.6e+00
cases:12.67%
controls:1.94%
cases:17.24%
controls:0.62%
cases:6.41%
controls:0.08%
—
—
cases:3.39%
controls:0.06%
cases:8.79%
controls:0.65%
cases:11.90%
controls:2.57%
490
748
3378
37760
667
238
3201
38270
248
32
3620
38476
—
131
25
3734
38441
335
246
3474
37570
420
886
3108
33643
Examination of ears and hearing
Z01.1 [45547279]
Z01.1 [45547279]
1.8e+00
2.9e+00
3.8e+00
—
4.3e+00
3.0e+00
2.1e+00
cases:5.35%
controls:0.91%
cases:5.46%
controls:0.31%
cases:1.22%
controls:0.03%
—
—
cases:1.81%
controls:0.03%
cases:7.04%
controls:0.36%
cases:10.26%
controls:1.36%
207
351
3661
38157
211
120
3657
38388
47
11
3821
38497
—
70
10
3795
38456
268
136
3541
37680
362
470
3166
34059
Other peripheral vertigo
H81.3 [45543140]
H81.3 [45543140]
4.2e+00
5.3e+00
1.0e+50
1.0e+50
1.0e+50
4.9e+00
3.4e+00
cases:2.33%
controls:0.04%
cases:3.39%
controls:0.02%
cases:1.24%
controls:0.00%
cases:0.96%
controls:0.00%
cases:0.78%
controls:0.00%
cases:2.13%
controls:0.02%
cases:2.18%
controls:0.07%
90
14
3778
38494
131
7
3737
38501
48
0
3820
38508
37
0
3831
38508
30
0
3835
38466
81
6
3728
37810
77
25
3451
34504
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
H90.4 [45572067]
H90.4 [45572067]
2.9e+00
4.4e+00
—
1.0e+50
3.3e+00
3.7e+00
2.8e+00
cases:4.34%
controls:0.25%
cases:4.89%
controls:0.06%
—
—
cases:2.33%
controls:0.00%
cases:0.36%
controls:0.01%
cases:3.18%
controls:0.08%
cases:4.71%
controls:0.31%
168
98
3700
38410
189
24
3679
38484
—
90
0
3778
38508
14
5
3851
38461
121
32
3688
37784
166
106
3362
34423
chlortalidone and potassium-sparing agents
C03EA06 [21601548]
C03EA06 [21601548]
2.1e+00
2.7e+00
2.4e+00
1.0e+50
3.5e+00
3.1e+00
3.0e+00
cases:1.84%
controls:0.22%
cases:2.20%
controls:0.15%
cases:0.62%
controls:0.05%
cases:0.75%
controls:0.00%
cases:1.22%
controls:0.04%
cases:3.12%
controls:0.15%
cases:3.51%
controls:0.19%
71
85
3797
38423
85
57
3783
38451
24
21
3844
38487
29
0
3839
38508
47
14
3818
38452
119
57
3690
37759
124
64
3404
34465
metolazone and potassium-sparing agents
C03EA12 [21601550]
C03EA12 [21601550]
2.1e+00
2.7e+00
2.4e+00
1.0e+50
3.5e+00
3.1e+00
3.0e+00
cases:1.84%
controls:0.22%
cases:2.20%
controls:0.15%
cases:0.62%
controls:0.05%
cases:0.75%
controls:0.00%
cases:1.22%
controls:0.04%
cases:3.12%
controls:0.15%
cases:3.51%
controls:0.19%
71
85
3797
38423
85
57
3783
38451
24
21
3844
38487
29
0
3839
38508
47
14
3818
38452
119
57
3690
37759
124
64
3404
34465
propranolol and thiazides
C07BA05 [21601704]
C07BA05 [21601704]
2.1e+00
2.7e+00
2.4e+00
1.0e+50
3.5e+00
3.1e+00
3.0e+00
cases:1.84%
controls:0.22%
cases:2.20%
controls:0.15%
cases:0.62%
controls:0.05%
cases:0.75%
controls:0.00%
cases:1.22%
controls:0.04%
cases:3.12%
controls:0.15%
cases:3.51%
controls:0.19%
71
85
3797
38423
85
57
3783
38451
24
21
3844
38487
29
0
3839
38508
47
14
3818
38452
119
57
3690
37759
124
64
3404
34465
epitizide and potassium-sparing agents
C03EA03 [21601545]
C03EA03 [21601545]
2.1e+00
2.7e+00
2.4e+00
1.0e+50
3.5e+00
3.1e+00
3.0e+00
cases:1.84%
controls:0.22%
cases:2.20%
controls:0.15%
cases:0.62%
controls:0.05%
cases:0.75%
controls:0.00%
cases:1.22%
controls:0.04%
cases:3.12%
controls:0.15%
cases:3.51%
controls:0.19%
71
85
3797
38423
85
57
3783
38451
24
21
3844
38487
29
0
3839
38508
47
14
3818
38452
119
57
3690
37759
124
64
3404
34465
trichlormethiazide; oral
C03AA06 [21601469]
C03AA06 [21601469]
2.1e+00
2.7e+00
2.4e+00
1.0e+50
3.5e+00
3.1e+00
3.0e+00
cases:1.84%
controls:0.22%
cases:2.20%
controls:0.15%
cases:0.62%
controls:0.05%
cases:0.75%
controls:0.00%
cases:1.22%
controls:0.04%
cases:3.12%
controls:0.15%
cases:3.51%
controls:0.19%
71
85
3797
38423
85
57
3783
38451
24
21
3844
38487
29
0
3839
38508
47
14
3818
38452
119
57
3690
37759
124
64
3404
34465
triamterene; oral
C03DB02 [21601540]
C03DB02 [21601540]
2.1e+00
2.7e+00
2.4e+00
1.0e+50
3.5e+00
3.1e+00
3.0e+00
cases:1.86%
controls:0.23%
cases:2.25%
controls:0.15%
cases:0.62%
controls:0.06%
cases:0.75%
controls:0.00%
cases:1.24%
controls:0.04%
cases:3.15%
controls:0.15%
cases:3.51%
controls:0.19%
72
87
3796
38421
87
58
3781
38450
24
22
3844
38486
29
0
3839
38508
48
14
3817
38452
120
58
3689
37758
124
65
3404
34464
hydrochlorothiazide and potassium-sparing agents
C03EA01 [21601543]
C03EA01 [21601543]
1.1e+00
1.7e+00
1.5e+00
5.1e+00
2.4e+00
2.2e+00
2.0e+00
cases:9.57%
controls:3.32%
cases:10.63%
controls:2.20%
cases:2.59%
controls:0.56%
cases:2.59%
controls:0.02%
cases:5.74%
controls:0.53%
cases:16.15%
controls:2.18%
cases:20.18%
controls:3.32%
370
1279
3498
37229
411
846
3457
37662
100
216
3768
38292
100
6
3768
38502
222
202
3643
38264
615
824
3194
36992
712
1145
2816
33384
Tinnitus
H93.1 [45543152]
H93.1 [45543152]
1.8e+00
3.3e+00
3.6e+00
1.0e+50
2.5e+00
2.6e+00
1.4e+00
cases:2.51%
controls:0.41%
cases:2.95%
controls:0.12%
cases:0.54%
controls:0.02%
cases:0.88%
controls:0.00%
cases:0.18%
controls:0.02%
cases:1.68%
controls:0.12%
cases:2.15%
controls:0.53%
97
156
3771
38352
114
45
3754
38463
21
6
3847
38502
34
0
3834
38508
7
6
3858
38460
64
46
3745
37770
76
182
3452
34347
Audiometric test
21727005 [4071702]
21727005 [4071702]
1.5e+00
2.6e+00
3.1e+00
—
3.3e+00
2.5e+00
1.9e+00
cases:5.09%
controls:1.14%
cases:5.35%
controls:0.41%
cases:0.80%
controls:0.04%
—
—
cases:0.80%
controls:0.03%
cases:5.22%
controls:0.43%
cases:8.99%
controls:1.39%
197
439
3671
38069
207
156
3661
38352
31
14
3837
38494
—
31
12
3834
38454
199
164
3610
37652
317
481
3211
34048
Audiology
64 [38004489]
64 [38004489]
1.5e+00
2.2e+00
2.6e+00
1.0e+50
3.5e+00
2.9e+00
2.0e+00
cases:6.98%
controls:1.67%
cases:5.69%
controls:0.64%
cases:1.45%
controls:0.11%
cases:11.27%
controls:0.00%
cases:2.35%
controls:0.07%
cases:11.74%
controls:0.70%
cases:15.36%
controls:2.30%
270
643
3598
37865
220
248
3648
38260
56
41
3812
38467
436
0
3432
38508
91
27
3774
38439
447
264
3362
37552
542
794
2986
33735
prochlorperazine; oral, parenteral, rectal
N05AB04 [21604503]
N05AB04 [21604503]
2.9e+00
3.9e+00
—
1.0e+50
—
4.1e+00
3.8e+00
cases:3.23%
controls:0.18%
cases:2.59%
controls:0.05%
—
—
cases:0.44%
controls:0.00%
—
—
cases:2.89%
controls:0.05%
cases:5.53%
controls:0.14%
125
70
3743
38438
100
20
3768
38488
—
17
0
3851
38508
—
110
19
3699
37797
195
47
3333
34482
Sudden idiopathic hearing loss
H91.2 [45552760]
H91.2 [45552760]
2.9e+00
4.4e+00
—
1.0e+50
—
3.7e+00
2.0e+00
cases:2.30%
controls:0.13%
cases:2.97%
controls:0.04%
—
—
cases:1.27%
controls:0.00%
—
—
cases:1.52%
controls:0.04%
cases:1.36%
controls:0.18%
89
50
3779
38458
115
14
3753
38494
—
49
0
3819
38508
—
58
14
3751
37802
48
63
3480
34466
Vertigo/dizziness
N17 [2002000728]
N17 [2002000728]
1.3e+00
2.4e+00
4.2e+00
—
2.3e+00
1.7e+00
1.0e+00
cases:2.69%
controls:0.77%
cases:2.90%
controls:0.26%
cases:1.06%
controls:0.02%
—
—
cases:0.41%
controls:0.04%
cases:1.37%
controls:0.25%
cases:3.23%
controls:1.20%
104
297
3764
38211
112
99
3756
38409
41
6
3827
38502
—
16
16
3849
38450
52
96
3757
37720
114
416
3414
34113
Ear microscopy
UDC00 [2001301558]
UDC00 [2001301558]
1.6e+00
2.4e+00
—
1.0e+50
3.1e+00
3.1e+00
2.0e+00
cases:2.15%
controls:0.46%
cases:1.78%
controls:0.16%
—
—
cases:3.83%
controls:0.00%
cases:0.34%
controls:0.02%
cases:3.62%
controls:0.17%
cases:4.14%
controls:0.60%
83
177
3785
38331
69
61
3799
38447
—
148
0
3720
38508
13
6
3852
38460
138
66
3671
37750
146
208
3382
34321
Neurology
13 [38004458]
13 [38004458]
6.1e-01
1.3e+00
1.6e+00
5.2e+00
1.4e+00
9.4e-01
7.6e-01
cases:13.91%
controls:8.09%
cases:10.78%
controls:3.32%
cases:3.05%
controls:0.64%
cases:4.21%
controls:0.02%
cases:2.56%
controls:0.64%
cases:8.30%
controls:3.42%
cases:17.83%
controls:9.23%
538
3117
3330
35391
417
1280
3451
37228
118
248
3750
38260
163
9
3705
38499
99
247
3766
38219
316
1292
3493
36524
629
3186
2899
31343
furosemide and potassium-sparing agents
C03EB01 [21601554]
C03EB01 [21601554]
1.3e+00
1.9e+00
1.6e+00
1.0e+50
2.8e+00
2.2e+00
1.9e+00
cases:2.77%
controls:0.75%
cases:2.87%
controls:0.45%
cases:0.70%
controls:0.14%
cases:0.80%
controls:0.00%
cases:1.50%
controls:0.09%
cases:3.94%
controls:0.47%
cases:4.48%
controls:0.71%
107
287
3761
38221
111
172
3757
38336
27
53
3841
38455
31
0
3837
38508
58
35
3807
38431
150
179
3659
37637
158
246
3370
34283
Outpatient Visit
OP [9202]
OP [9202]
5.3e-01
7.0e-01
6.2e-01
6.0e+00
1.1e+00
1.4e+00
9.5e-01
cases:70.58%
controls:58.66%
cases:56.72%
controls:39.53%
cases:15.31%
controls:8.87%
cases:60.70%
controls:0.37%
cases:21.53%
controls:8.60%
cases:73.90%
controls:40.96%
cases:85.49%
controls:69.50%
2730
22587
1138
15921
2194
15224
1674
23284
592
3416
3276
35092
2348
144
1520
38364
832
3309
3033
35157
2815
15488
994
22328
3016
23998
512
10531
Sensorineural hearing loss, bilateral
H90.3 [45576850]
H90.3 [45576850]
1.3e+00
1.9e+00
1.9e+00
—
2.6e+00
2.1e+00
1.5e+00
cases:6.57%
controls:1.87%
cases:5.12%
controls:0.83%
cases:0.88%
controls:0.14%
—
—
cases:1.24%
controls:0.10%
cases:6.54%
controls:0.86%
cases:11.39%
controls:2.82%
254
722
3614
37786
198
319
3670
38189
34
52
3834
38456
—
48
37
3817
38429
249
325
3560
37491
402
974
3126
33555
Benign paroxysmal vertigo
H81.1 [45572061]
H81.1 [45572061]
2.3e+00
3.6e+00
—
—
—
3.3e+00
1.8e+00
cases:3.28%
controls:0.33%
cases:3.62%
controls:0.10%
—
—
—
—
—
—
cases:2.76%
controls:0.10%
cases:3.17%
controls:0.52%
127
128
3741
38380
140
40
3728
38468
—
—
—
105
38
3704
37778
112
181
3416
34348
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
3.3e-01
8.2e-01
1.4e+00
5.4e+00
1.9e+00
6.8e-01
5.2e-01
cases:9.13%
controls:6.76%
cases:4.68%
controls:2.12%
cases:1.03%
controls:0.25%
cases:2.66%
controls:0.01%
cases:1.86%
controls:0.30%
cases:4.12%
controls:2.14%
cases:11.11%
controls:6.90%
353
2605
3515
35903
181
815
3687
37693
40
96
3828
38412
103
5
3765
38503
72
114
3793
38352
157
808
3652
37008
392
2381
3136
32148
Emergency Room Visit
ER [9203]
ER [9203]
4.0e-01
8.9e-01
1.8e+00
5.9e+00
9.8e-01
5.0e-01
4.9e-01
cases:35.01%
controls:26.45%
cases:20.53%
controls:9.62%
cases:7.01%
controls:1.18%
cases:12.77%
controls:0.04%
cases:3.36%
controls:1.28%
cases:14.70%
controls:9.44%
cases:39.06%
controls:28.10%
1354
10184
2514
28324
794
3705
3074
34803
271
454
3597
38054
494
16
3374
38492
130
494
3735
37972
560
3571
3249
34245
1378
9702
2150
24827
Vertiginous syndrome
H82 [2002000537]
H82 [2002000537]
2.4e+00
2.9e+00
—
—
—
2.9e+00
2.3e+00
cases:0.52%
controls:0.05%
cases:0.44%
controls:0.02%
—
—
—
—
—
—
cases:0.34%
controls:0.02%
cases:0.77%
controls:0.08%
20
19
3848
38489
17
9
3851
38499
—
—
—
13
7
3796
37809
27
27
3501
34502
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
8.8e-01
1.6e+00
2.3e+00
—
2.8e+00
1.7e+00
1.3e+00
cases:6.00%
controls:2.57%
cases:5.20%
controls:1.10%
cases:1.40%
controls:0.15%
—
—
cases:2.72%
controls:0.18%
cases:5.33%
controls:1.03%
cases:9.81%
controls:2.97%
232
990
3636
37518
201
424
3667
38084
54
57
3814
38451
—
105
68
3760
38398
203
388
3606
37428
346
1026
3182
33503
Acoustic channel extensive MRI examination with high intensity magnet
DE2CG [2001301607]
DE2CG [2001301607]
3.0e+00
—
—
1.0e+50
—
4.2e+00
2.7e+00
cases:0.75%
controls:0.04%
—
—
—
—
cases:0.88%
controls:0.00%
—
—
cases:1.02%
controls:0.02%
cases:0.85%
controls:0.06%
29
14
3839
38494
—
—
34
0
3834
38508
—
39
6
3770
37810
30
19
3498
34510
Emergency Medicine
93 [38004510]
93 [38004510]
2.8e-01
5.9e-01
1.6e+00
5.8e+00
9.3e-01
4.3e-01
3.1e-01
cases:9.57%
controls:7.42%
cases:7.01%
controls:4.01%
cases:2.46%
controls:0.51%
cases:4.24%
controls:0.01%
cases:1.42%
controls:0.57%
cases:6.48%
controls:4.33%
cases:16.75%
controls:12.90%
370
2857
3498
35651
271
1544
3597
36964
95
197
3773
38311
164
5
3704
38503
55
218
3810
38248
247
1637
3562
36179
591
4454
2937
30075
Insertion of ventilating tube through tympanic membrane
DCA20 [2001301563]
DCA20 [2001301563]
1.7e+00
2.3e+00
—
—
—
3.2e+00
2.5e+00
cases:0.23%
controls:0.04%
cases:0.16%
controls:0.02%
—
—
—
—
—
—
cases:0.50%
controls:0.02%
cases:0.68%
controls:0.06%
9
17
3859
38491
6
6
3862
38502
—
—
—
19
8
3790
37808
24
19
3504
34510
Acoustic channel MRI examination with high intensity magnet
DE2BG [2001301604]
DE2BG [2001301604]
2.8e+00
—
—
1.0e+50
—
3.6e+00
2.8e+00
cases:0.52%
controls:0.03%
—
—
—
—
cases:0.54%
controls:0.00%
—
—
cases:0.68%
controls:0.02%
cases:0.54%
controls:0.03%
20
12
3848
38496
—
—
21
0
3847
38508
—
26
7
3783
37809
19
11
3509
34518
Hearing loss, unspecified
H91.9 [45547996]
H91.9 [45547996]
1.4e+00
2.5e+00
—
1.0e+50
2.5e+00
1.6e+00
1.0e+00
cases:1.01%
controls:0.25%
cases:1.34%
controls:0.11%
—
—
cases:0.21%
controls:0.00%
cases:0.16%
controls:0.01%
cases:0.50%
controls:0.10%
cases:1.08%
controls:0.39%
39
97
3829
38411
52
42
3816
38466
—
8
0
3860
38508
6
5
3859
38461
19
38
3790
37778
38
135
3490
34394
Fitting and adjustment of hearing aid
Z46.1 [45595518]
Z46.1 [45595518]
1.1e+00
9.8e-01
—
—
2.8e+00
2.4e+00
1.4e+00
cases:1.37%
controls:0.45%
cases:0.49%
controls:0.18%
—
—
—
—
cases:0.28%
controls:0.02%
cases:1.84%
controls:0.16%
cases:3.12%
controls:0.75%
53
173
3815
38335
19
71
3849
38437
—
—
11
7
3854
38459
70
62
3739
37754
110
260
3418
34269
Hearing complaint
H02 [2002000476]
H02 [2002000476]
1.2e+00
2.4e+00
2.6e+00
—
1.7e+00
5.9e-01
8.7e-01
cases:3.02%
controls:0.97%
cases:3.46%
controls:0.32%
cases:0.47%
controls:0.04%
—
—
cases:0.21%
controls:0.04%
cases:0.74%
controls:0.41%
cases:3.37%
controls:1.44%
117
372
3751
38136
134
125
3734
38383
18
14
3850
38494
—
8
14
3857
38452
28
154
3781
37662
119
496
3409
34033
Other minor procedure in surgery of ear, nose and larynx
TDW99 [2001301879]
TDW99 [2001301879]
1.5e+00
2.7e+00
—
1.0e+50
—
2.5e+00
2.0e+00
cases:0.72%
controls:0.16%
cases:0.57%
controls:0.04%
—
—
cases:0.49%
controls:0.00%
—
—
cases:0.55%
controls:0.05%
cases:0.88%
controls:0.12%
28
60
3840
38448
22
15
3846
38493
—
19
0
3849
38508
—
21
18
3788
37798
31
43
3497
34486
Inpatient Hospital
21 [8717]
21 [8717]
2.6e-01
4.7e-01
9.7e-01
5.1e+00
1.0e+00
3.9e-01
3.9e-01
cases:36.22%
controls:30.50%
cases:15.28%
controls:10.14%
cases:3.57%
controls:1.38%
cases:9.44%
controls:0.06%
cases:3.57%
controls:1.34%
cases:13.49%
controls:9.51%
cases:34.01%
controls:25.92%
1401
11746
2467
26762
591
3905
3277
34603
138
531
3730
37977
365
24
3503
38484
138
516
3727
37950
514
3598
3295
34218
1200
8950
2328
25579
Speech audiometry
252592009 [4091138]
252592009 [4091138]
1.6e+00
1.8e+00
—
1.0e+50
—
2.5e+00
2.1e+00
cases:0.85%
controls:0.18%
cases:0.54%
controls:0.09%
—
—
cases:0.80%
controls:0.00%
—
—
cases:0.92%
controls:0.08%
cases:2.38%
controls:0.31%
33
69
3835
38439
21
35
3847
38473
—
31
0
3837
38508
—
35
29
3774
37787
84
106
3444
34423
Tension-type headache
G44.2 [45581495]
G44.2 [45581495]
7.2e-01
1.3e+00
2.1e+00
—
1.6e+00
1.0e+00
9.5e-01
cases:2.25%
controls:1.10%
cases:1.32%
controls:0.37%
cases:0.16%
controls:0.02%
—
—
cases:0.28%
controls:0.06%
cases:0.92%
controls:0.33%
cases:3.23%
controls:1.28%
87
425
3781
38083
51
143
3817
38365
6
7
3862
38501
—
11
23
3854
38443
35
123
3774
37693
114
441
3414
34088
General Practice
1 [38004446]
1 [38004446]
1.7e-01
4.0e-01
8.9e-01
4.9e+00
1.2e+00
2.3e-01
2.2e-01
cases:10.86%
controls:9.28%
cases:5.56%
controls:3.81%
cases:1.40%
controls:0.58%
cases:3.13%
controls:0.02%
cases:1.97%
controls:0.62%
cases:5.17%
controls:4.15%
cases:14.94%
controls:12.33%
420
3573
3448
34935
215
1468
3653
37040
54
222
3814
38286
121
9
3747
38499
76
237
3789
38229
197
1569
3612
36247
527
4258
3001
30271
Other healthcare associate professional
Z3229 [2001311561]
Z3229 [2001311561]
7.4e-01
1.4e+00
1.6e+00
—
1.9e+00
2.1e+00
1.5e+00
cases:1.55%
controls:0.74%
cases:0.98%
controls:0.25%
cases:0.13%
controls:0.03%
—
—
cases:0.31%
controls:0.05%
cases:1.97%
controls:0.24%
cases:3.34%
controls:0.79%
60
286
3808
38222
38
98
3830
38410
5
10
3863
38498
—
12
18
3853
38448
75
89
3734
37727
118
272
3410
34257
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
2.2e-01
4.1e-01
1.0e+00
4.8e+00
7.4e-01
2.6e-01
3.2e-01
cases:8.17%
controls:6.68%
cases:4.91%
controls:3.33%
cases:1.24%
controls:0.46%
cases:1.63%
controls:0.01%
cases:1.01%
controls:0.48%
cases:4.49%
controls:3.51%
cases:13.80%
controls:10.45%
316
2571
3552
35937
190
1281
3678
37227
48
177
3820
38331
63
5
3805
38503
39
186
3826
38280
171
1329
3638
36487
487
3608
3041
30921
Internal Medicine
11 [38004456]
11 [38004456]
3.2e-01
4.7e-01
9.5e-01
4.4e+00
6.8e-01
3.5e-01
3.6e-01
cases:25.59%
controls:19.93%
cases:12.82%
controls:8.43%
cases:3.75%
controls:1.48%
cases:4.58%
controls:0.06%
cases:2.82%
controls:1.45%
cases:11.53%
controls:8.40%
cases:26.93%
controls:20.45%
990
7675
2878
30833
496
3246
3372
35262
145
571
3723
37937
177
23
3691
38485
109
557
3756
37909
439
3177
3370
34639
950
7062
2578
27467
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
AA1CG [2001300116]
7.6e-01
1.6e+00
—
1.0e+50
2.0e+00
1.8e+00
8.1e-01
cases:1.03%
controls:0.49%
cases:0.83%
controls:0.17%
—
—
cases:0.39%
controls:0.00%
cases:0.16%
controls:0.02%
cases:0.87%
controls:0.14%
cases:1.25%
controls:0.56%
40
187
3828
38321
32
66
3836
38442
—
15
0
3853
38508
6
8
3859
38458
33
52
3776
37764
44
193
3484
34336
Removal wax from ear
TDA90 [2001301543]
TDA90 [2001301543]
1.2e+00
2.4e+00
—
1.0e+50
—
2.2e+00
2.2e+00
cases:0.18%
controls:0.05%
cases:0.21%
controls:0.02%
—
—
cases:0.21%
controls:0.00%
—
—
cases:0.24%
controls:0.03%
cases:0.45%
controls:0.05%
7
20
3861
38488
8
7
3860
38501
—
8
0
3860
38508
—
9
10
3800
37806
16
18
3512
34511
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
A04AA01 [21600493]
8.4e-01
1.2e+00
—
—
2.1e+00
1.5e+00
1.1e+00
cases:0.80%
controls:0.35%
cases:0.72%
controls:0.22%
—
—
—
—
cases:0.41%
controls:0.05%
cases:1.08%
controls:0.25%
cases:1.90%
controls:0.63%
31
134
3837
38374
28
83
3840
38425
—
—
16
19
3849
38447
41
93
3768
37723
67
218
3461
34311
Acoustic neuroma
D33.30 [2000501332]
D33.30 [2000501332]
2.3e+00
—
—
—
—
2.7e+00
1.8e+00
cases:0.21%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.02%
cases:0.37%
controls:0.06%
8
8
3860
38500
—
—
—
—
13
9
3796
37807
13
21
3515
34508
Outpatient Hospital
22 [8756]
22 [8756]
2.3e-01
4.1e-01
4.2e-01
4.3e+00
9.7e-01
3.9e-01
4.1e-01
cases:27.97%
controls:23.51%
cases:10.19%
controls:7.02%
cases:1.24%
controls:0.82%
cases:2.90%
controls:0.04%
cases:2.02%
controls:0.77%
cases:9.37%
controls:6.54%
cases:27.38%
controls:20.06%
1082
9054
2786
29454
394
2705
3474
35803
48
316
3820
38192
112
15
3756
38493
78
297
3787
38169
357
2472
3452
35344
966
6925
2562
27604
Presence of external hearing-aid
Z97.4 [45542504]
Z97.4 [45542504]
1.4e+00
1.3e+00
—
1.0e+50
—
2.2e+00
1.8e+00
cases:1.19%
controls:0.31%
cases:0.52%
controls:0.14%
—
—
cases:0.13%
controls:0.00%
—
—
cases:1.34%
controls:0.15%
cases:3.23%
controls:0.56%
46
118
3822
38390
20
54
3848
38454
—
5
0
3863
38508
—
51
56
3758
37760
114
192
3414
34337
hydrochlorothiazide; oral
C03AA03 [21601466]
C03AA03 [21601466]
3.4e-01
5.0e-01
6.8e-01
3.3e+00
1.1e+00
8.3e-01
5.1e-01
cases:3.18%
controls:2.28%
cases:2.40%
controls:1.47%
cases:0.72%
controls:0.37%
cases:0.36%
controls:0.01%
cases:1.03%
controls:0.35%
cases:3.31%
controls:1.46%
cases:4.59%
controls:2.81%
123
878
3745
37630
93
565
3775
37943
28
142
3840
38366
14
5
3854
38503
40
133
3825
38333
126
554
3683
37262
162
971
3366
33558
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
4.6e-01
7.7e-01
9.2e-01
2.1e+00
1.1e+00
6.2e-01
5.7e-01
cases:12.44%
controls:8.26%
cases:7.55%
controls:3.64%
cases:1.55%
controls:0.62%
cases:0.31%
controls:0.04%
cases:1.73%
controls:0.59%
cases:6.64%
controls:3.67%
cases:16.47%
controls:10.04%
481
3181
3387
35327
292
1401
3576
37107
60
240
3808
38268
12
14
3856
38494
67
227
3798
38239
253
1388
3556
36428
581
3465
2947
31064
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
4.5e-01
7.7e-01
9.2e-01
2.1e+00
1.1e+00
6.2e-01
5.7e-01
cases:12.33%
controls:8.23%
cases:7.52%
controls:3.63%
cases:1.55%
controls:0.62%
cases:0.31%
controls:0.04%
cases:1.73%
controls:0.59%
cases:6.62%
controls:3.66%
cases:16.44%
controls:9.99%
477
3170
3391
35338
291
1396
3577
37112
60
240
3808
38268
12
14
3856
38494
67
227
3798
38239
252
1383
3557
36433
580
3449
2948
31080
Systemic lupus erythematosus, unspecified
M32.9 [45553167]
M32.9 [45553167]
1.4e+00
2.3e+00
—
—
—
1.8e+00
2.1e+00
cases:0.18%
controls:0.04%
cases:0.23%
controls:0.02%
—
—
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.37%
controls:0.04%
7
17
3861
38491
9
9
3859
38499
—
—
—
8
13
3801
37803
13
15
3515
34514
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
4.0e-01
7.9e-01
5.7e-01
2.3e+00
8.5e-01
8.4e-01
5.0e-01
cases:92.04%
controls:88.55%
cases:89.25%
controls:79.07%
cases:55.30%
controls:41.23%
cases:17.99%
controls:2.16%
cases:62.02%
controls:41.19%
cases:90.42%
controls:80.32%
cases:95.07%
controls:92.11%
3560
34098
308
4410
3452
30450
416
8058
2139
15878
1729
22630
696
833
3172
37675
2397
15845
1468
22621
3444
30374
365
7442
3354
31806
174
2723
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.4e-01
3.5e-01
7.2e-01
3.5e+00
9.1e-01
3.6e-01
2.5e-01
cases:18.54%
controls:16.45%
cases:14.53%
controls:10.66%
cases:4.27%
controls:2.13%
cases:4.01%
controls:0.13%
cases:4.94%
controls:2.05%
cases:15.15%
controls:11.07%
cases:30.19%
controls:25.15%
717
6335
3151
32173
562
4104
3306
34404
165
819
3703
37689
155
49
3713
38459
191
790
3674
37676
577
4187
3232
33629
1065
8684
2463
25845
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
4.5e-02
1.3e-01
5.1e-01
4.4e+00
8.8e-01
2.5e-01
1.1e-01
cases:13.31%
controls:12.81%
cases:7.50%
controls:6.66%
cases:1.86%
controls:1.12%
cases:3.49%
controls:0.04%
cases:2.46%
controls:1.03%
cases:8.32%
controls:6.58%
cases:19.87%
controls:18.23%
515
4932
3353
33576
290
2565
3578
35943
72
432
3796
38076
135
17
3733
38491
95
397
3770
38069
317
2488
3492
35328
701
6295
2827
28234
Disorder of vestibular function, unspecified
H81.9 [45567145]
H81.9 [45567145]
3.2e+00
—
1.0e+50
1.0e+50
1.0e+50
—
2.6e+00
cases:0.31%
controls:0.01%
—
—
cases:0.31%
controls:0.00%
cases:0.18%
controls:0.00%
cases:0.16%
controls:0.00%
—
—
cases:0.71%
controls:0.05%
12
5
3856
38503
—
12
0
3856
38508
7
0
3861
38508
6
0
3859
38466
—
25
18
3503
34511
Migraine with aura [classical migraine]
G43.1 [45562086]
G43.1 [45562086]
6.7e-01
8.7e-01
2.1e+00
—
—
1.1e+00
1.1e+00
cases:0.96%
controls:0.49%
cases:0.52%
controls:0.22%
cases:0.21%
controls:0.03%
—
—
—
—
cases:0.58%
controls:0.20%
cases:1.73%
controls:0.59%
37
190
3831
38318
20
84
3848
38424
8
10
3860
38498
—
—
22
74
3787
37742
61
202
3467
34327
Extensive MRI examination of brain with 3 Tesla magnet
AA1CM [2001300117]
AA1CM [2001300117]
1.4e+00
2.8e+00
—
—
—
—
1.5e+00
cases:0.34%
controls:0.08%
cases:0.34%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.37%
controls:0.08%
13
31
3855
38477
13
8
3855
38500
—
—
—
—
13
28
3515
34501
fluticasone furoate; nasal
R01AD12 [21605053]
R01AD12 [21605053]
6.1e-01
6.9e-01
4.2e-01
2.7e+00
6.2e-01
4.7e-01
5.8e-01
cases:12.18%
controls:7.00%
cases:5.97%
controls:3.10%
cases:0.80%
controls:0.53%
cases:0.23%
controls:0.02%
cases:0.93%
controls:0.50%
cases:4.73%
controls:3.00%
cases:12.13%
controls:7.16%
471
2694
3397
35814
231
1192
3637
37316
31
204
3837
38304
9
6
3859
38502
36
193
3829
38273
180
1133
3629
36683
428
2474
3100
32055
fluticasone; nasal
R01AD08 [21605050]
R01AD08 [21605050]
6.1e-01
6.9e-01
4.2e-01
2.7e+00
6.2e-01
4.7e-01
5.8e-01
cases:12.18%
controls:7.00%
cases:5.97%
controls:3.10%
cases:0.80%
controls:0.53%
cases:0.23%
controls:0.02%
cases:0.93%
controls:0.50%
cases:4.73%
controls:3.00%
cases:12.13%
controls:7.16%
471
2694
3397
35814
231
1192
3637
37316
31
204
3837
38304
9
6
3859
38502
36
193
3829
38273
180
1133
3629
36683
428
2474
3100
32055
Ear symptom/complaint other
H29 [2002000484]
H29 [2002000484]
8.0e-01
1.6e+00
2.5e+00
—
—
5.4e-01
7.2e-01
cases:1.53%
controls:0.69%
cases:1.14%
controls:0.23%
cases:0.44%
controls:0.04%
—
—
—
—
cases:0.50%
controls:0.29%
cases:2.24%
controls:1.10%
59
266
3809
38242
44
89
3824
38419
17
14
3851
38494
—
—
19
110
3790
37706
79
379
3449
34150
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
8.7e-02
2.4e-01
6.1e-01
3.6e+00
7.6e-01
2.5e-01
1.7e-01
cases:19.60%
controls:18.27%
cases:17.45%
controls:14.21%
cases:5.09%
controls:2.84%
cases:4.19%
controls:0.12%
cases:5.61%
controls:2.70%
cases:18.69%
controls:15.22%
cases:32.85%
controls:29.18%
758
7034
3110
31474
675
5472
3193
33036
197
1092
3671
37416
162
47
3706
38461
217
1038
3648
37428
712
5757
3097
32059
1159
10077
2369
24452
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
8.0e-02
2.5e-01
6.0e-01
3.6e+00
7.7e-01
2.4e-01
1.6e-01
cases:19.67%
controls:18.44%
cases:17.81%
controls:14.40%
cases:5.20%
controls:2.91%
cases:4.14%
controls:0.12%
cases:5.77%
controls:2.77%
cases:18.85%
controls:15.42%
cases:32.77%
controls:29.38%
761
7099
3107
31409
689
5545
3179
32963
201
1122
3667
37386
160
46
3708
38462
223
1065
3642
37401
718
5832
3091
31984
1156
10144
2372
24385
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
H90.1 [45567150]
H90.1 [45567150]
2.4e+00
—
—
—
—
1.7e+00
1.5e+00
cases:0.72%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.21%
controls:0.04%
cases:0.37%
controls:0.08%
28
25
3840
38483
—
—
—
—
8
15
3801
37801
13
29
3515
34500
Nausea and vomiting
R11 [45539317]
R11 [45539317]
7.2e-01
1.6e+00
2.3e+00
1.0e+50
2.0e+00
9.1e-01
5.4e-01
cases:1.06%
controls:0.52%
cases:0.93%
controls:0.19%
cases:0.26%
controls:0.03%
cases:0.26%
controls:0.00%
cases:0.13%
controls:0.02%
cases:0.60%
controls:0.24%
cases:1.19%
controls:0.70%
41
199
3827
38309
36
73
3832
38435
10
10
3858
38498
10
0
3858
38508
5
7
3860
38459
23
92
3786
37724
42
240
3486
34289
Headache
R51.80 [2000503603]
R51.80 [2000503603]
7.6e-01
1.2e+00
1.7e+00
1.0e+50
—
8.7e-01
9.1e-01
cases:2.64%
controls:1.25%
cases:1.24%
controls:0.36%
cases:0.21%
controls:0.04%
cases:0.16%
controls:0.00%
—
—
cases:1.00%
controls:0.42%
cases:3.43%
controls:1.41%
102
481
3766
38027
48
139
3820
38369
8
15
3860
38493
6
0
3862
38508
—
38
159
3771
37657
121
486
3407
34043
Cardiac arrhythmia, unspecified
I49.9 [45581778]
I49.9 [45581778]
9.3e-01
9.1e-01
—
—
1.9e+00
9.7e-01
7.1e-01
cases:2.22%
controls:0.89%
cases:0.65%
controls:0.26%
—
—
—
—
cases:0.23%
controls:0.03%
cases:0.71%
controls:0.27%
cases:2.27%
controls:1.13%
86
344
3782
38164
25
101
3843
38407
—
—
9
13
3856
38453
27
102
3782
37714
80
389
3448
34140
Neck symptom/complaint
L01 [2002000626]
L01 [2002000626]
7.7e-01
9.8e-01
1.3e+00
—
2.1e+00
7.1e-01
7.2e-01
cases:2.22%
controls:1.04%
cases:1.09%
controls:0.41%
cases:0.13%
controls:0.03%
—
—
cases:0.28%
controls:0.03%
cases:0.74%
controls:0.36%
cases:2.95%
controls:1.46%
86
401
3782
38107
42
158
3826
38350
5
13
3863
38495
—
11
13
3854
38453
28
137
3781
37679
104
505
3424
34024
Acute suppurative otitis media
H66.0 [45572040]
H66.0 [45572040]
9.2e-01
2.0e+00
—
—
—
1.4e+00
8.9e-01
cases:0.75%
controls:0.30%
cases:0.41%
controls:0.06%
—
—
—
—
—
—
cases:0.39%
controls:0.10%
cases:1.05%
controls:0.43%
29
116
3839
38392
16
22
3852
38486
—
—
—
15
38
3794
37778
37
149
3491
34380
Ménière disease
H81.0 [45567143]
H81.0 [45567143]
5.1e+00
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
—
cases:2.53%
controls:0.02%
cases:4.06%
controls:0.00%
cases:1.63%
controls:0.00%
cases:93.56%
controls:0.00%
cases:11.82%
controls:0.00%
—
—
—
—
98
6
3770
38502
157
0
3711
38508
63
0
3805
38508
3619
0
249
38508
457
0
3408
38466
—
—
Person consulting for explanation of investigation findings
Z71.2 [45552100]
Z71.2 [45552100]
5.1e-01
5.5e-01
1.3e+00
—
1.3e+00
8.8e-01
5.1e-01
cases:4.24%
controls:2.59%
cases:1.99%
controls:1.16%
cases:0.59%
controls:0.16%
—
—
cases:0.57%
controls:0.15%
cases:3.10%
controls:1.31%
cases:6.63%
controls:4.11%
164
999
3704
37509
77
448
3791
38060
23
61
3845
38447
—
22
59
3843
38407
118
496
3691
37320
234
1418
3294
33111
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-1.1e+00
-1.3e+00
-2.5e-01
—
1.8e+00
2.7e+00
3.0e+00
cases:10.57%
controls:27.11%
cases:2.38%
controls:8.14%
cases:0.62%
controls:0.79%
—
—
cases:0.36%
controls:0.06%
cases:3.70%
controls:0.26%
cases:12.02%
controls:0.70%
409
10439
3459
28069
92
3134
3776
35374
24
305
3844
38203
—
14
22
3851
38444
141
100
3668
37716
424
240
3104
34289
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
4.1e-01
4.8e-01
8.7e-01
2.5e+00
5.9e-01
4.1e-01
3.7e-01
cases:17.11%
controls:12.04%
cases:6.33%
controls:4.02%
cases:1.19%
controls:0.50%
cases:0.16%
controls:0.01%
cases:0.88%
controls:0.49%
cases:5.99%
controls:4.06%
cases:15.99%
controls:11.66%
662
4636
3206
33872
245
1547
3623
36961
46
194
3822
38314
6
5
3862
38503
34
189
3831
38277
228
1537
3581
36279
564
4025
2964
30504
Ankylosing spondylitis
M45 [45591841]
M45 [45591841]
9.7e-01
1.4e+00
1.9e+00
1.0e+50
—
1.5e+00
1.2e+00
cases:0.67%
controls:0.26%
cases:0.47%
controls:0.12%
cases:0.16%
controls:0.02%
cases:0.21%
controls:0.00%
—
—
cases:0.47%
controls:0.11%
cases:0.82%
controls:0.24%
26
99
3842
38409
18
46
3850
38462
6
9
3862
38499
8
0
3860
38508
—
18
42
3791
37774
29
84
3499
34445
Mixed conductive and sensorineural hearing loss, bilateral
H90.6 [45601013]
H90.6 [45601013]
1.6e+00
2.0e+00
—
1.0e+50
—
1.4e+00
1.4e+00
cases:0.59%
controls:0.12%
cases:0.36%
controls:0.05%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.21%
controls:0.05%
cases:0.68%
controls:0.17%
23
47
3845
38461
14
19
3854
38489
—
5
0
3863
38508
—
8
19
3801
37797
24
59
3504
34470
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
9.1e-02
1.9e-01
5.7e-01
3.3e+00
6.7e-01
2.2e-01
1.2e-01
cases:21.35%
controls:19.87%
cases:19.34%
controls:16.53%
cases:6.05%
controls:3.53%
cases:4.19%
controls:0.17%
cases:6.42%
controls:3.38%
cases:20.92%
controls:17.59%
cases:34.50%
controls:31.81%
826
7650
3042
30858
748
6364
3120
32144
234
1358
3634
37150
162
64
3706
38444
248
1300
3617
37166
797
6651
3012
31165
1217
10984
2311
23545
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
6.9e-01
7.5e-01
1.8e+00
—
1.0e+00
8.4e-01
8.0e-01
cases:3.93%
controls:2.00%
cases:1.42%
controls:0.68%
cases:0.28%
controls:0.05%
—
—
cases:0.18%
controls:0.06%
cases:1.55%
controls:0.67%
cases:5.27%
controls:2.44%
152
771
3716
37737
55
261
3813
38247
11
18
3857
38490
—
7
25
3858
38441
59
255
3750
37561
186
842
3342
33687
Paracentesis of tympanic membrane
DCA10 [2001301562]
DCA10 [2001301562]
1.7e+00
—
—
1.0e+50
—
—
3.1e+00
cases:0.31%
controls:0.05%
—
—
—
—
cases:0.18%
controls:0.00%
—
—
—
—
cases:0.77%
controls:0.03%
12
21
3856
38487
—
—
7
0
3861
38508
—
—
27
12
3501
34517
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
9.0e-02
1.6e-01
5.3e-01
3.3e+00
5.8e-01
2.1e-01
2.1e-01
cases:14.45%
controls:13.37%
cases:13.21%
controls:11.44%
cases:4.03%
controls:2.42%
cases:2.74%
controls:0.11%
cases:3.98%
controls:2.27%
cases:14.31%
controls:11.88%
cases:25.94%
controls:22.14%
559
5150
3309
33358
511
4407
3357
34101
156
933
3712
37575
106
41
3762
38467
154
873
3711
37593
545
4494
3264
33322
915
7644
2613
26885
Pulmonary Disease
29 [38004472]
29 [38004472]
2.6e-01
2.4e-01
3.2e-01
2.7e+00
7.2e-01
4.8e-01
4.9e-01
cases:8.43%
controls:6.60%
cases:4.34%
controls:3.46%
cases:0.88%
controls:0.64%
cases:0.44%
controls:0.03%
cases:1.27%
controls:0.62%
cases:5.25%
controls:3.31%
cases:12.07%
controls:7.78%
326
2542
3542
35966
168
1333
3700
37175
34
246
3834
38262
17
11
3851
38497
49
240
3816
38226
200
1251
3609
36565
426
2688
3102
31841
fluocinolone acetonide and antiinfectives
S02CA05 [21605177]
S02CA05 [21605177]
6.8e-01
7.2e-01
—
—
2.1e+00
1.0e+00
7.8e-01
cases:0.90%
controls:0.46%
cases:0.41%
controls:0.20%
—
—
—
—
cases:0.16%
controls:0.02%
cases:0.60%
controls:0.21%
cases:1.28%
controls:0.59%
35
177
3833
38331
16
78
3852
38430
—
—
6
7
3859
38459
23
81
3786
37735
45
203
3483
34326
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
AA1BG [2001300112]
8.9e-01
1.3e+00
1.5e+00
1.0e+50
—
1.5e+00
9.3e-01
cases:1.29%
controls:0.53%
cases:0.49%
controls:0.14%
cases:0.13%
controls:0.03%
cases:0.26%
controls:0.00%
—
—
cases:0.84%
controls:0.19%
cases:1.70%
controls:0.67%
50
206
3818
38302
19
52
3849
38456
5
11
3863
38497
10
0
3858
38508
—
32
71
3777
37745
60
233
3468
34296
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
2742-5 [3034780]
3.5e-01
5.6e-01
-1.0e+50
—
2.3e+00
1.4e+00
7.7e-01
cases:0.57%
controls:0.40%
cases:0.23%
controls:0.13%
cases:0.00%
controls:0.02%
—
—
cases:0.16%
controls:0.02%
cases:0.50%
controls:0.13%
cases:1.05%
controls:0.49%
22
154
3846
38354
9
51
3859
38457
0
6
3868
38502
—
6
6
3859
38460
19
48
3790
37768
37
169
3491
34360
Temporalbone CT
DC1AD [2001301548]
DC1AD [2001301548]
1.8e+00
—
—
—
—
—
2.6e+00
cases:0.18%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.03%
7
11
3861
38497
—
—
—
—
—
16
12
3512
34517
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
6.9e-02
1.9e-01
4.3e-01
3.1e+00
5.4e-01
1.4e-01
1.1e-01
cases:22.83%
controls:21.63%
cases:21.28%
controls:18.29%
cases:6.26%
controls:4.15%
cases:4.19%
controls:0.19%
cases:6.75%
controls:4.06%
cases:21.92%
controls:19.54%
cases:36.56%
controls:34.15%
883
8330
2985
30178
823
7045
3045
31463
242
1598
3626
36910
162
75
3706
38433
261
1561
3604
36905
835
7390
2974
30426
1290
11790
2238
22739
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
6.5e-02
1.8e-01
4.3e-01
3.1e+00
5.4e-01
1.4e-01
1.0e-01
cases:22.70%
controls:21.57%
cases:21.17%
controls:18.26%
cases:6.23%
controls:4.13%
cases:4.19%
controls:0.20%
cases:6.75%
controls:4.03%
cases:21.87%
controls:19.51%
cases:36.37%
controls:34.06%
878
8308
2990
30200
819
7033
3049
31475
241
1592
3627
36916
162
76
3706
38432
261
1552
3604
36914
833
7377
2976
30439
1283
11760
2245
22769
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
6.1e-02
1.8e-01
4.3e-01
3.1e+00
5.4e-01
1.4e-01
1.0e-01
cases:22.60%
controls:21.55%
cases:21.15%
controls:18.25%
cases:6.23%
controls:4.14%
cases:4.19%
controls:0.20%
cases:6.75%
controls:4.05%
cases:21.82%
controls:19.47%
cases:36.34%
controls:34.03%
874
8297
2994
30211
818
7027
3050
31481
241
1593
3627
36915
162
76
3706
38432
261
1556
3604
36910
831
7364
2978
30452
1282
11750
2246
22779
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
6.5e-02
1.8e-01
4.3e-01
3.1e+00
5.4e-01
1.4e-01
1.0e-01
cases:22.72%
controls:21.60%
cases:21.20%
controls:18.29%
cases:6.23%
controls:4.14%
cases:4.19%
controls:0.20%
cases:6.75%
controls:4.05%
cases:21.87%
controls:19.54%
cases:36.37%
controls:34.10%
879
8318
2989
30190
820
7043
3048
31465
241
1593
3627
36915
162
76
3706
38432
261
1556
3604
36910
833
7389
2976
30427
1283
11773
2245
22756
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
6.5e-02
1.8e-01
4.3e-01
3.1e+00
5.4e-01
1.4e-01
1.0e-01
cases:22.72%
controls:21.60%
cases:21.12%
controls:18.27%
cases:6.23%
controls:4.13%
cases:4.19%
controls:0.20%
cases:6.73%
controls:4.05%
cases:21.87%
controls:19.52%
cases:36.37%
controls:34.09%
879
8317
2989
30191
817
7037
3051
31471
241
1592
3627
36916
162
76
3706
38432
260
1557
3605
36909
833
7381
2976
30435
1283
11770
2245
22759
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
6.6e-02
1.8e-01
4.3e-01
3.1e+00
5.4e-01
1.4e-01
9.8e-02
cases:22.78%
controls:21.63%
cases:21.23%
controls:18.32%
cases:6.23%
controls:4.15%
cases:4.19%
controls:0.20%
cases:6.75%
controls:4.06%
cases:21.92%
controls:19.57%
cases:36.37%
controls:34.14%
881
8329
2987
30179
821
7053
3047
31455
241
1599
3627
36909
162
76
3706
38432
261
1563
3604
36903
835
7400
2974
30416
1283
11788
2245
22741
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
6.8e-02
1.8e-01
4.3e-01
3.1e+00
5.4e-01
1.4e-01
1.0e-01
cases:22.78%
controls:21.60%
cases:21.17%
controls:18.29%
cases:6.23%
controls:4.14%
cases:4.19%
controls:0.20%
cases:6.78%
controls:4.05%
cases:21.87%
controls:19.53%
cases:36.37%
controls:34.08%
881
8318
2987
30190
819
7043
3049
31465
241
1595
3627
36913
162
77
3706
38431
262
1559
3603
36907
833
7387
2976
30429
1283
11768
2245
22761
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
R5110 [2001310246]
5.0e-01
7.0e-01
—
1.0e+50
1.7e+00
1.5e+00
1.1e+00
cases:1.34%
controls:0.82%
cases:0.62%
controls:0.31%
—
—
cases:0.16%
controls:0.00%
cases:0.21%
controls:0.04%
cases:1.47%
controls:0.34%
cases:3.49%
controls:1.18%
52
317
3816
38191
24
119
3844
38389
—
6
0
3862
38508
8
14
3857
38452
56
129
3753
37687
123
406
3405
34123
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
6.8e-02
1.4e-01
4.2e-01
3.2e+00
4.1e-01
1.2e-01
1.1e-01
cases:45.29%
controls:43.61%
cases:40.43%
controls:37.09%
cases:20.37%
controls:14.35%
cases:17.53%
controls:0.84%
cases:20.49%
controls:14.57%
cases:42.03%
controls:39.15%
cases:61.42%
controls:58.74%
1752
16795
2116
21713
1564
14284
2304
24224
788
5526
3080
32982
678
325
3190
38183
792
5606
3073
32860
1601
14805
2208
23011
2167
20282
1361
14247
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
AA1DG [2001300120]
-6.3e-02
2.1e+00
—
—
—
2.2e+00
5.6e-01
cases:0.13%
controls:0.14%
cases:0.23%
controls:0.03%
—
—
—
—
—
—
cases:0.29%
controls:0.03%
cases:0.28%
controls:0.16%
5
53
3863
38455
9
11
3859
38497
—
—
—
11
12
3798
37804
10
56
3518
34473
Otalgia
H92.0 [45596177]
H92.0 [45596177]
8.5e-01
1.4e+00
—
—
—
1.4e+00
6.9e-01
cases:0.72%
controls:0.31%
cases:0.34%
controls:0.08%
—
—
—
—
—
—
cases:0.39%
controls:0.10%
cases:0.96%
controls:0.49%
28
120
3840
38388
13
32
3855
38476
—
—
—
15
38
3794
37778
34
168
3494
34361
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
6.2e-02
1.5e-01
4.8e-01
3.0e+00
4.9e-01
1.7e-01
1.3e-01
cases:19.21%
controls:18.27%
cases:14.48%
controls:12.68%
cases:3.77%
controls:2.37%
cases:2.38%
controls:0.12%
cases:3.83%
controls:2.37%
cases:14.91%
controls:12.93%
cases:30.22%
controls:27.45%
743
7034
3125
31474
560
4884
3308
33624
146
913
3722
37595
92
46
3776
38462
148
912
3717
37554
568
4890
3241
32926
1066
9478
2462
25051
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
1.9e-01
1.4e-01
3.3e-01
3.5e+00
4.4e-01
3.4e-01
2.9e-01
cases:10.50%
controls:8.82%
cases:5.17%
controls:4.53%
cases:0.96%
controls:0.69%
cases:0.83%
controls:0.03%
cases:1.16%
controls:0.75%
cases:6.09%
controls:4.43%
cases:16.50%
controls:12.91%
406
3397
3462
35111
200
1743
3668
36765
37
266
3831
38242
32
10
3836
38498
45
290
3820
38176
232
1675
3577
36141
582
4459
2946
30070
Preparation of an aid
R5120 [2001310247]
R5120 [2001310247]
8.3e-01
6.9e-01
—
1.0e+50
—
2.4e+00
1.9e+00
cases:0.31%
controls:0.14%
cases:0.13%
controls:0.06%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.47%
controls:0.04%
cases:1.39%
controls:0.22%
12
52
3856
38456
5
25
3863
38483
—
5
0
3863
38508
—
18
17
3791
37799
49
76
3479
34453
General Surgery
2 [38004447]
2 [38004447]
3.2e-01
3.3e-01
3.3e-01
2.8e+00
4.0e-01
4.0e-01
3.0e-01
cases:24.97%
controls:19.42%
cases:8.51%
controls:6.24%
cases:1.37%
controls:0.99%
cases:0.54%
controls:0.03%
cases:1.37%
controls:0.93%
cases:9.14%
controls:6.31%
cases:22.85%
controls:17.98%
966
7477
2902
31031
329
2403
3539
36105
53
382
3815
38126
21
13
3847
38495
53
356
3812
38110
348
2387
3461
35429
806
6209
2722
28320
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
3.3e-01
5.2e-01
1.1e+00
—
9.2e-01
7.6e-01
5.0e-01
cases:7.34%
controls:5.39%
cases:3.18%
controls:1.91%
cases:0.88%
controls:0.30%
—
—
cases:0.72%
controls:0.29%
cases:3.86%
controls:1.84%
cases:9.75%
controls:6.17%
284
2076
3584
36432
123
734
3745
37774
34
116
3834
38392
—
28
111
3837
38355
147
695
3662
37121
344
2132
3184
32397
Neurosurgery
14 [38004459]
14 [38004459]
5.1e-01
6.4e-01
7.3e-01
—
1.4e+00
9.3e-01
6.4e-01
cases:3.26%
controls:1.98%
cases:1.47%
controls:0.78%
cases:0.28%
controls:0.14%
—
—
cases:0.36%
controls:0.09%
cases:1.81%
controls:0.72%
cases:3.85%
controls:2.08%
126
764
3742
37744
57
302
3811
38206
11
53
3857
38455
—
14
35
3851
38431
69
272
3740
37544
136
717
3392
33812
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
3.9e-02
1.5e-01
4.3e-01
3.1e+00
5.9e-01
8.7e-02
-4.5e-02
cases:16.55%
controls:16.02%
cases:14.30%
controls:12.52%
cases:4.29%
controls:2.82%
cases:3.10%
controls:0.15%
cases:4.71%
controls:2.65%
cases:14.31%
controls:13.28%
cases:24.77%
controls:25.62%
640
6169
3228
32339
553
4820
3315
33688
166
1087
3702
37421
120
57
3748
38451
182
1021
3683
37445
545
5021
3264
32795
874
8848
2654
25681
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
2.2e-01
7.8e-01
1.1e+00
—
1.1e+00
5.2e-01
5.3e-01
cases:3.83%
controls:3.09%
cases:2.64%
controls:1.23%
cases:0.49%
controls:0.16%
—
—
cases:0.44%
controls:0.15%
cases:2.15%
controls:1.29%
cases:7.54%
controls:4.59%
148
1188
3720
37320
102
472
3766
38036
19
62
3849
38446
—
17
56
3848
38410
82
489
3727
37327
266
1586
3262
32943
Repair work or maintenance done on the aid
R5130 [2001310248]
R5130 [2001310248]
9.3e-01
5.9e-01
-1.0e+50
1.0e+50
—
1.4e+00
1.6e+00
cases:0.44%
controls:0.17%
cases:0.16%
controls:0.09%
cases:0.00%
controls:0.02%
cases:0.13%
controls:0.00%
—
—
cases:0.50%
controls:0.12%
cases:1.42%
controls:0.28%
17
67
3851
38441
6
33
3862
38475
0
7
3868
38501
5
0
3863
38508
—
19
47
3790
37769
50
98
3478
34431
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
2.2e-01
6.2e-01
4.7e-01
1.0e+50
1.9e+00
7.7e-01
6.2e-01
cases:2.07%
controls:1.66%
cases:1.06%
controls:0.57%
cases:0.13%
controls:0.08%
cases:0.36%
controls:0.00%
cases:0.44%
controls:0.06%
cases:1.05%
controls:0.49%
cases:3.23%
controls:1.77%
80
639
3788
37869
41
221
3827
38287
5
31
3863
38477
14
0
3854
38508
17
25
3848
38441
40
184
3769
37632
114
610
3414
33919
Headache
N01 [2002000720]
N01 [2002000720]
3.6e-01
1.1e+00
1.9e+00
—
—
2.8e-01
9.0e-01
cases:0.98%
controls:0.69%
cases:0.67%
controls:0.23%
cases:0.18%
controls:0.03%
—
—
—
—
cases:0.29%
controls:0.22%
cases:1.79%
controls:0.73%
38
264
3830
38244
26
89
3842
38419
7
10
3861
38498
—
—
11
83
3798
37733
63
253
3465
34276
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
3.5e-01
6.9e-01
1.2e+00
—
9.5e-01
3.7e-01
3.4e-01
cases:5.71%
controls:4.11%
cases:3.62%
controls:1.86%
cases:0.80%
controls:0.24%
—
—
cases:0.67%
controls:0.26%
cases:2.86%
controls:1.99%
cases:9.18%
controls:6.74%
221
1582
3647
36926
140
715
3728
37793
31
93
3837
38415
—
26
100
3839
38366
109
751
3700
37065
324
2326
3204
32203
Plugged feeling ear
H13 [2002000480]
H13 [2002000480]
6.2e-01
1.4e+00
1.5e+00
—
—
2.9e-01
3.6e-01
cases:2.92%
controls:1.59%
cases:2.20%
controls:0.55%
cases:0.39%
controls:0.09%
—
—
—
—
cases:0.81%
controls:0.61%
cases:3.66%
controls:2.58%
113
613
3755
37895
85
210
3783
38298
15
34
3853
38474
—
—
31
230
3778
37586
129
891
3399
33638
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
8.2e-01
9.6e-01
—
—
—
1.1e+00
9.6e-01
cases:1.40%
controls:0.62%
cases:0.49%
controls:0.19%
—
—
—
—
—
—
cases:0.60%
controls:0.20%
cases:1.98%
controls:0.77%
54
238
3814
38270
19
73
3849
38435
—
—
—
23
76
3786
37740
70
266
3458
34263
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
-6.3e-02
3.8e-02
3.0e-01
3.2e+00
5.9e-01
1.6e-02
-2.8e-03
cases:12.69%
controls:13.41%
cases:11.53%
controls:11.15%
cases:3.46%
controls:2.60%
cases:3.00%
controls:0.12%
cases:4.22%
controls:2.39%
cases:11.92%
controls:11.75%
cases:21.80%
controls:21.85%
491
5165
3377
33343
446
4292
3422
34216
134
1000
3734
37508
116
48
3752
38460
163
918
3702
37548
454
4443
3355
33373
769
7543
2759
26986
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
1.1e-01
2.4e-01
5.6e-01
2.3e+00
4.4e-01
1.3e-01
2.5e-01
cases:16.96%
controls:15.44%
cases:8.79%
controls:7.05%
cases:2.20%
controls:1.26%
cases:0.34%
controls:0.03%
cases:1.86%
controls:1.21%
cases:7.72%
controls:6.85%
cases:20.58%
controls:16.81%
656
5946
3212
32562
340
2713
3528
35795
85
486
3783
38022
13
13
3855
38495
72
465
3793
38001
294
2591
3515
35225
726
5806
2802
28723
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
-1.2e-01
-1.4e-01
5.1e-01
3.8e+00
4.6e-01
7.6e-02
-7.9e-02
cases:3.52%
controls:3.94%
cases:1.91%
controls:2.20%
cases:0.62%
controls:0.37%
cases:0.78%
controls:0.02%
cases:0.65%
controls:0.41%
cases:2.42%
controls:2.24%
cases:5.22%
controls:5.62%
136
1517
3732
36991
74
849
3794
37659
24
144
3844
38364
30
7
3838
38501
25
158
3840
38308
92
848
3717
36968
184
1941
3344
32588
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
1.5e-01
1.2e-01
2.4e-01
3.1e+00
4.9e-01
2.7e-01
3.4e-01
cases:10.65%
controls:9.33%
cases:5.35%
controls:4.79%
cases:0.96%
controls:0.75%
cases:0.47%
controls:0.02%
cases:1.29%
controls:0.80%
cases:6.48%
controls:5.02%
cases:18.08%
controls:13.54%
412
3593
3456
34915
207
1843
3661
36665
37
289
3831
38219
18
8
3850
38500
50
306
3815
38160
247
1897
3562
35919
638
4675
2890
29854
rabeprazole; oral
A02BC04 [21600099]
A02BC04 [21600099]
5.7e-01
8.7e-01
7.8e-01
—
1.5e+00
5.6e-01
7.7e-01
cases:1.32%
controls:0.75%
cases:0.85%
controls:0.36%
cases:0.18%
controls:0.08%
—
—
cases:0.26%
controls:0.06%
cases:0.66%
controls:0.38%
cases:1.93%
controls:0.90%
51
290
3817
38218
33
138
3835
38370
7
32
3861
38476
—
10
22
3855
38444
25
142
3784
37674
68
312
3460
34217
dexrabeprazole
A02BC07 [45893509]
A02BC07 [45893509]
5.7e-01
8.7e-01
7.8e-01
—
1.5e+00
5.6e-01
7.7e-01
cases:1.32%
controls:0.75%
cases:0.85%
controls:0.36%
cases:0.18%
controls:0.08%
—
—
cases:0.26%
controls:0.06%
cases:0.66%
controls:0.38%
cases:1.93%
controls:0.90%
51
290
3817
38218
33
138
3835
38370
7
32
3861
38476
—
10
22
3855
38444
25
142
3784
37674
68
312
3460
34217
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
G45.9 [45542892]
-8.9e-04
1.2e+00
1.8e+00
—
—
8.1e-01
7.3e-01
cases:0.72%
controls:0.72%
cases:0.78%
controls:0.24%
cases:0.23%
controls:0.04%
—
—
—
—
cases:0.47%
controls:0.21%
cases:1.90%
controls:0.93%
28
279
3840
38229
30
91
3838
38417
9
15
3859
38493
—
—
18
80
3791
37736
67
320
3461
34209
Orthopedic Surgery
20 [38004465]
20 [38004465]
3.3e-01
3.8e-01
3.1e-01
2.3e+00
3.9e-01
2.9e-01
4.1e-01
cases:14.99%
controls:11.30%
cases:6.39%
controls:4.47%
cases:0.90%
controls:0.66%
cases:0.44%
controls:0.04%
cases:1.14%
controls:0.77%
cases:6.09%
controls:4.63%
cases:19.73%
controls:14.08%
580
4353
3288
34155
247
1721
3621
36787
35
256
3833
38252
17
17
3851
38491
44
297
3821
38169
232
1750
3577
36066
696
4860
2832
29669
Subjective visual disturbances
H53.1 [45557467]
H53.1 [45557467]
3.0e-01
1.2e+00
—
—
—
1.5e+00
1.0e+00
cases:0.54%
controls:0.40%
cases:0.49%
controls:0.15%
—
—
—
—
—
—
cases:0.53%
controls:0.12%
cases:1.50%
controls:0.54%
21
155
3847
38353
19
57
3849
38451
—
—
—
20
46
3789
37770
53
188
3475
34341
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
1.0e-01
3.2e-01
3.7e-01
3.0e+00
3.9e-01
2.0e-01
3.6e-01
cases:6.23%
controls:5.65%
cases:4.40%
controls:3.22%
cases:1.55%
controls:1.07%
cases:1.53%
controls:0.08%
cases:1.68%
controls:1.14%
cases:3.91%
controls:3.24%
cases:11.14%
controls:8.06%
241
2177
3627
36331
170
1241
3698
37267
60
413
3808
38095
59
31
3809
38477
65
440
3800
38026
149
1225
3660
36591
393
2782
3135
31747
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
3.1e-02
1.3e-01
3.8e-01
2.5e+00
4.5e-01
1.4e-01
7.4e-02
cases:24.41%
controls:23.85%
cases:25.23%
controls:22.78%
cases:10.39%
controls:7.38%
cases:4.86%
controls:0.41%
cases:10.82%
controls:7.20%
cases:27.25%
controls:24.61%
cases:38.95%
controls:37.20%
944
9183
2924
29325
976
8771
2892
29737
402
2840
3466
35668
188
156
3680
38352
418
2768
3447
35698
1038
9306
2771
28510
1374
12844
2154
21685
Central perforation of tympanic membrane
H72.0 [45538342]
H72.0 [45538342]
—
—
—
—
—
2.3e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.24%
controls:0.02%
cases:0.45%
controls:0.13%
—
—
—
—
—
9
9
3800
37807
16
45
3512
34484
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
2.8e-01
3.8e-01
1.9e-01
2.0e+00
-3.2e-01
4.3e-01
4.1e-01
cases:7.03%
controls:5.42%
cases:3.36%
controls:2.32%
cases:0.52%
controls:0.43%
cases:0.18%
controls:0.02%
cases:0.28%
controls:0.39%
cases:3.52%
controls:2.32%
cases:9.21%
controls:6.31%
272
2089
3596
36419
130
893
3738
37615
20
164
3848
38344
7
9
3861
38499
11
150
3854
38316
134
879
3675
36937
325
2178
3203
32351
Loudness discomfort Level (LDL)
DFF30 [2001301650]
DFF30 [2001301650]
7.1e-01
-1.0e+50
—
—
—
1.7e+00
1.8e+00
cases:0.23%
controls:0.11%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.21%
controls:0.04%
cases:0.91%
controls:0.15%
9
44
3859
38464
0
19
3868
38489
—
—
—
8
14
3801
37802
32
53
3496
34476
Adjustment or review of hearing aid
DAX00 [2001301528]
DAX00 [2001301528]
8.5e-01
4.9e-01
-1.0e+50
—
—
1.2e+00
1.4e+00
cases:0.59%
controls:0.25%
cases:0.26%
controls:0.16%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.50%
controls:0.15%
cases:2.04%
controls:0.50%
23
98
3845
38410
10
61
3858
38447
0
10
3868
38498
—
—
19
55
3790
37761
72
171
3456
34358
Other specified hearing loss
H91.8 [45533421]
H91.8 [45533421]
1.8e+00
—
1.0e+50
—
—
—
1.8e+00
cases:0.18%
controls:0.03%
—
—
cases:0.13%
controls:0.00%
—
—
—
—
—
—
cases:0.28%
controls:0.05%
7
12
3861
38496
—
5
0
3863
38508
—
—
—
10
17
3518
34512
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
ZY020 [2001311600]
1.8e-01
1.2e+00
1.3e+00
—
1.2e+00
1.3e+00
9.7e-01
cases:0.59%
controls:0.50%
cases:0.52%
controls:0.15%
cases:0.13%
controls:0.03%
—
—
cases:0.13%
controls:0.04%
cases:0.66%
controls:0.18%
cases:1.19%
controls:0.45%
23
192
3845
38316
20
59
3848
38449
5
13
3863
38495
—
5
15
3860
38451
25
69
3784
37747
42
157
3486
34372
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
7.7e-01
1.2e+00
—
—
—
1.6e+00
1.1e+00
cases:0.72%
controls:0.33%
cases:0.21%
controls:0.06%
—
—
—
—
—
—
cases:0.42%
controls:0.09%
cases:0.96%
controls:0.34%
28
129
3840
38379
8
25
3860
38483
—
—
—
16
33
3793
37783
34
116
3494
34413
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
4.8e-01
4.8e-01
5.4e-01
1.4e+00
6.1e-01
6.1e-01
6.6e-01
cases:10.44%
controls:6.72%
cases:5.74%
controls:3.63%
cases:1.32%
controls:0.77%
cases:0.13%
controls:0.03%
cases:1.47%
controls:0.81%
cases:6.72%
controls:3.78%
cases:15.08%
controls:8.42%
404
2587
3464
35921
222
1396
3646
37112
51
297
3817
38211
5
12
3863
38496
57
310
3808
38156
256
1428
3553
36388
532
2909
2996
31620
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
-1.6e-01
-7.8e-02
1.7e-01
2.8e+00
5.5e-01
-2.1e-02
2.0e-01
cases:4.32%
controls:5.03%
cases:3.70%
controls:3.98%
cases:1.06%
controls:0.89%
cases:0.70%
controls:0.04%
cases:1.50%
controls:0.87%
cases:4.17%
controls:4.26%
cases:9.75%
controls:8.15%
167
1936
3701
36572
143
1534
3725
36974
41
344
3827
38164
27
16
3841
38492
58
334
3807
38132
159
1610
3650
36206
344
2813
3184
31716
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
2.2e-01
9.0e-02
3.4e-01
3.2e+00
3.8e-01
1.9e-01
1.8e-01
cases:6.77%
controls:5.49%
cases:3.49%
controls:3.20%
cases:0.70%
controls:0.50%
cases:0.44%
controls:0.02%
cases:0.78%
controls:0.53%
cases:4.23%
controls:3.53%
cases:12.64%
controls:10.74%
262
2114
3606
36394
135
1232
3733
37276
27
191
3841
38317
17
7
3851
38501
30
204
3835
38262
161
1336
3648
36480
446
3710
3082
30819
Rhinopharyngoscopy
UDH02 [2001301680]
UDH02 [2001301680]
5.5e-01
1.1e+00
—
1.0e+50
—
1.4e+00
8.7e-01
cases:0.72%
controls:0.42%
cases:0.34%
controls:0.11%
—
—
cases:0.26%
controls:0.00%
—
—
cases:0.47%
controls:0.12%
cases:0.96%
controls:0.41%
28
162
3840
38346
13
42
3855
38466
—
10
0
3858
38508
—
18
46
3791
37770
34
140
3494
34389
Other therapy enhancing rehabilitation
R4160 [2001310240]
R4160 [2001310240]
—
—
—
—
—
1.9e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.43%
controls:0.10%
—
—
—
—
—
8
12
3801
37804
15
35
3513
34494
Paraesthesia of skin
R20.2 [45568120]
R20.2 [45568120]
5.5e-01
1.0e+00
—
—
-1.0e+50
1.3e+00
9.6e-01
cases:0.70%
controls:0.41%
cases:0.36%
controls:0.13%
—
—
—
—
cases:0.00%
controls:0.02%
cases:0.45%
controls:0.12%
cases:1.25%
controls:0.48%
27
156
3841
38352
14
49
3854
38459
—
—
0
8
3865
38458
17
46
3792
37770
44
166
3484
34363
Cervicocranial syndrome
M53.0 [45562750]
M53.0 [45562750]
5.4e-01
1.4e+00
—
—
—
1.3e+00
5.7e-01
cases:0.93%
controls:0.54%
cases:0.72%
controls:0.18%
—
—
—
—
—
—
cases:0.63%
controls:0.17%
cases:1.39%
controls:0.79%
36
209
3832
38299
28
69
3840
38439
—
—
—
24
63
3785
37753
49
272
3479
34257
Other infective otitis externa
H60.3 [45576803]
H60.3 [45576803]
1.0e+00
1.7e+00
—
—
—
—
1.6e+00
cases:0.31%
controls:0.11%
cases:0.21%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.54%
controls:0.11%
12
42
3856
38466
8
14
3860
38494
—
—
—
—
19
39
3509
34490
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
1.3e-01
1.5e-01
5.5e-01
3.3e+00
6.2e-01
2.3e-01
2.4e-01
cases:4.34%
controls:3.84%
cases:2.69%
controls:2.32%
cases:0.78%
controls:0.45%
cases:0.83%
controls:0.03%
cases:0.91%
controls:0.49%
cases:2.81%
controls:2.24%
cases:6.49%
controls:5.20%
168
1480
3700
37028
104
895
3764
37613
30
173
3838
38335
32
12
3836
38496
35
189
3830
38277
107
846
3702
36970
229
1794
3299
32735
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
2.3e-01
9.4e-02
3.1e-01
3.1e+00
4.1e-01
1.8e-01
1.7e-01
cases:6.93%
controls:5.60%
cases:3.54%
controls:3.24%
cases:0.70%
controls:0.51%
cases:0.44%
controls:0.02%
cases:0.80%
controls:0.53%
cases:4.25%
controls:3.59%
cases:12.76%
controls:10.97%
268
2157
3600
36351
137
1246
3731
37262
27
197
3841
38311
17
8
3851
38500
31
205
3834
38261
162
1357
3647
36459
450
3787
3078
30742
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
9.7e-02
2.6e-01
—
1.0e+50
1.8e+00
7.4e-01
7.1e-01
cases:2.90%
controls:2.64%
cases:0.83%
controls:0.64%
—
—
cases:0.18%
controls:0.00%
cases:0.21%
controls:0.03%
cases:0.97%
controls:0.47%
cases:4.05%
controls:2.04%
112
1015
3756
37493
32
247
3836
38261
—
7
0
3861
38508
8
13
3857
38453
37
177
3772
37639
143
706
3385
33823
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
59026-5 [40762119]
59026-5 [40762119]
—
—
—
—
-1.0e+50
2.0e+00
1.2e+00
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.01%
cases:0.18%
controls:0.02%
cases:0.45%
controls:0.14%
—
—
—
—
0
5
3865
38461
7
9
3802
37807
16
47
3512
34482
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
2.3e-01
6.0e-02
1.1e-01
2.4e+00
6.1e-02
3.2e-01
3.0e-01
cases:16.62%
controls:13.63%
cases:5.27%
controls:4.98%
cases:0.93%
controls:0.84%
cases:0.41%
controls:0.04%
cases:0.91%
controls:0.85%
cases:6.17%
controls:4.57%
cases:15.99%
controls:12.33%
643
5249
3225
33259
204
1918
3664
36590
36
322
3832
38186
16
15
3852
38493
35
328
3830
38138
235
1730
3574
36086
564
4258
2964
30271
Rheumatology
66 [38004491]
66 [38004491]
4.3e-01
5.1e-01
6.3e-01
—
8.6e-01
6.7e-01
7.2e-01
cases:3.80%
controls:2.50%
cases:2.38%
controls:1.44%
cases:0.62%
controls:0.33%
—
—
cases:0.62%
controls:0.26%
cases:2.65%
controls:1.37%
cases:5.67%
controls:2.84%
147
963
3721
37545
92
553
3776
37955
24
128
3844
38380
—
24
101
3841
38365
101
519
3708
37297
200
980
3328
33549
Puncture of maxillary antrum
TDM10 [2001301819]
TDM10 [2001301819]
7.6e-01
1.7e+00
—
—
—
1.5e+00
8.1e-01
cases:0.44%
controls:0.21%
cases:0.31%
controls:0.05%
—
—
—
—
—
—
cases:0.34%
controls:0.08%
cases:0.57%
controls:0.25%
17
79
3851
38429
12
21
3856
38487
—
—
—
13
30
3796
37786
20
87
3508
34442
mometasone; nasal
R01AD09 [21605051]
R01AD09 [21605051]
5.1e-01
7.2e-01
6.0e-01
—
9.6e-01
4.6e-01
5.5e-01
cases:11.43%
controls:7.22%
cases:5.82%
controls:2.92%
cases:0.78%
controls:0.43%
—
—
cases:1.01%
controls:0.39%
cases:4.75%
controls:3.05%
cases:13.27%
controls:8.12%
442
2781
3426
35727
225
1125
3643
37383
30
164
3838
38344
—
39
150
3826
38316
181
1152
3628
36664
468
2804
3060
31725
Impingement syndrome of shoulder
M75.4 [45553266]
M75.4 [45553266]
6.9e-01
1.2e+00
—
—
—
1.3e+00
2.8e-01
cases:0.98%
controls:0.49%
cases:0.44%
controls:0.14%
—
—
—
—
—
—
cases:0.47%
controls:0.13%
cases:0.82%
controls:0.62%
38
190
3830
38318
17
52
3851
38456
—
—
—
18
49
3791
37767
29
215
3499
34314
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
H90.7 [45567151]
H90.7 [45567151]
1.6e+00
—
—
—
—
1.8e+00
1.5e+00
cases:0.34%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.13%
controls:0.02%
cases:0.26%
controls:0.06%
13
26
3855
38482
—
—
—
—
5
8
3804
37808
9
19
3519
34510
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
8.0e-01
6.3e-01
—
—
—
1.3e+00
9.6e-01
cases:1.63%
controls:0.73%
cases:0.47%
controls:0.25%
—
—
—
—
—
—
cases:0.79%
controls:0.21%
cases:2.13%
controls:0.82%
63
283
3805
38225
18
96
3850
38412
—
—
—
30
78
3779
37738
75
284
3453
34245
Gastroscopy
UJD02 [2001304787]
UJD02 [2001304787]
4.5e-01
1.8e+00
—
—
—
1.3e+00
5.7e-01
cases:0.59%
controls:0.38%
cases:0.34%
controls:0.05%
—
—
—
—
—
—
cases:0.34%
controls:0.10%
cases:0.51%
controls:0.29%
23
147
3845
38361
13
21
3855
38487
—
—
—
13
36
3796
37780
18
100
3510
34429
acrivastine; oral
R06AX18 [21603518]
R06AX18 [21603518]
5.8e-01
6.3e-01
1.2e+00
—
7.0e-01
3.5e-01
3.7e-01
cases:11.25%
controls:6.64%
cases:4.21%
controls:2.29%
cases:0.83%
controls:0.26%
—
—
cases:0.49%
controls:0.24%
cases:2.99%
controls:2.12%
cases:8.62%
controls:6.10%
435
2556
3433
35952
163
881
3705
37627
32
100
3836
38408
—
19
94
3846
38372
114
802
3695
37014
304
2107
3224
32422
Tinnitus, ringing/buzzing ear
H03 [2002000477]
H03 [2002000477]
1.1e+00
3.1e+00
—
—
—
—
9.0e-01
cases:0.26%
controls:0.09%
cases:0.57%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.14%
10
34
3858
38474
22
10
3846
38498
—
—
—
—
12
48
3516
34481
sulfasalazine; oral, rectal
A07EC01 [21600663]
A07EC01 [21600663]
5.1e-01
5.2e-01
2.3e-01
—
8.5e-01
5.1e-01
6.8e-01
cases:1.99%
controls:1.20%
cases:1.37%
controls:0.82%
cases:0.31%
controls:0.25%
—
—
cases:0.52%
controls:0.22%
cases:1.34%
controls:0.81%
cases:2.24%
controls:1.15%
77
464
3791
38044
53
314
3815
38194
12
95
3856
38413
—
20
85
3845
38381
51
305
3758
37511
79
396
3449
34133
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
1.9e-01
5.1e-02
1.3e-01
3.1e+00
2.3e-01
1.9e-01
1.8e-01
cases:5.79%
controls:4.84%
cases:2.66%
controls:2.53%
cases:0.44%
controls:0.39%
cases:0.34%
controls:0.02%
cases:0.52%
controls:0.41%
cases:3.31%
controls:2.76%
cases:10.09%
controls:8.53%
224
1864
3644
36644
103
976
3765
37532
17
149
3851
38359
13
6
3855
38502
20
159
3845
38307
126
1044
3683
36772
356
2946
3172
31583
Vertebro-basilar artery syndrome
G45.0 [45538120]
G45.0 [45538120]
1.1e+00
2.0e+00
—
—
—
—
8.1e-01
cases:0.44%
controls:0.15%
cases:0.34%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.31%
controls:0.14%
17
57
3851
38451
13
18
3855
38490
—
—
—
—
11
48
3517
34481
Irrigation or wax removal of outer auditory canal
SPAT1033 [2001700134]
SPAT1033 [2001700134]
3.8e-01
8.9e-01
1.4e+00
—
—
4.0e-01
4.1e-01
cases:2.71%
controls:1.87%
cases:1.65%
controls:0.69%
cases:0.36%
controls:0.09%
—
—
—
—
cases:1.02%
controls:0.69%
cases:3.85%
controls:2.60%
105
719
3763
37789
64
265
3804
38243
14
35
3854
38473
—
—
39
260
3770
37556
136
898
3392
33631
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
2.2e-01
9.5e-02
3.0e-01
3.1e+00
3.5e-01
1.8e-01
1.7e-01
cases:6.95%
controls:5.68%
cases:3.62%
controls:3.30%
cases:0.70%
controls:0.52%
cases:0.44%
controls:0.02%
cases:0.78%
controls:0.55%
cases:4.31%
controls:3.62%
cases:12.87%
controls:11.03%
269
2187
3599
36321
140
1272
3728
37236
27
200
3841
38308
17
8
3851
38500
30
211
3835
38255
164
1368
3645
36448
454
3810
3074
30719
sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]
N02CC01 [21604376]
5.0e-01
5.2e-01
8.4e-01
—
6.3e-01
5.3e-01
6.5e-01
cases:3.44%
controls:2.11%
cases:1.89%
controls:1.13%
cases:0.59%
controls:0.26%
—
—
cases:0.54%
controls:0.29%
cases:1.92%
controls:1.14%
cases:3.77%
controls:2.01%
133
811
3735
37697
73
434
3795
38074
23
99
3845
38409
—
21
112
3844
38354
73
432
3736
37384
133
695
3395
33834
Lumbar puncture
TAB00 [2001300538]
TAB00 [2001300538]
3.1e-01
1.5e+00
—
—
—
1.6e+00
8.1e-01
cases:0.36%
controls:0.26%
cases:0.26%
controls:0.06%
—
—
—
—
—
—
cases:0.29%
controls:0.06%
cases:0.57%
controls:0.25%
14
102
3854
38406
10
23
3858
38485
—
—
—
11
23
3798
37793
20
87
3508
34442
Sacroiliitis, not elsewhere classified
M46.1 [45577263]
M46.1 [45577263]
1.5e+00
—
—
—
—
—
1.5e+00
cases:0.34%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.08%
13
28
3855
38480
—
—
—
—
—
12
27
3516
34502
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
9.2e-02
5.2e-01
7.0e-01
—
1.2e+00
7.0e-01
5.8e-01
cases:3.96%
controls:3.62%
cases:2.04%
controls:1.22%
cases:0.36%
controls:0.18%
—
—
cases:0.54%
controls:0.16%
cases:2.31%
controls:1.17%
cases:5.16%
controls:2.97%
153
1394
3715
37114
79
470
3789
38038
14
69
3854
38439
—
21
63
3844
38403
88
441
3721
37375
182
1025
3346
33504
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
7817-0 [3016888]
4.6e-01
1.3e+00
1.3e+00
—
1.7e+00
1.1e+00
6.5e-01
cases:0.98%
controls:0.62%
cases:0.78%
controls:0.22%
cases:0.13%
controls:0.04%
—
—
cases:0.16%
controls:0.03%
cases:0.60%
controls:0.21%
cases:1.39%
controls:0.73%
38
240
3830
38268
30
85
3838
38423
5
14
3863
38494
—
6
11
3859
38455
23
78
3786
37738
49
251
3479
34278
Excessive ear wax
H81 [2002000536]
H81 [2002000536]
4.8e-01
8.9e-01
1.6e+00
—
—
3.9e-01
2.3e-01
cases:2.33%
controls:1.46%
cases:1.47%
controls:0.61%
cases:0.26%
controls:0.05%
—
—
—
—
cases:0.84%
controls:0.57%
cases:2.75%
controls:2.21%
90
561
3778
37947
57
236
3811
38272
10
20
3858
38488
—
—
32
216
3777
37600
97
762
3431
33767
Monitoring the use of the aid
R5140 [2001310249]
R5140 [2001310249]
6.5e-01
5.1e-01
1.1e+00
—
1.5e+00
1.2e+00
1.2e+00
cases:1.40%
controls:0.73%
cases:0.59%
controls:0.36%
cases:0.13%
controls:0.04%
—
—
cases:0.16%
controls:0.03%
cases:1.18%
controls:0.38%
cases:2.98%
controls:0.95%
54
283
3814
38225
23
138
3845
38370
5
17
3863
38491
—
6
13
3859
38453
45
142
3764
37674
105
328
3423
34201
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
1.3e-01
6.0e-02
5.3e-01
2.6e+00
5.8e-01
2.4e-01
3.8e-01
cases:6.23%
controls:5.51%
cases:3.28%
controls:3.10%
cases:0.83%
controls:0.49%
cases:0.21%
controls:0.02%
cases:0.98%
controls:0.55%
cases:4.25%
controls:3.37%
cases:12.16%
controls:8.68%
241
2122
3627
36386
127
1193
3741
37315
32
188
3836
38320
8
6
3860
38502
38
213
3827
38253
162
1274
3647
36542
429
2997
3099
31532
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
7818-8 [3008230]
4.5e-01
1.3e+00
1.1e+00
—
1.5e+00
1.0e+00
6.5e-01
cases:1.09%
controls:0.69%
cases:0.85%
controls:0.24%
cases:0.13%
controls:0.04%
—
—
cases:0.16%
controls:0.03%
cases:0.63%
controls:0.22%
cases:1.56%
controls:0.82%
42
267
3826
38241
33
94
3835
38414
5
17
3863
38491
—
6
13
3859
38453
24
84
3785
37732
55
283
3473
34246
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
SPAT1223 [2001700324]
4.2e-01
5.4e-01
2.1e-01
—
9.6e-01
5.2e-01
5.1e-01
cases:4.37%
controls:2.92%
cases:2.07%
controls:1.22%
cases:0.34%
controls:0.27%
—
—
cases:0.57%
controls:0.22%
cases:1.81%
controls:1.08%
cases:6.26%
controls:3.85%
169
1126
3699
37382
80
470
3788
38038
13
105
3855
38403
—
22
84
3843
38382
69
410
3740
37406
221
1328
3307
33201
Vestibular function test
42987007 [4180728]
42987007 [4180728]
2.9e+00
—
1.0e+50
1.0e+50
1.0e+50
—
—
cases:0.62%
controls:0.03%
—
—
cases:0.21%
controls:0.00%
cases:2.02%
controls:0.00%
cases:0.31%
controls:0.00%
—
—
—
—
24
13
3844
38495
—
8
0
3860
38508
78
0
3790
38508
12
0
3853
38466
—
—
pseudoephedrine, combinations; oral
R01BA52 [21603213]
R01BA52 [21603213]
5.0e-01
6.8e-01
1.0e+00
—
7.2e-01
3.3e-01
3.8e-01
cases:14.50%
controls:9.32%
cases:5.79%
controls:3.03%
cases:0.96%
controls:0.35%
—
—
cases:0.67%
controls:0.33%
cases:4.02%
controls:2.92%
cases:11.79%
controls:8.35%
561
3590
3307
34918
224
1167
3644
37341
37
133
3831
38375
—
26
126
3839
38340
153
1106
3656
36710
416
2883
3112
31646
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
C50.41 [2000501002]
C50.41 [2000501002]
1.8e-02
1.4e-02
4.4e-01
2.9e+00
7.7e-01
2.7e-01
2.6e-01
cases:0.83%
controls:0.81%
cases:0.57%
controls:0.56%
cases:0.26%
controls:0.17%
cases:0.23%
controls:0.01%
cases:0.34%
controls:0.16%
cases:0.74%
controls:0.56%
cases:1.28%
controls:0.98%
32
313
3836
38195
22
216
3846
38292
10
64
3858
38444
9
5
3859
38503
13
60
3852
38406
28
212
3781
37604
45
340
3483
34189
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
2.7e-01
3.4e-01
2.4e-01
1.7e+00
2.6e-01
3.0e-01
3.0e-01
cases:34.33%
controls:28.52%
cases:17.40%
controls:13.07%
cases:2.43%
controls:1.93%
cases:0.28%
controls:0.05%
cases:2.35%
controls:1.83%
cases:16.83%
controls:13.06%
cases:37.98%
controls:31.19%
1328
10982
2540
27526
673
5034
3195
33474
94
743
3774
37765
11
21
3857
38487
91
703
3774
37763
641
4939
3168
32877
1340
10768
2188
23761
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
2.7e-01
3.4e-01
2.4e-01
1.7e+00
2.6e-01
3.0e-01
3.0e-01
cases:34.33%
controls:28.52%
cases:17.40%
controls:13.07%
cases:2.43%
controls:1.93%
cases:0.28%
controls:0.05%
cases:2.35%
controls:1.83%
cases:16.83%
controls:13.06%
cases:37.98%
controls:31.19%
1328
10982
2540
27526
673
5034
3195
33474
94
743
3774
37765
11
21
3857
38487
91
703
3774
37763
641
4939
3168
32877
1340
10768
2188
23761
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
1.3e-01
5.3e-02
6.2e-01
2.5e+00
5.4e-01
2.7e-01
3.8e-01
cases:5.46%
controls:4.82%
cases:2.87%
controls:2.73%
cases:0.72%
controls:0.39%
cases:0.16%
controls:0.01%
cases:0.80%
controls:0.47%
cases:3.70%
controls:2.86%
cases:10.40%
controls:7.37%
211
1855
3657
36653
111
1050
3757
37458
28
150
3840
38358
6
5
3862
38503
31
181
3834
38285
141
1080
3668
36736
367
2545
3161
31984
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
4.9e-01
4.9e-01
—
—
—
1.0e+00
1.3e+00
cases:1.89%
controls:1.17%
cases:0.59%
controls:0.37%
—
—
—
—
—
—
cases:0.74%
controls:0.26%
cases:2.55%
controls:0.70%
73
449
3795
38059
23
141
3845
38367
—
—
—
28
100
3781
37716
90
240
3438
34289
FEV1
20150-9 [3024653]
20150-9 [3024653]
4.9e-01
4.9e-01
—
—
—
1.0e+00
1.3e+00
cases:1.89%
controls:1.17%
cases:0.59%
controls:0.37%
—
—
—
—
—
—
cases:0.74%
controls:0.26%
cases:2.55%
controls:0.70%
73
449
3795
38059
23
141
3845
38367
—
—
—
28
100
3781
37716
90
240
3438
34289
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
4.9e-01
4.9e-01
—
—
—
1.0e+00
1.3e+00
cases:1.89%
controls:1.17%
cases:0.59%
controls:0.37%
—
—
—
—
—
—
cases:0.74%
controls:0.26%
cases:2.55%
controls:0.70%
73
449
3795
38059
23
141
3845
38367
—
—
—
28
100
3781
37716
90
240
3438
34289
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
2.2e-01
3.9e-01
-5.3e-02
—
1.2e+00
6.7e-01
5.7e-01
cases:6.54%
controls:5.33%
cases:2.22%
controls:1.51%
cases:0.16%
controls:0.16%
—
—
cases:0.41%
controls:0.13%
cases:2.55%
controls:1.32%
cases:8.05%
controls:4.71%
253
2051
3615
36457
86
583
3782
37925
6
63
3862
38445
—
16
49
3849
38417
97
499
3712
37317
284
1627
3244
32902
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
E11.8 [45561951]
-4.5e-03
-3.2e-01
4.3e-01
2.8e+00
—
1.1e-01
6.4e-02
cases:0.83%
controls:0.83%
cases:0.31%
controls:0.43%
cases:0.16%
controls:0.10%
cases:0.26%
controls:0.02%
—
—
cases:0.55%
controls:0.49%
cases:1.62%
controls:1.52%
32
320
3836
38188
12
165
3856
38343
6
39
3862
38469
10
6
3858
38502
—
21
186
3788
37630
57
524
3471
34005
Alzheimer disease with late onset
G30.1 [45552521]
G30.1 [45552521]
-3.4e-01
3.3e-03
3.8e-01
2.8e+00
9.1e-01
-6.7e-02
-3.9e-01
cases:0.34%
controls:0.47%
cases:0.34%
controls:0.33%
cases:0.13%
controls:0.09%
cases:0.26%
controls:0.02%
cases:0.18%
controls:0.07%
cases:0.34%
controls:0.36%
cases:0.71%
controls:1.04%
13
181
3855
38327
13
129
3855
38379
5
34
3863
38474
10
6
3858
38502
7
28
3858
38438
13
138
3796
37678
25
360
3503
34169
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
4.7e-01
2.1e-01
—
—
—
1.0e+00
1.3e+00
cases:1.65%
controls:1.04%
cases:0.39%
controls:0.31%
—
—
—
—
—
—
cases:0.63%
controls:0.22%
cases:2.24%
controls:0.62%
64
401
3804
38107
15
121
3853
38387
—
—
—
24
85
3785
37731
79
213
3449
34316
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
4.7e-01
2.1e-01
—
—
—
1.0e+00
1.3e+00
cases:1.65%
controls:1.04%
cases:0.39%
controls:0.31%
—
—
—
—
—
—
cases:0.63%
controls:0.22%
cases:2.24%
controls:0.62%
64
401
3804
38107
15
121
3853
38387
—
—
—
24
85
3785
37731
79
213
3449
34316
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
4.7e-01
2.1e-01
—
—
—
1.0e+00
1.3e+00
cases:1.65%
controls:1.04%
cases:0.39%
controls:0.31%
—
—
—
—
—
—
cases:0.63%
controls:0.22%
cases:2.24%
controls:0.62%
64
401
3804
38107
15
121
3853
38387
—
—
—
24
85
3785
37731
79
213
3449
34316
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
4.7e-01
2.1e-01
—
—
—
1.0e+00
1.3e+00
cases:1.65%
controls:1.04%
cases:0.39%
controls:0.31%
—
—
—
—
—
—
cases:0.63%
controls:0.22%
cases:2.24%
controls:0.62%
64
401
3804
38107
15
121
3853
38387
—
—
—
24
85
3785
37731
79
213
3449
34316
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
4.7e-01
2.1e-01
—
—
—
1.0e+00
1.3e+00
cases:1.65%
controls:1.04%
cases:0.39%
controls:0.31%
—
—
—
—
—
—
cases:0.63%
controls:0.22%
cases:2.24%
controls:0.62%
64
401
3804
38107
15
121
3853
38387
—
—
—
24
85
3785
37731
79
213
3449
34316
Fitting of hearing aid
DAX08 [2001301529]
DAX08 [2001301529]
6.1e-01
3.1e-01
—
—
—
1.7e+00
1.0e+00
cases:0.41%
controls:0.23%
cases:0.18%
controls:0.13%
—
—
—
—
—
—
cases:0.50%
controls:0.09%
cases:1.45%
controls:0.52%
16
87
3852
38421
7
51
3861
38457
—
—
—
19
33
3790
37783
51
178
3477
34351
Vestibular neuronitis
H81.2 [45562323]
H81.2 [45562323]
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
2.8e+00
—
—
cases:0.93%
controls:0.00%
cases:0.47%
controls:0.00%
cases:0.47%
controls:0.00%
cases:0.28%
controls:0.00%
—
—
cases:0.37%
controls:0.02%
—
36
0
3832
38508
18
0
3850
38508
18
0
3850
38508
11
0
3854
38466
—
13
8
3515
34521
Syncope and collapse
R55 [45568141]
R55 [45568141]
2.9e-01
5.0e-01
1.8e+00
—
9.1e-01
9.3e-01
4.6e-01
cases:1.24%
controls:0.93%
cases:0.52%
controls:0.31%
cases:0.23%
controls:0.04%
—
—
cases:0.13%
controls:0.05%
cases:0.74%
controls:0.29%
cases:1.76%
controls:1.12%
48
357
3820
38151
20
121
3848
38387
9
15
3859
38493
—
5
20
3860
38446
28
110
3781
37706
62
386
3466
34143
ranitidine; oral, parenteral
A02BA02 [21600083]
A02BA02 [21600083]
4.3e-01
7.5e-01
3.9e-01
—
4.3e-01
8.4e-01
6.9e-01
cases:3.96%
controls:2.60%
cases:1.73%
controls:0.83%
cases:0.23%
controls:0.16%
—
—
cases:0.21%
controls:0.14%
cases:1.79%
controls:0.78%
cases:3.34%
controls:1.71%
153
1000
3715
37508
67
319
3801
38189
9
61
3859
38447
—
8
52
3857
38414
68
295
3741
37521
118
590
3410
33939
ranitidine bismuth citrate; oral
A02BA07 [21600088]
A02BA07 [21600088]
4.3e-01
7.5e-01
3.9e-01
—
4.3e-01
8.4e-01
6.9e-01
cases:3.96%
controls:2.60%
cases:1.73%
controls:0.83%
cases:0.23%
controls:0.16%
—
—
cases:0.21%
controls:0.14%
cases:1.79%
controls:0.78%
cases:3.34%
controls:1.71%
153
1000
3715
37508
67
319
3801
38189
9
61
3859
38447
—
8
52
3857
38414
68
295
3741
37521
118
590
3410
33939
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
2.4e-01
5.1e-02
1.7e-01
2.7e+00
4.6e-01
2.2e-01
1.2e-01
cases:5.79%
controls:4.60%
cases:2.56%
controls:2.44%
cases:0.49%
controls:0.42%
cases:0.23%
controls:0.02%
cases:0.62%
controls:0.39%
cases:3.36%
controls:2.72%
cases:9.55%
controls:8.53%
224
1772
3644
36736
99
938
3769
37570
19
160
3849
38348
9
6
3859
38502
24
151
3841
38315
128
1028
3681
36788
337
2944
3191
31585
Pain in thoracic spine
M54.6 [45606247]
M54.6 [45606247]
5.3e-01
5.6e-01
2.0e+00
—
—
8.5e-01
6.8e-01
cases:0.80%
controls:0.47%
cases:0.31%
controls:0.18%
cases:0.16%
controls:0.02%
—
—
—
—
cases:0.39%
controls:0.17%
cases:1.19%
controls:0.61%
31
182
3837
38326
12
68
3856
38440
6
8
3862
38500
—
—
15
64
3794
37752
42
209
3486
34320
hyoscyamine; oral
A03BA03 [21600193]
A03BA03 [21600193]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.02%
—
—
—
—
—
—
9
6
3519
34523
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
4.0e-01
4.1e-01
2.4e-01
—
8.1e-01
4.6e-01
6.0e-01
cases:3.90%
controls:2.66%
cases:2.51%
controls:1.68%
cases:0.44%
controls:0.35%
—
—
cases:0.78%
controls:0.35%
cases:2.86%
controls:1.83%
cases:6.69%
controls:3.78%
151
1023
3717
37485
97
646
3771
37862
17
133
3851
38375
—
30
133
3835
38333
109
691
3700
37125
236
1306
3292
33223
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
2.8e-01
3.4e-01
5.6e-01
1.5e+00
6.7e-01
4.5e-01
3.8e-01
cases:13.37%
controls:10.47%
cases:7.21%
controls:5.24%
cases:1.29%
controls:0.74%
cases:0.13%
controls:0.03%
cases:1.37%
controls:0.71%
cases:8.16%
controls:5.37%
cases:20.72%
controls:15.16%
517
4030
3351
34478
279
2018
3589
36490
50
285
3818
38223
5
11
3863
38497
53
273
3812
38193
311
2031
3498
35785
731
5235
2797
29294
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
4.8e-01
5.2e-01
1.2e-01
—
7.5e-01
4.9e-01
4.2e-01
cases:6.28%
controls:3.97%
cases:2.95%
controls:1.77%
cases:0.41%
controls:0.37%
—
—
cases:0.70%
controls:0.33%
cases:2.91%
controls:1.81%
cases:6.07%
controls:4.09%
243
1527
3625
36981
114
680
3754
37828
16
142
3852
38366
—
27
127
3838
38339
111
683
3698
37133
214
1411
3314
33118
Consultation of another employee
SPAT1260 [2001700361]
SPAT1260 [2001700361]
3.8e-01
5.4e-01
1.1e+00
—
1.6e+00
6.2e-01
4.8e-01
cases:2.22%
controls:1.53%
cases:1.06%
controls:0.62%
cases:0.21%
controls:0.07%
—
—
cases:0.23%
controls:0.05%
cases:1.02%
controls:0.56%
cases:3.32%
controls:2.08%
86
589
3782
37919
41
239
3827
38269
8
26
3860
38482
—
9
19
3856
38447
39
210
3770
37606
117
718
3411
33811
azithromycin; oral, parenteral
J01FA10 [21602978]
J01FA10 [21602978]
4.0e-01
4.4e-01
9.7e-01
—
4.6e-01
4.3e-01
4.0e-01
cases:12.98%
controls:9.08%
cases:3.90%
controls:2.55%
cases:0.65%
controls:0.25%
—
—
cases:0.34%
controls:0.21%
cases:3.70%
controls:2.44%
cases:10.86%
controls:7.51%
502
3498
3366
35010
151
981
3717
37527
25
95
3843
38413
—
13
82
3852
38384
141
924
3668
36892
383
2594
3145
31935
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 [3007368]
2464-6 [3007368]
4.8e-01
2.6e+00
—
—
—
1.5e+00
1.2e+00
cases:0.16%
controls:0.10%
cases:0.18%
controls:0.01%
—
—
—
—
—
—
cases:0.13%
controls:0.03%
cases:0.20%
controls:0.06%
6
37
3862
38471
7
5
3861
38503
—
—
—
5
11
3804
37805
7
20
3521
34509
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 [3024474]
1746-7 [3024474]
5.4e-01
2.6e+00
—
—
—
1.5e+00
1.3e+00
cases:0.16%
controls:0.09%
cases:0.18%
controls:0.01%
—
—
—
—
—
—
cases:0.13%
controls:0.03%
cases:0.20%
controls:0.05%
6
35
3862
38473
7
5
3861
38503
—
—
—
5
11
3804
37805
7
18
3521
34511
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
2.3e-01
3.5e-01
4.5e-01
—
1.5e+00
6.6e-01
4.4e-01
cases:4.01%
controls:3.22%
cases:1.68%
controls:1.19%
cases:0.23%
controls:0.15%
—
—
cases:0.65%
controls:0.14%
cases:2.00%
controls:1.04%
cases:5.07%
controls:3.33%
155
1240
3713
37268
65
459
3803
38049
9
57
3859
38451
—
25
55
3840
38411
76
393
3733
37423
179
1149
3349
33380
General symptoms, Dizziness and giddiness
7804A [2000406894]
7804A [2000406894]
2.6e+00
—
—
—
—
—
—
cases:0.39%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
—
—
15
11
3853
38497
—
—
—
—
—
—
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
6.4e-01
4.9e-01
—
—
—
1.2e+00
7.7e-01
cases:1.29%
controls:0.69%
cases:0.34%
controls:0.21%
—
—
—
—
—
—
cases:0.53%
controls:0.16%
cases:1.73%
controls:0.81%
50
264
3818
38244
13
79
3855
38429
—
—
—
20
60
3789
37756
61
279
3467
34250
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
4.6e-01
4.9e-01
6.5e-01
—
6.7e-01
5.0e-01
4.9e-01
cases:7.06%
controls:4.58%
cases:3.44%
controls:2.14%
cases:0.78%
controls:0.41%
—
—
cases:0.83%
controls:0.43%
cases:3.57%
controls:2.21%
cases:8.08%
controls:5.09%
273
1764
3595
36744
133
823
3735
37685
30
156
3838
38352
—
32
164
3833
38302
136
834
3673
36982
285
1759
3243
32770
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
14744-7 [3020044]
3.0e-01
1.6e+00
—
—
—
1.2e+00
9.9e-01
cases:0.26%
controls:0.19%
cases:0.26%
controls:0.05%
—
—
—
—
—
—
cases:0.21%
controls:0.06%
cases:0.57%
controls:0.21%
10
74
3858
38434
10
20
3858
38488
—
—
—
8
23
3801
37793
20
73
3508
34456
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
N04AB02 [21604458]
4.4e-01
4.1e-01
5.4e-01
—
8.5e-01
4.2e-01
4.7e-01
cases:8.43%
controls:5.62%
cases:2.64%
controls:1.77%
cases:0.41%
controls:0.24%
—
—
cases:0.57%
controls:0.24%
cases:2.81%
controls:1.87%
cases:9.16%
controls:5.91%
326
2163
3542
36345
102
680
3766
37828
16
93
3852
38415
—
22
94
3843
38372
107
706
3702
37110
323
2042
3205
32487
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
M03BC01 [21604112]
4.4e-01
4.1e-01
5.4e-01
—
8.5e-01
4.2e-01
4.7e-01
cases:8.43%
controls:5.62%
cases:2.64%
controls:1.77%
cases:0.41%
controls:0.24%
—
—
cases:0.57%
controls:0.24%
cases:2.81%
controls:1.87%
cases:9.16%
controls:5.91%
326
2163
3542
36345
102
680
3766
37828
16
93
3852
38415
—
22
94
3843
38372
107
706
3702
37110
323
2042
3205
32487
Chronic maxillary sinusitis
J32.0 [45586667]
J32.0 [45586667]
7.5e-01
8.7e-01
—
—
—
1.1e+00
7.1e-01
cases:1.22%
controls:0.58%
cases:0.41%
controls:0.17%
—
—
—
—
—
—
cases:0.68%
controls:0.22%
cases:1.39%
controls:0.69%
47
223
3821
38285
16
67
3852
38441
—
—
—
26
85
3783
37731
49
237
3479
34292
Low back symptom/complaint
L03 [2002000628]
L03 [2002000628]
4.4e-01
5.7e-01
1.2e+00
—
6.6e-01
4.4e-01
4.1e-01
cases:3.34%
controls:2.18%
cases:1.42%
controls:0.81%
cases:0.36%
controls:0.11%
—
—
cases:0.21%
controls:0.11%
cases:1.34%
controls:0.87%
cases:5.10%
controls:3.44%
129
838
3739
37670
55
313
3813
38195
14
44
3854
38464
—
8
41
3857
38425
51
329
3758
37487
180
1188
3348
33341
Sensorineural hearing loss, unspecified
H90.5 [45547994]
H90.5 [45547994]
1.4e+00
2.6e+00
—
1.0e+50
—
—
9.3e-01
cases:0.23%
controls:0.06%
cases:0.34%
controls:0.03%
—
—
cases:0.23%
controls:0.00%
—
—
—
—
cases:0.20%
controls:0.08%
9
22
3859
38486
13
10
3855
38498
—
9
0
3859
38508
—
—
7
27
3521
34502
Limited function/disability (H)
H28 [2002000483]
H28 [2002000483]
1.2e+00
2.6e+00
—
—
—
—
1.1e+00
cases:0.16%
controls:0.05%
cases:0.23%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.17%
controls:0.06%
6
18
3862
38490
9
7
3859
38501
—
—
—
—
6
20
3522
34509
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
M51.1 [45562747]
4.8e-01
7.4e-01
9.4e-01
—
1.1e+00
6.5e-01
6.2e-01
cases:2.43%
controls:1.52%
cases:1.09%
controls:0.52%
cases:0.21%
controls:0.08%
—
—
cases:0.31%
controls:0.10%
cases:0.95%
controls:0.49%
cases:2.86%
controls:1.56%
94
587
3774
37921
42
200
3826
38308
8
31
3860
38477
—
12
38
3853
38428
36
187
3773
37629
101
540
3427
33989
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
1.7e-01
4.2e-01
1.0e+00
—
1.0e+00
3.1e-01
4.0e-01
cases:3.80%
controls:3.24%
cases:1.94%
controls:1.29%
cases:0.39%
controls:0.14%
—
—
cases:0.47%
controls:0.16%
cases:1.92%
controls:1.41%
cases:7.37%
controls:5.06%
147
1247
3721
37261
75
496
3793
38012
15
53
3853
38455
—
18
63
3847
38403
73
533
3736
37283
260
1748
3268
32781
Acute salpingitis and oophoritis
N70.0 [45539062]
N70.0 [45539062]
2.5e+00
—
—
—
—
—
—
cases:0.16%
controls:0.01%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
3862
38503
—
—
—
—
—
—
Short MRI examination of brain with median intensity magnet
AA1AG [2001300107]
AA1AG [2001300107]
—
2.5e+00
—
—
—
2.3e+00
1.0e+00
—
—
cases:0.16%
controls:0.01%
—
—
—
—
—
—
cases:0.13%
controls:0.01%
cases:0.20%
controls:0.07%
—
6
5
3862
38503
—
—
—
5
5
3804
37811
7
25
3521
34504
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
1.5e-02
3.6e-02
1.0e-01
2.5e+00
5.0e-01
1.7e-01
1.7e-01
cases:3.21%
controls:3.16%
cases:1.71%
controls:1.65%
cases:0.28%
controls:0.26%
cases:0.16%
controls:0.01%
cases:0.36%
controls:0.22%
cases:2.00%
controls:1.70%
cases:6.60%
controls:5.65%
124
1217
3744
37291
66
634
3802
37874
11
99
3857
38409
6
5
3862
38503
14
85
3851
38381
76
641
3733
37175
233
1952
3295
32577
Other specified disorders of Eustachian tube
H69.8 [45533394]
H69.8 [45533394]
2.5e+00
—
—
—
—
—
—
cases:0.16%
controls:0.01%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
3862
38503
—
—
—
—
—
—
General evaluation of the need for rehabilitation
R1100 [2001310172]
R1100 [2001310172]
1.5e+00
-1.0e+50
—
—
—
2.5e+00
—
cases:0.13%
controls:0.03%
cases:0.00%
controls:0.02%
—
—
—
—
—
—
cases:0.16%
controls:0.01%
—
—
5
11
3863
38497
0
7
3868
38501
—
—
—
6
5
3803
37811
—
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
4.5e-01
7.8e-01
1.2e+00
—
1.1e+00
7.5e-01
4.6e-01
cases:2.97%
controls:1.91%
cases:1.24%
controls:0.57%
cases:0.26%
controls:0.08%
—
—
cases:0.23%
controls:0.08%
cases:1.31%
controls:0.62%
cases:3.83%
controls:2.44%
115
736
3753
37772
48
220
3820
38288
10
31
3858
38477
—
9
30
3856
38436
50
236
3759
37580
135
842
3393
33687
Arthropathy in ulcerative colitis
M07.5*K51.9 [2000503012]
M07.5*K51.9 [2000503012]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.20%
controls:0.02%
—
—
—
—
—
—
7
6
3521
34523
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
4.9e-01
7.0e-01
1.5e+00
—
1.1e+00
4.0e-01
9.0e-01
cases:0.88%
controls:0.54%
cases:0.44%
controls:0.22%
cases:0.34%
controls:0.07%
—
—
cases:0.21%
controls:0.07%
cases:0.34%
controls:0.23%
cases:1.30%
controls:0.53%
34
208
3834
38300
17
84
3851
38424
13
28
3855
38480
—
8
27
3857
38439
13
87
3796
37729
46
184
3482
34345
Vertigo of central origin
H81.4 [45538354]
H81.4 [45538354]
2.4e+00
—
—
1.0e+50
1.0e+50
—
1.9e+00
cases:0.21%
controls:0.02%
—
—
—
—
cases:0.13%
controls:0.00%
cases:0.13%
controls:0.00%
—
—
cases:0.17%
controls:0.03%
8
7
3860
38501
—
—
5
0
3863
38508
5
0
3860
38466
—
6
9
3522
34520
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35333-4 [3036086]
35333-4 [3036086]
-3.1e-01
7.2e-01
—
—
-1.0e+50
1.5e+00
9.4e-01
cases:0.13%
controls:0.18%
cases:0.16%
controls:0.08%
—
—
—
—
cases:0.00%
controls:0.02%
cases:0.29%
controls:0.07%
cases:0.85%
controls:0.33%
5
68
3863
38440
6
29
3862
38479
—
—
0
6
3865
38460
11
25
3798
37791
30
115
3498
34414
Flexible laryngoscopy
UDQ12 [2001301827]
UDQ12 [2001301827]
5.4e-01
7.4e-01
—
—
—
1.4e+00
1.1e+00
cases:0.57%
controls:0.33%
cases:0.23%
controls:0.11%
—
—
—
—
—
—
cases:0.42%
controls:0.11%
cases:0.99%
controls:0.35%
22
128
3846
38380
9
43
3859
38465
—
—
—
16
41
3793
37775
35
120
3493
34409
Inpatient Visit
IP [9201]
IP [9201]
2.2e-01
2.3e-01
2.3e-01
—
1.6e+00
4.9e-01
3.6e-01
cases:6.49%
controls:5.27%
cases:2.38%
controls:1.89%
cases:0.28%
controls:0.23%
—
—
cases:1.03%
controls:0.22%
cases:3.05%
controls:1.89%
cases:8.16%
controls:5.82%
251
2031
3617
36477
92
728
3776
37780
11
87
3857
38421
—
40
85
3825
38381
116
715
3693
37101
288
2008
3240
32521
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
3.3e-01
2.6e-01
1.3e-01
—
1.1e+00
5.6e-01
4.0e-01
cases:8.61%
controls:6.33%
cases:2.15%
controls:1.67%
cases:0.21%
controls:0.18%
—
—
cases:0.47%
controls:0.16%
cases:2.65%
controls:1.53%
cases:8.36%
controls:5.78%
333
2436
3535
36072
83
642
3785
37866
8
70
3860
38438
—
18
60
3847
38406
101
577
3708
37239
295
1996
3233
32533
Exploration of joint of shoulder or upper arm, arthroscopic
NBA30 [2001307269]
NBA30 [2001307269]
1.3e+00
1.7e+00
—
—
—
—
1.1e+00
cases:0.41%
controls:0.11%
cases:0.16%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.14%
16
44
3852
38464
6
11
3862
38497
—
—
—
—
15
50
3513
34479
bilastine; oral
R06AX29 [40256760]
R06AX29 [40256760]
1.4e+00
1.4e+00
—
—
—
1.3e+00
9.8e-01
cases:0.41%
controls:0.10%
cases:0.18%
controls:0.05%
—
—
—
—
—
—
cases:0.18%
controls:0.05%
cases:0.45%
controls:0.17%
16
40
3852
38468
7
18
3861
38490
—
—
—
7
19
3802
37797
16
59
3512
34470
Ear pain/earache
H01 [2002000475]
H01 [2002000475]
5.4e-01
1.3e+00
1.9e+00
—
—
2.1e-01
5.5e-01
cases:1.27%
controls:0.74%
cases:0.83%
controls:0.23%
cases:0.16%
controls:0.02%
—
—
—
—
cases:0.29%
controls:0.24%
cases:1.84%
controls:1.07%
49
286
3819
38222
32
90
3836
38418
6
9
3862
38499
—
—
11
89
3798
37727
65
370
3463
34159
Gastroenterology
10 [38004455]
10 [38004455]
5.5e-01
4.2e-01
2.0e-01
—
6.9e-01
7.0e-01
6.7e-01
cases:5.74%
controls:3.39%
cases:2.17%
controls:1.44%
cases:0.31%
controls:0.25%
—
—
cases:0.54%
controls:0.27%
cases:2.91%
controls:1.47%
cases:8.48%
controls:4.54%
222
1304
3646
37204
84
553
3784
37955
12
98
3856
38410
—
21
105
3844
38361
111
555
3698
37261
299
1569
3229
32960
Neck artery ultrasound examination with Doppler method
PA6DE [2001308705]
PA6DE [2001308705]
8.5e-02
1.5e+00
—
1.0e+50
—
1.1e+00
7.9e-01
cases:0.36%
controls:0.33%
cases:0.34%
controls:0.07%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.21%
controls:0.07%
cases:0.68%
controls:0.31%
14
128
3854
38380
13
28
3855
38480
—
5
0
3863
38508
—
8
27
3801
37789
24
107
3504
34422
Migraine, unspecified
G43.9 [45595943]
G43.9 [45595943]
5.7e-01
1.5e+00
1.8e+00
—
—
7.7e-01
8.5e-01
cases:0.80%
controls:0.45%
cases:0.59%
controls:0.14%
cases:0.16%
controls:0.03%
—
—
—
—
cases:0.39%
controls:0.18%
cases:1.13%
controls:0.49%
31
175
3837
38333
23
53
3845
38455
6
10
3862
38498
—
—
15
69
3794
37747
40
168
3488
34361
triamcinolone; nasal
R01AD11 [21605052]
R01AD11 [21605052]
5.8e-01
1.1e+00
1.3e+00
—
1.2e+00
7.1e-01
6.4e-01
cases:1.42%
controls:0.81%
cases:0.85%
controls:0.29%
cases:0.13%
controls:0.03%
—
—
cases:0.16%
controls:0.05%
cases:0.63%
controls:0.31%
cases:1.39%
controls:0.74%
55
310
3813
38198
33
110
3835
38398
5
13
3863
38495
—
6
18
3859
38448
24
117
3785
37699
49
254
3479
34275
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
1.7e-01
4.0e-01
7.7e-01
—
8.8e-01
5.3e-01
5.0e-01
cases:6.13%
controls:5.23%
cases:3.08%
controls:2.08%
cases:0.54%
controls:0.25%
—
—
cases:0.49%
controls:0.21%
cases:3.15%
controls:1.87%
cases:10.37%
controls:6.53%
237
2015
3631
36493
119
802
3749
37706
21
97
3847
38411
—
19
79
3846
38387
120
707
3689
37109
366
2256
3162
32273
celecoxib; oral
M01AH01 [21603992]
M01AH01 [21603992]
6.1e-01
5.7e-01
1.9e-01
—
1.2e+00
6.0e-01
5.3e-01
cases:3.52%
controls:1.93%
cases:1.11%
controls:0.63%
cases:0.13%
controls:0.11%
—
—
cases:0.28%
controls:0.09%
cases:1.18%
controls:0.65%
cases:3.85%
controls:2.30%
136
745
3732
37763
43
244
3825
38264
5
41
3863
38467
—
11
34
3854
38432
45
246
3764
37570
136
795
3392
33734
celecoxib
L01XX33 [21603805]
L01XX33 [21603805]
6.1e-01
5.7e-01
1.9e-01
—
1.2e+00
6.0e-01
5.3e-01
cases:3.52%
controls:1.93%
cases:1.11%
controls:0.63%
cases:0.13%
controls:0.11%
—
—
cases:0.28%
controls:0.09%
cases:1.18%
controls:0.65%
cases:3.85%
controls:2.30%
136
745
3732
37763
43
244
3825
38264
5
41
3863
38467
—
11
34
3854
38432
45
246
3764
37570
136
795
3392
33734
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
2.3e-01
5.5e-01
1.4e+00
—
8.1e-01
3.9e-01
3.8e-01
cases:2.46%
controls:1.96%
cases:1.65%
controls:0.96%
cases:0.39%
controls:0.10%
—
—
cases:0.28%
controls:0.13%
cases:1.34%
controls:0.91%
cases:4.28%
controls:2.96%
95
753
3773
37755
64
370
3804
38138
15
38
3853
38470
—
11
49
3854
38417
51
345
3758
37471
151
1023
3377
33506
Counselling related to known health issue
SPAT1310 [2001700411]
SPAT1310 [2001700411]
3.4e-01
5.2e-01
1.1e+00
—
8.9e-01
3.9e-01
3.8e-01
cases:5.07%
controls:3.66%
cases:2.02%
controls:1.21%
cases:0.47%
controls:0.16%
—
—
cases:0.34%
controls:0.14%
cases:1.79%
controls:1.21%
cases:5.98%
controls:4.18%
196
1409
3672
37099
78
465
3790
38043
18
62
3850
38446
—
13
53
3852
38413
68
458
3741
37358
211
1444
3317
33085
Comprehensive hearing test
SPAT1041 [2001700142]
SPAT1041 [2001700142]
—
2.3e+00
—
—
—
—
8.5e-01
—
—
cases:0.18%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.14%
controls:0.06%
—
7
7
3861
38501
—
—
—
—
5
21
3523
34508
Concussion
S06.0 [45582805]
S06.0 [45582805]
2.5e-01
7.2e-01
2.3e+00
—
—
3.4e-01
4.0e-01
cases:0.90%
controls:0.71%
cases:0.39%
controls:0.19%
cases:0.16%
controls:0.02%
—
—
—
—
cases:0.29%
controls:0.21%
cases:1.45%
controls:0.97%
35
273
3833
38235
15
73
3853
38435
6
6
3862
38502
—
—
11
78
3798
37738
51
335
3477
34194
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
SPAT1217 [2001700318]
-4.3e-01
5.3e-01
—
—
2.3e+00
1.7e-01
-6.5e-02
cases:0.28%
controls:0.44%
cases:0.41%
controls:0.24%
—
—
—
—
cases:0.16%
controls:0.02%
cases:0.26%
controls:0.22%
cases:0.71%
controls:0.76%
11
168
3857
38340
16
94
3852
38414
—
—
6
6
3859
38460
10
84
3799
37732
25
261
3503
34268
Other specified cataract
H26.8 [45552644]
H26.8 [45552644]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.16%
controls:0.02%
—
—
—
—
—
—
—
6
6
3803
37810
—
Hypothyroidism, unspecified
E03.9 [45537945]
E03.9 [45537945]
1.8e-01
2.7e-01
7.2e-01
1.0e+50
1.2e+00
6.0e-01
4.5e-01
cases:1.65%
controls:1.39%
cases:0.85%
controls:0.65%
cases:0.21%
controls:0.10%
cases:0.80%
controls:0.00%
cases:0.39%
controls:0.11%
cases:1.26%
controls:0.70%
cases:3.23%
controls:2.09%
64
535
3804
37973
33
251
3835
38257
8
39
3860
38469
31
0
3837
38508
15
43
3850
38423
48
263
3761
37553
114
723
3414
33806
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
2.8e-02
6.7e-01
—
—
1.4e+00
1.0e+00
6.1e-01
cases:1.47%
controls:1.43%
cases:0.98%
controls:0.50%
—
—
—
—
cases:0.18%
controls:0.05%
cases:1.18%
controls:0.43%
cases:3.32%
controls:1.83%
57
552
3811
37956
38
194
3830
38314
—
—
7
18
3858
38448
45
164
3764
37652
117
632
3411
33897
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
G03CA03 [21602517]
3.6e-01
4.0e-01
3.8e-01
8.5e-01
3.0e-01
4.0e-01
4.2e-01
cases:23.81%
controls:17.88%
cases:17.92%
controls:12.74%
cases:4.42%
controls:3.08%
cases:0.28%
controls:0.12%
cases:4.24%
controls:3.18%
cases:18.40%
controls:13.13%
cases:28.83%
controls:21.09%
921
6887
2947
31621
693
4906
3175
33602
171
1185
3697
37323
11
47
3857
38461
164
1223
3701
37243
701
4965
3108
32851
1017
7282
2511
27247
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
1.4e-01
1.4e-02
8.3e-01
—
1.3e+00
6.2e-01
3.4e-01
cases:2.28%
controls:1.99%
cases:1.01%
controls:0.99%
cases:0.39%
controls:0.17%
—
—
cases:0.60%
controls:0.17%
cases:1.94%
controls:1.05%
cases:4.88%
controls:3.50%
88
766
3780
37742
39
383
3829
38125
15
65
3853
38443
—
23
64
3842
38402
74
398
3735
37418
172
1210
3356
33319
Polyneuropathy, unspecified
G62.9 [45566898]
G62.9 [45566898]
6.5e-01
8.6e-01
—
—
—
1.4e+00
8.0e-01
cases:0.47%
controls:0.24%
cases:0.23%
controls:0.10%
—
—
—
—
—
—
cases:0.45%
controls:0.11%
cases:0.65%
controls:0.30%
18
94
3850
38414
9
38
3859
38470
—
—
—
17
41
3792
37775
23
102
3505
34427
amoxicillin; oral, parenteral
J01CA04 [21602823]
J01CA04 [21602823]
3.7e-01
4.6e-01
7.1e-01
-1.0e+50
3.6e-01
3.0e-01
3.8e-01
cases:24.84%
controls:18.65%
cases:8.89%
controls:5.81%
cases:1.24%
controls:0.62%
cases:0.00%
controls:0.02%
cases:0.83%
controls:0.58%
cases:7.77%
controls:5.87%
cases:25.71%
controls:19.17%
961
7182
2907
31326
344
2236
3524
36272
48
237
3820
38271
0
6
3868
38502
32
222
3833
38244
296
2220
3513
35596
907
6619
2621
27910
Fear of ear disease
H27 [2002000482]
H27 [2002000482]
2.2e+00
—
—
—
—
—
—
cases:0.23%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
—
—
9
10
3859
38498
—
—
—
—
—
—
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
6.9e-02
1.3e-01
4.4e-01
1.2e+00
3.7e-01
1.5e-01
1.4e-01
cases:19.73%
controls:18.66%
cases:16.13%
controls:14.41%
cases:3.96%
controls:2.59%
cases:0.39%
controls:0.11%
cases:3.54%
controls:2.49%
cases:17.27%
controls:15.27%
cases:32.99%
controls:30.00%
763
7184
3105
31324
624
5548
3244
32960
153
998
3715
37510
15
43
3853
38465
137
956
3728
37510
658
5773
3151
32043
1164
10360
2364
24169
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
K08.1 [45591573]
1.7e-01
4.8e-01
1.7e+00
—
7.7e-01
1.9e-01
4.5e-01
cases:0.88%
controls:0.75%
cases:0.52%
controls:0.32%
cases:0.21%
controls:0.04%
—
—
cases:0.13%
controls:0.06%
cases:0.39%
controls:0.33%
cases:1.90%
controls:1.22%
34
287
3834
38221
20
124
3848
38384
8
14
3860
38494
—
5
23
3860
38443
15
123
3794
37693
67
422
3461
34107
Cervicobrachial syndrome
M53.1 [45567577]
M53.1 [45567577]
6.9e-01
8.4e-01
1.5e+00
—
—
6.1e-01
6.6e-01
cases:1.68%
controls:0.85%
cases:0.62%
controls:0.27%
cases:0.21%
controls:0.04%
—
—
—
—
cases:0.58%
controls:0.31%
cases:1.98%
controls:1.04%
65
328
3803
38180
24
104
3844
38404
8
17
3860
38491
—
—
22
119
3787
37697
70
359
3458
34170
adalimumab; parenteral
L04AB04 [21603911]
L04AB04 [21603911]
1.1e+00
7.7e-01
—
—
—
6.6e-01
1.1e+00
cases:0.39%
controls:0.13%
cases:0.21%
controls:0.10%
—
—
—
—
—
—
cases:0.21%
controls:0.11%
cases:0.43%
controls:0.14%
15
50
3853
38458
8
37
3860
38471
—
—
—
8
41
3801
37775
15
50
3513
34479
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
4.0e-01
5.4e-01
6.4e-01
—
6.5e-01
5.7e-01
6.3e-01
cases:3.59%
controls:2.44%
cases:1.96%
controls:1.15%
cases:0.44%
controls:0.23%
—
—
cases:0.52%
controls:0.27%
cases:1.97%
controls:1.12%
cases:4.05%
controls:2.20%
139
938
3729
37570
76
443
3792
38065
17
89
3851
38419
—
20
104
3845
38362
75
424
3734
37392
143
760
3385
33769
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
XJC02 [2001304667]
XJC02 [2001304667]
2.1e+00
—
—
—
—
—
—
cases:0.16%
controls:0.02%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
3862
38501
—
—
—
—
—
—
Evaluation of communicative skills
R1260 [2001310179]
R1260 [2001310179]
—
—
—
—
—
2.1e+00
9.7e-01
—
—
—
—
—
—
—
—
—
—
cases:0.16%
controls:0.02%
cases:0.31%
controls:0.12%
—
—
—
—
—
6
7
3803
37809
11
41
3517
34488
UNS Panic Syndrome
F41.09 [2000501997]
F41.09 [2000501997]
1.1e+00
—
—
—
-1.0e+50
7.7e-01
1.1e+00
cases:0.36%
controls:0.12%
—
—
—
—
—
—
cases:0.00%
controls:0.01%
cases:0.13%
controls:0.06%
cases:0.45%
controls:0.16%
14
48
3854
38460
—
—
—
0
5
3865
38461
5
23
3804
37793
16
54
3512
34475
Intraoral radiographic dental examination
EB1AA [2001301903]
EB1AA [2001301903]
2.8e-01
3.2e-01
7.6e-01
—
-4.8e-03
4.3e-01
3.2e-01
cases:10.42%
controls:8.07%
cases:4.24%
controls:3.10%
cases:0.67%
controls:0.32%
—
—
cases:0.34%
controls:0.34%
cases:4.28%
controls:2.84%
cases:13.72%
controls:10.37%
403
3108
3465
35400
164
1195
3704
37313
26
122
3842
38386
—
13
130
3852
38336
163
1073
3646
36743
484
3582
3044
30947
Destruction of endometrium
LCA16 [2001306554]
LCA16 [2001306554]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.03%
—
—
—
—
—
—
9
11
3519
34518
Amaurosis fugax
G45.3 [45600791]
G45.3 [45600791]
5.8e-01
—
—
—
—
2.1e+00
3.2e-01
cases:0.18%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.20%
controls:0.14%
7
39
3861
38469
—
—
—
—
8
10
3801
37806
7
50
3521
34479
Injection of diagnostic or therapeutic substance in knee
TNG11 [2001308222]
TNG11 [2001308222]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.23%
controls:0.03%
—
—
—
—
—
—
8
10
3520
34519
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
4.7e-01
5.1e-01
—
—
—
1.2e+00
9.0e-01
cases:0.78%
controls:0.49%
cases:0.41%
controls:0.25%
—
—
—
—
—
—
cases:0.63%
controls:0.20%
cases:1.79%
controls:0.74%
30
188
3838
38320
16
96
3852
38412
—
—
—
24
75
3785
37741
63
254
3465
34275
Other specified headache syndromes
G44.8 [45547741]
G44.8 [45547741]
1.1e+00
—
—
—
—
-1.0e+50
2.0e+00
cases:0.18%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.01%
cases:0.31%
controls:0.04%
7
24
3861
38484
—
—
—
—
0
5
3809
37811
11
14
3517
34515
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
4.2e-01
4.6e-01
8.0e-01
—
1.2e-01
5.0e-01
6.6e-01
cases:6.10%
controls:4.08%
cases:1.96%
controls:1.25%
cases:0.34%
controls:0.15%
—
—
cases:0.16%
controls:0.14%
cases:2.23%
controls:1.36%
cases:8.62%
controls:4.65%
236
1572
3632
36936
76
483
3792
38025
13
58
3855
38450
—
6
53
3859
38413
85
514
3724
37302
304
1607
3224
32922
Derangement of meniscus due to old tear or injury
M23.2 [45591779]
M23.2 [45591779]
6.4e-01
8.0e-01
—
—
—
8.5e-01
5.6e-01
cases:1.58%
controls:0.84%
cases:0.41%
controls:0.19%
—
—
—
—
—
—
cases:0.58%
controls:0.25%
cases:1.53%
controls:0.88%
61
324
3807
38184
16
72
3852
38436
—
—
—
22
94
3787
37722
54
304
3474
34225
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
A04AA02 [21600494]
-2.4e-01
-3.4e-01
—
—
2.0e+00
8.4e-01
3.8e-01
cases:0.28%
controls:0.36%
cases:0.13%
controls:0.18%
—
—
—
—
cases:0.26%
controls:0.03%
cases:0.29%
controls:0.12%
cases:0.57%
controls:0.39%
11
139
3857
38369
5
70
3863
38438
—
—
10
13
3855
38453
11
47
3798
37769
20
134
3508
34395
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
3.0e-02
1.3e-01
1.8e-01
1.7e+00
3.6e-01
1.8e-01
3.5e-01
cases:7.42%
controls:7.22%
cases:5.02%
controls:4.43%
cases:1.40%
controls:1.17%
cases:0.34%
controls:0.06%
cases:1.53%
controls:1.07%
cases:5.43%
controls:4.56%
cases:13.58%
controls:10.01%
287
2780
3581
35728
194
1704
3674
36804
54
449
3814
38059
13
24
3855
38484
59
413
3806
38053
207
1725
3602
36091
479
3457
3049
31072
Acute otitis media/myringitis
H71 [2002000526]
H71 [2002000526]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.20%
controls:0.03%
—
—
—
—
—
—
7
9
3521
34520
Rheumatism, unspecified
M79.0 [45567658]
M79.0 [45567658]
6.4e-01
8.0e-01
—
—
—
1.2e+00
7.8e-01
cases:0.65%
controls:0.34%
cases:0.26%
controls:0.12%
—
—
—
—
—
—
cases:0.39%
controls:0.11%
cases:0.77%
controls:0.35%
25
131
3843
38377
10
45
3858
38463
—
—
—
15
43
3794
37773
27
122
3501
34407
Other hearing loss
H91 [45581753]
H91 [45581753]
2.0e+00
—
—
—
—
—
—
cases:0.23%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
—
—
9
12
3859
38496
—
—
—
—
—
—
Biopsy of liver with ultrasound guidance
JJ2AT [2001305254]
JJ2AT [2001305254]
—
-1.0e+50
—
—
—
2.0e+00
2.0e-01
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.16%
controls:0.02%
cases:0.14%
controls:0.12%
—
0
13
3868
38495
—
—
—
6
8
3803
37808
5
40
3523
34489
Cone beam CT of paranasal sinus
DM1AI [2001301744]
DM1AI [2001301744]
5.3e-01
1.7e+00
—
—
—
2.0e+00
6.4e-01
cases:0.21%
controls:0.12%
cases:0.16%
controls:0.03%
—
—
—
—
—
—
cases:0.16%
controls:0.02%
cases:0.31%
controls:0.17%
8
47
3860
38461
6
11
3862
38497
—
—
—
6
8
3803
37808
11
57
3517
34472
terbutaline; inhalant
R03AC03 [21603257]
R03AC03 [21603257]
4.0e-01
5.6e-01
2.8e-01
—
2.7e-01
5.6e-01
4.8e-01
cases:3.65%
controls:2.47%
cases:1.94%
controls:1.12%
cases:0.31%
controls:0.23%
—
—
cases:0.21%
controls:0.16%
cases:1.97%
controls:1.14%
cases:3.66%
controls:2.29%
141
950
3727
37558
75
431
3793
38077
12
90
3856
38418
—
8
61
3857
38405
75
431
3734
37385
129
790
3399
33739
Counselling and guidance in rehabilitation
R21 [2001310193]
R21 [2001310193]
-1.0e+50
—
—
—
—
—
2.0e+00
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.17%
controls:0.02%
0
12
3868
38496
—
—
—
—
—
6
8
3522
34521
norethisterone and ethinylestradiol
G03AA05 [21602478]
G03AA05 [21602478]
4.3e-01
6.1e-01
3.8e-01
—
5.2e-01
5.3e-01
4.2e-01
cases:3.39%
controls:2.23%
cases:2.38%
controls:1.31%
cases:0.54%
controls:0.37%
—
—
cases:0.67%
controls:0.40%
cases:2.34%
controls:1.39%
cases:3.57%
controls:2.39%
131
859
3737
37649
92
503
3776
38005
21
143
3847
38365
—
26
154
3839
38312
89
524
3720
37292
126
824
3402
33705
General and Unspecified, Preventive immunization/medic
A44 [2002000178]
A44 [2002000178]
-1.6e-02
1.0e+00
—
—
—
9.8e-01
4.6e-01
cases:0.47%
controls:0.47%
cases:0.39%
controls:0.14%
—
—
—
—
—
—
cases:0.39%
controls:0.15%
cases:1.19%
controls:0.76%
18
182
3850
38326
15
55
3853
38453
—
—
—
15
56
3794
37760
42
261
3486
34268
Stopping epidural fluid escape with coagulated blood
TAB22 [2001300541]
TAB22 [2001300541]
2.0e+00
—
—
—
—
—
1.5e+00
cases:0.21%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.14%
controls:0.03%
8
11
3860
38497
—
—
—
—
—
5
11
3523
34518
Lamotrigin and topiramate
183 [2001600182]
183 [2001600182]
—
-1.0e+50
—
—
—
—
2.0e+00
—
—
cases:0.00%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.23%
controls:0.03%
—
0
5
3868
38503
—
—
—
—
8
11
3520
34518
Chronic rhinitis
J31.0 [45572165]
J31.0 [45572165]
6.1e-01
2.6e-01
—
—
—
1.2e+00
7.8e-01
cases:0.90%
controls:0.50%
cases:0.26%
controls:0.20%
—
—
—
—
—
—
cases:0.55%
controls:0.17%
cases:1.56%
controls:0.72%
35
191
3833
38317
10
77
3858
38431
—
—
—
21
64
3788
37752
55
249
3473
34280
Application of heat
ZXC60 [2001311371]
ZXC60 [2001311371]
2.0e+00
—
—
—
—
—
1.7e+00
cases:0.26%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:0.20%
controls:0.03%
10
14
3858
38494
—
—
—
—
—
7
12
3521
34517
Polymyalgia rheumatica
M35.3 [45533830]
M35.3 [45533830]
2.2e-01
2.2e-01
1.9e+00
—
—
-1.9e-01
2.8e-01
cases:0.39%
controls:0.31%
cases:0.23%
controls:0.19%
cases:0.18%
controls:0.03%
—
—
—
—
cases:0.16%
controls:0.19%
cases:0.62%
controls:0.47%
15
120
3853
38388
9
72
3859
38436
7
10
3861
38498
—
—
6
72
3803
37744
22
163
3506
34366
Diffuse lymphoma with large B cells
C83.31 [2000501224]
C83.31 [2000501224]
—
—
—
—
1.9e+00
8.7e-01
6.0e-01
—
—
—
—
—
—
—
—
cases:0.18%
controls:0.03%
cases:0.16%
controls:0.07%
cases:0.23%
controls:0.12%
—
—
—
—
7
10
3858
38456
6
25
3803
37791
8
43
3520
34486
Acute maxillary sinusitis
J01.0 [45601112]
J01.0 [45601112]
5.4e-01
5.0e-01
8.9e-01
1.0e+50
3.8e-01
7.7e-01
6.3e-01
cases:3.67%
controls:2.18%
cases:1.29%
controls:0.79%
cases:0.23%
controls:0.10%
cases:0.13%
controls:0.00%
cases:0.13%
controls:0.09%
cases:1.52%
controls:0.71%
cases:5.36%
controls:2.93%
142
840
3726
37668
50
304
3818
38204
9
37
3859
38471
5
0
3863
38508
5
34
3860
38432
58
268
3751
37548
189
1012
3339
33517
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
3.3e-01
4.8e-01
6.3e-01
—
4.9e-01
5.8e-01
5.5e-01
cases:4.01%
controls:2.92%
cases:2.46%
controls:1.53%
cases:0.47%
controls:0.25%
—
—
cases:0.52%
controls:0.32%
cases:2.86%
controls:1.63%
cases:6.55%
controls:3.88%
155
1123
3713
37385
95
590
3773
37918
18
96
3850
38412
—
20
122
3845
38344
109
616
3700
37200
231
1341
3297
33188
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
4.6e-01
3.3e-01
—
—
—
6.5e-01
8.2e-01
cases:3.21%
controls:2.04%
cases:0.93%
controls:0.67%
—
—
—
—
—
—
cases:1.08%
controls:0.56%
cases:5.41%
controls:2.47%
124
785
3744
37723
36
259
3832
38249
—
—
—
41
213
3768
37603
191
852
3337
33677
dexamethasone and antiinfectives
S01CA01 [21603652]
S01CA01 [21603652]
6.1e-01
6.3e-01
—
—
1.2e+00
7.3e-01
5.9e-01
cases:2.09%
controls:1.15%
cases:0.72%
controls:0.39%
—
—
—
—
cases:0.13%
controls:0.04%
cases:0.84%
controls:0.41%
cases:2.52%
controls:1.41%
81
441
3787
38067
28
149
3840
38359
—
—
5
15
3860
38451
32
154
3777
37662
89
488
3439
34041
desloratadine; oral
R06AX27 [21603526]
R06AX27 [21603526]
4.5e-01
5.8e-01
6.0e-01
—
1.0e-01
4.4e-01
4.5e-01
cases:5.35%
controls:3.47%
cases:3.18%
controls:1.80%
cases:0.49%
controls:0.27%
—
—
cases:0.36%
controls:0.33%
cases:2.97%
controls:1.92%
cases:6.75%
controls:4.41%
207
1336
3661
37172
123
694
3745
37814
19
104
3849
38404
—
14
126
3851
38340
113
727
3696
37089
238
1522
3290
33007
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
38445-3 [3048689]
3.2e-01
6.1e-01
9.6e-01
—
—
5.8e-01
7.3e-01
cases:1.76%
controls:1.29%
cases:1.09%
controls:0.59%
cases:0.16%
controls:0.06%
—
—
—
—
cases:1.05%
controls:0.59%
cases:3.74%
controls:1.83%
68
495
3800
38013
42
228
3826
38280
6
23
3862
38485
—
—
40
223
3769
37593
132
632
3396
33897
Recurrent dislocation and subluxation of joint
M24.4 [45557843]
M24.4 [45557843]
1.1e+00
—
—
—
—
-1.0e+50
1.9e+00
cases:0.13%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.01%
cases:0.20%
controls:0.03%
5
16
3863
38492
—
—
—
—
0
5
3809
37811
7
10
3521
34519
Medical Oncology
90 [38004507]
90 [38004507]
-2.4e-01
-2.7e-01
-1.5e-01
1.9e+00
2.7e-02
-9.8e-03
1.6e-01
cases:2.33%
controls:2.95%
cases:1.63%
controls:2.12%
cases:0.59%
controls:0.69%
cases:0.39%
controls:0.06%
cases:0.75%
controls:0.73%
cases:2.26%
controls:2.28%
cases:4.42%
controls:3.78%
90
1135
3778
37373
63
818
3805
37690
23
266
3845
38242
15
22
3853
38486
29
281
3836
38185
86
862
3723
36954
156
1304
3372
33225
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
4.1e-02
9.1e-02
2.7e-01
—
1.4e+00
4.2e-01
5.3e-01
cases:1.06%
controls:1.02%
cases:0.54%
controls:0.50%
cases:0.13%
controls:0.10%
—
—
cases:0.36%
controls:0.09%
cases:0.84%
controls:0.55%
cases:2.49%
controls:1.48%
41
392
3827
38116
21
191
3847
38317
5
38
3863
38470
—
14
35
3851
38431
32
209
3777
37607
88
511
3440
34018
lodoxamide
S01GX05 [21605089]
S01GX05 [21605089]
8.6e-01
—
—
—
—
—
1.9e+00
cases:0.13%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.31%
controls:0.05%
5
21
3863
38487
—
—
—
—
—
11
16
3517
34513
Pelvic, hip and femur extensive MRI examination with high intensity magnet
NE1CG [2001307805]
NE1CG [2001307805]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.31%
controls:0.05%
—
—
—
—
—
—
11
16
3517
34513
azelastine; nasal
R01AC03 [21605035]
R01AC03 [21605035]
4.1e-01
5.7e-01
1.6e-01
—
8.8e-01
4.9e-01
4.2e-01
cases:3.70%
controls:2.48%
cases:2.22%
controls:1.27%
cases:0.26%
controls:0.22%
—
—
cases:0.36%
controls:0.15%
cases:2.13%
controls:1.31%
cases:4.96%
controls:3.31%
143
955
3725
37553
86
488
3782
38020
10
85
3858
38423
—
14
58
3851
38408
81
497
3728
37319
175
1142
3353
33387
Nausea
D09 [2002000308]
D09 [2002000308]
6.2e-01
1.9e+00
—
—
—
9.5e-01
7.9e-01
cases:0.34%
controls:0.18%
cases:0.36%
controls:0.05%
—
—
—
—
—
—
cases:0.16%
controls:0.06%
cases:0.45%
controls:0.21%
13
70
3855
38438
14
21
3854
38487
—
—
—
6
23
3803
37793
16
71
3512
34458
CT of neck arteries
PA6AD [2001308692]
PA6AD [2001308692]
1.1e+00
1.9e+00
—
—
—
1.3e+00
8.5e-01
cases:0.23%
controls:0.08%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
cases:0.13%
controls:0.04%
cases:0.48%
controls:0.21%
9
31
3859
38477
8
12
3860
38496
—
—
—
5
14
3804
37802
17
71
3511
34458
Tympanometry
SPAT1044 [2001700145]
SPAT1044 [2001700145]
5.7e-01
1.9e+00
—
—
—
-1.0e+50
—
cases:0.21%
controls:0.12%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
8
45
3860
38463
8
12
3860
38496
—
—
—
0
18
3809
37798
—
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
2.4e-01
3.2e-01
9.9e-01
—
6.7e-01
5.4e-01
3.6e-01
cases:2.92%
controls:2.31%
cases:1.55%
controls:1.13%
cases:0.44%
controls:0.16%
—
—
cases:0.28%
controls:0.15%
cases:2.28%
controls:1.34%
cases:5.87%
controls:4.17%
113
888
3755
37620
60
434
3808
38074
17
63
3851
38445
—
11
56
3854
38410
87
507
3722
37309
207
1439
3321
33090
amitriptyline and psycholeptics
N06CA01 [21604789]
N06CA01 [21604789]
4.6e-01
4.6e-01
2.7e-01
—
7.4e-01
7.4e-01
6.8e-01
cases:2.38%
controls:1.51%
cases:1.19%
controls:0.75%
cases:0.18%
controls:0.14%
—
—
cases:0.34%
controls:0.16%
cases:1.37%
controls:0.65%
cases:2.21%
controls:1.13%
92
582
3776
37926
46
289
3822
38219
7
53
3861
38455
—
13
62
3852
38404
52
247
3757
37569
78
391
3450
34138
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
5130-0 [3023420]
-4.8e-01
2.2e-01
—
—
—
1.1e+00
7.7e-01
cases:0.23%
controls:0.38%
cases:0.21%
controls:0.17%
—
—
—
—
—
—
cases:0.37%
controls:0.12%
cases:1.08%
controls:0.50%
9
145
3859
38363
8
64
3860
38444
—
—
—
14
46
3795
37770
38
173
3490
34356
fluticasone, combinations
R01AD58 [43534837]
R01AD58 [43534837]
4.0e-01
5.8e-01
1.6e-01
—
8.8e-01
4.8e-01
4.1e-01
cases:3.65%
controls:2.46%
cases:2.22%
controls:1.26%
cases:0.26%
controls:0.22%
—
—
cases:0.36%
controls:0.15%
cases:2.10%
controls:1.31%
cases:4.90%
controls:3.30%
141
948
3727
37560
86
485
3782
38023
10
85
3858
38423
—
14
58
3851
38408
80
495
3729
37321
173
1139
3355
33390
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
M01AE03 [21603969]
2.4e-01
3.5e-01
-1.2e-01
—
8.4e-01
3.4e-01
4.4e-01
cases:8.32%
controls:6.66%
cases:2.77%
controls:1.96%
cases:0.21%
controls:0.23%
—
—
cases:0.65%
controls:0.28%
cases:2.55%
controls:1.83%
cases:6.69%
controls:4.42%
322
2563
3546
35945
107
754
3761
37754
8
90
3860
38418
—
25
108
3840
38358
97
692
3712
37124
236
1526
3292
33003
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
3117
26603
1.78
48.23
5.4
4.5
11.79
13.23
mm/h
7.26
2941
24827
1618
11796
1.62
45.93
2.2
2.2
137.61
206.63
u/l
6.25
1522
11141
1839
14291
1.53
36.85
4.4
4.0
36.93
89.11
ng/l
1.00
1316
10446
1581
11921
1.54
36.22
2.6
2.7
57.64
66.95
u/l
0.74
1457
11034
2569
21779
1.50
31.68
4.7
5.0
6.60
6.74
mmol/l
3.27
2480
20751
3137
27949
1.57
29.00
8.6
8.6
77.14
80.52
u/l
4.63
2972
26519
2759
23991
1.48
27.94
5.6
5.1
1048.87
2407.27
e6/l
0.86
53
331
2129
17625
1.45
27.89
15.9
16.2
1.27
1.28
inr
0.27
1834
14673
3653
33969
1.88
27.34
19.5
17.5
22.48
24.83
mg/l
4.20
3122
28314
2338
19787
1.44
26.58
5.8
6.7
11.13
11.52
umol/l
1.10
2232
18888
3483
32073
1.67
25.35
6.6
5.7
1.95
1.95
mu/l
0.01
3260
29567
3729
35031
1.97
25.24
22.5
20.7
139.64
139.66
mmol/l
0.22
3680
34386
3733
35085
1.98
25.17
22.7
21.0
3.95
3.98
mmol/l
6.02
3680
34384
412
2413
1.79
24.90
2.5
2.4
23.63
22.44
au/ml
0.08
40
224
2296
19521
1.41
24.42
6.5
7.3
1.22
1.21
mmol/l
4.50
1982
16848
3055
27415
1.49
23.87
5.3
4.6
14.98
14.89
pmol/l
1.15
2812
25080
3512
32536
1.66
23.40
7.1
6.7
39.36
39.61
mmol/mol
1.07
3267
30286
2269
19365
1.40
22.89
4.6
4.2
2.79
3.84
estimate
0.14
445
4220
655
4438
1.57
22.50
2.3
2.3
111.03
139.90
ug/g
1.76
526
3511
3641
34116
1.76
22.49
6.7
6.1
2.66
2.68
mmol/l
0.55
3393
31560
3767
35670
1.98
22.45
14.0
12.9
24.90
25.07
u/l
0.29
3671
34613
2240
19117
1.39
22.35
4.6
4.2
0.00
0.00
estimate
1.08
430
4077
3559
33160
1.67
22.24
6.0
5.4
5.93
5.97
mmol/l
1.48
3293
30329
1504
12021
1.40
22.16
3.4
3.2
1237.24
1471.72
ng/l
0.86
1297
10448
2073
17480
1.39
22.16
5.7
6.6
1.22
1.21
mmol/l
3.39
1907
16128
1063
8002
1.45
21.85
1.3
1.3
1.17
1.57
u/ml
0.80
250
2118
373
2203
1.76
21.82
1.3
1.3
64.58
52.53
au/ml
0.33
19
159
2269
19498
1.38
21.16
4.6
4.2
0.06
0.34
estimate
0.53
432
3960
3789
36035
2.00
20.97
25.5
23.0
77.49
77.36
umol/l
0.10
3756
35600
2226
19108
1.37
20.67
6.6
6.5
0.19
0.19
e9/l
0.01
1965
16568
3557
33294
1.62
19.89
5.7
5.2
1.48
1.50
mmol/l
2.17
3295
30705
3575
33516
1.63
19.71
5.8
5.3
4.59
4.64
mmol/l
1.77
3333
31129
2156
18500
1.36
19.58
6.5
6.3
0.58
0.59
e9/l
0.37
1884
15753
2160
18553
1.36
19.41
6.5
6.3
0.04
0.04
e9/l
0.37
1883
15804
787
5721
1.47
19.06
1.9
2.0
29.03
29.72
s
3.20
759
5564
3422
31809
1.53
19.05
4.8
4.4
1.28
1.28
mmol/l
0.18
3115
28993
1043
8001
1.41
18.82
1.9
1.8
1.14
1.31
mg/l
0.79
804
6254
2184
18882
1.35
18.31
6.5
6.4
1.94
1.89
e9/l
0.81
1951
16490
2548
22560
1.36
18.19
3.5
3.3
48.32
50.14
u/l
0.51
2379
21013
894
6767
1.41
17.17
1.4
1.3
31.12
32.12
iu/ml
0.08
265
2093
1707
14337
1.33
16.89
4.5
4.2
0.02
0.53
estimate
1.30
351
3324
842
6327
1.42
16.81
1.4
1.3
9.08
11.79
u/ml
0.66
313
2368
3498
32837
1.52
16.80
18.2
17.2
77.20
77.54
ml/min/173m2
0.49
3312
30627
3809
36538
1.91
16.76
29.5
26.6
251.40
251.52
e9/l
0.04
3757
35790
3810
36552
1.91
16.73
29.6
26.8
134.43
133.11
g/l
7.26
3780
36147
3809
36541
1.91
16.71
29.4
26.5
91.24
91.43
fl
2.05
3779
36124
3809
36543
1.91
16.67
29.7
27.0
40.21
39.81
%
5.43
3779
36112
3809
36544
1.91
16.66
29.4
26.6
4.46
4.42
e12/l
5.02
3745
35666
3809
36546
1.91
16.62
29.5
26.6
6.77
6.75
e9/l
0.13
3745
35664
2366
20868
1.33
16.43
9.1
9.8
4.16
4.13
e9/l
0.23
2079
18056
1202
9617
1.36
16.33
2.7
2.8
337.34
342.62
umol/l
0.98
1058
8411
621
4451
1.47
15.90
5.4
5.1
33.21
33.16
%
0.04
434
2904
1976
17040
1.32
15.85
6.7
6.4
57.29
57.70
%
0.83
1874
16241
902
6939
1.39
15.54
1.5
1.5
2.31
2.49
g/l
2.04
536
4169
1971
17110
1.30
14.54
2.3
2.2
98.96
96.37
pmol/l
1.44
1022
8839
1929
16722
1.30
14.28
3.3
3.1
120.67
126.46
ug/l
0.36
1784
15522
2206
19471
1.30
14.19
2.9
2.7
—
—
—
0
0
1987
17309
1.29
14.10
4.6
5.1
35.86
35.29
g/l
5.13
1855
16211
941
7388
1.36
14.08
4.4
4.0
218.24
380.65
ng/l
1.46
729
5982
1994
17390
1.29
13.97
7.0
6.6
28.03
27.25
%
2.35
1891
16438
492
3501
1.46
12.93
2.2
2.3
378.67
382.80
nmol/l
0.17
455
3228
194
1106
1.79
12.79
1.3
1.2
37.60
43.30
u/ml
0.08
13
59
1044
8483
1.31
12.04
4.9
4.5
1.02
1.19
kg/l
0.50
733
5725
440
3110
1.47
11.94
2.6
2.5
0.24
0.48
e6/l
3.25
422
2979
181
1042
1.77
11.57
1.3
1.3
2.79
5.66
u/ml
0.45
17
105
331
2221
1.53
11.56
1.3
1.3
219.52
203.29
u/ml
0.09
316
2042
157
870
1.84
11.39
1.3
1.2
3.63
3.10
u/ml
0.10
11
59
1201
10034
1.28
11.02
3.9
3.6
0.06
0.23
estimate
0.82
344
3185
179
1044
1.75
10.95
1.3
1.3
6.03
8.37
u/ml
0.22
23
165
1938
17185
1.25
10.57
2.6
2.5
79.52
79.27
nmol/l
0.15
1752
15448
393
2796
1.45
10.27
1.5
1.5
—
—
—
0
0
1274
10796
1.26
10.24
4.8
4.4
0.00
0.00
estimate
0.18
414
3766
1568
13612
1.25
10.22
3.1
3.6
2.36
2.36
mmol/l
0.24
1400
12301
1209
10235
1.26
9.69
2.6
2.4
2.78
2.91
mg/l
1.44
1054
8817
1316
11270
1.25
9.49
1.7
1.7
20.22
20.46
nmol/l
0.21
1122
9502
236
1542
1.56
9.30
2.0
1.7
5.97
6.34
iu/ml
0.10
57
363
388
2808
1.42
9.23
3.1
2.9
10.14
10.65
g/l
1.40
363
2589
1683
14859
1.23
9.03
2.0
1.9
1.36
1.34
mmol/l
0.47
1402
12351
72
335
2.17
8.64
1.3
1.2
112.00
73.55
u/ml
—
5
11
184
1155
1.62
8.61
1.7
1.7
—
—
—
0
0
644
5113
1.31
8.46
1.6
1.5
—
—
—
0
0
250
1716
1.49
7.87
1.0
1.0
—
—
—
0
0
1407
12340
1.22
7.70
3.6
3.5
59.46
77.86
e6/l
0.48
1103
9418
1177
10154
1.23
7.55
3.3
3.2
0.20
0.05
0.45
20
303
824
6852
1.26
7.40
1.7
1.8
1121.84
1175.94
nmol/l
1.00
645
5193
102
574
1.80
7.17
1.4
1.3
0.15
0.34
nmol/l
—
6
34
1565
13939
1.20
7.14
4.3
4.1
72.28
110.19
e6/l
1.73
1156
9860
78
405
1.94
7.05
1.3
1.2
24.50
55.13
u/ml
—
6
23
1069
9196
1.22
6.95
6.1
5.8
3.58
3.49
ug/l
0.03
985
8252
90
493
1.84
6.92
1.3
1.3
0.19
0.22
nmol/l
0.49
75
393
85
461
1.86
6.75
2.7
2.2
25.00
22.53
mg/l
0.18
39
168
550
4405
1.29
6.69
2.5
2.7
8.80
8.37
umol/l
0.14
484
3856
1879
17089
1.19
6.62
2.7
2.8
—
—
estimate
—
0
0
260
1866
1.42
6.52
2.4
2.2
0.00
0.44
estimate
0.51
62
583
137
860
1.61
6.49
1.1
1.1
4.93
7.05
eliau/ml
—
6
92
130
806
1.63
6.48
1.2
1.2
49.17
45.86
u/ml
0.05
12
85
792
6653
1.24
6.41
2.0
1.9
—
—
—
0
0
997
8579
1.22
6.38
2.8
2.7
4.26
5.95
e6/l
6.87
906
7832
207
1438
1.46
6.19
1.3
1.2
1.22
1.46
u/ml
0.09
23
112
47
214
2.21
6.06
1.1
1.1
0.29
8.80
nmol/l
—
8
48
436
3434
1.30
6.02
2.8
2.8
65.92
66.30
g/l
0.51
403
3149
306
2301
1.36
5.82
3.4
3.5
4.41
4.43
pmol/l
0.21
275
2052
324
2473
1.34
5.60
3.3
3.8
5.11
5.17
kpa
0.62
308
2370
858
7372
1.21
5.48
5.1
4.7
22.14
21.90
%
0.18
424
3754
66
357
1.86
5.37
1.1
1.1
—
5.42
—
0
7
213
1536
1.41
5.25
1.7
1.9
38.75
39.49
u/l
0.23
192
1362
402
3203
1.28
5.09
3.2
3.1
197.30
212.10
ng/l
0.27
379
2937
44
211
2.10
5.04
1.2
1.6
5.08
7.01
u/l
1.33
37
184
46
225
2.06
5.01
1.2
1.1
—
—
—
0
0
47
232
2.04
5.00
1.1
1.1
261.01
280.74
mg/l
0.34
42
200
48
240
2.01
4.93
1.2
1.1
33.75
42.51
mg/l
0.97
43
203
58
310
1.88
4.92
1.1
1.1
—
—
—
0
0
275
2095
1.34
4.84
3.2
3.6
1.63
2.02
mmol/l
1.04
201
1582
1382
12484
1.16
4.80
3.5
3.4
32.94
44.44
mg/l
1.67
821
7842
171
1206
1.44
4.80
1.4
1.4
292.30
272.63
ug/g
0.51
101
714
46
229
2.02
4.79
1.9
1.8
17.38
17.22
nmol/l
0.05
46
211
396
3175
1.27
4.77
3.0
3.7
76.58
90.77
ng/l
4.02
337
2707
179
1277
1.42
4.72
3.7
3.9
24.98
24.97
mmol/l
0.03
165
1167
1425
12917
1.16
4.71
3.5
3.4
7.09
7.05
mmol/l
0.14
1185
10872
527
4374
1.24
4.70
8.0
7.4
—
—
—
0
0
72
418
1.74
4.69
1.5
1.4
31.55
32.82
u/l
0.11
58
348
184
1325
1.41
4.61
1.6
1.6
24.77
18.79
u/ml
0.17
32
282
155
1082
1.45
4.61
2.2
1.6
0.24
0.24
g/l
0.01
150
1031
107
694
1.56
4.53
1.5
1.3
11.93
12.31
u/l
0.11
91
563
365
2919
1.28
4.50
1.6
1.7
—
—
—
0
0
545
4565
1.22
4.46
3.9
4.4
238.75
248.03
u/l
0.81
515
4322
12
23
5.23
4.45
1.8
1.7
14.75
29.21
pmol/l
0.52
12
18
1332
12054
1.16
4.44
3.2
3.2
29.99
36.32
u/l
3.53
1242
11344
1395
12698
1.15
4.25
4.3
4.1
6.28
8.38
mg/mmol
1.15
799
7771
285
2231
1.30
4.17
2.1
2.0
1.13
1.40
g/l
2.21
262
2045
156
1113
1.42
4.16
2.1
1.6
1.19
1.18
g/l
0.15
151
1063
769
6699
1.18
4.12
2.4
2.6
13.28
12.58
umol/l
1.92
715
6224
102
673
1.53
4.04
1.3
1.2
75.00
368.71
titre
—
8
62
48
259
1.86
4.02
2.1
1.7
385.55
309.33
mu/l
0.71
42
208
435
3612
1.23
3.88
2.4
2.5
67.94
69.88
e9/l
0.55
343
2626
1032
9249
1.16
3.83
2.3
2.4
—
—
—
0
0
581
4992
1.19
3.64
1.8
1.8
—
—
—
0
0
393
3254
1.23
3.61
2.5
2.4
6.44
6.89
ug/l
0.18
339
2856
156
1143
1.38
3.61
1.4
1.3
—
—
—
0
0
292
2339
1.27
3.60
1.2
1.2
124.88
144.59
u/ml
0.35
118
853
197
1500
1.33
3.56
2.2
1.9
—
—
—
0
0
545
4672
1.19
3.50
1.8
1.9
—
—
—
0
0
904
8072
1.15
3.50
2.8
3.1
2.45
2.46
mmol/l
1.06
796
7235
744
6552
1.17
3.46
3.1
3.3
0.82
0.81
mmol/l
0.55
680
6155
59
356
1.67
3.44
1.3
1.2
—
—
—
0
0
35
180
1.95
3.42
1.2
1.2
0.57
0.54
ratio
0.17
26
104
182
1383
1.33
3.35
2.1
1.8
—
—
—
0
0
22
95
2.32
3.33
1.0
1.2
99.18
86.61
%
0.99
11
51
1174
10715
1.14
3.27
3.4
3.3
0.40
0.46
e6/l
0.42
887
7915
301
2464
1.24
3.10
5.9
6.8
24.81
24.58
mmol/l
0.57
286
2362
109
775
1.42
3.05
1.2
1.4
11.99
37.09
e6/l
1.35
89
566
71
463
1.54
3.05
1.4
1.3
88.72
62.97
u/ml
—
8
24
905
8169
1.14
2.96
1.7
1.7
535.87
32949783.67
pmol/l
6.69
752
6771
40
227
1.77
2.94
1.4
1.2
—
—
—
0
0
110
790
1.40
2.93
1.3
1.4
1364.28
1290.52
e6/l
0.03
93
617
19
83
2.30
2.83
1.2
1.1
248.43
321.08
pmol/l
0.64
14
63
40
230
1.75
2.83
1.4
1.2
—
—
—
0
0
302
2506
1.22
2.77
1.8
1.7
—
—
—
0
0
19
84
2.27
2.77
1.1
1.2
—
—
—
0
0
584
5138
1.16
2.75
4.3
5.8
1.01
1.04
mmol/l
2.23
540
4760
34
188
1.82
2.74
1.9
1.6
—
—
—
0
0
34
188
1.82
2.74
1.9
1.6
—
—
—
0
0
34
188
1.82
2.74
1.9
1.6
—
—
—
0
0
34
188
1.82
2.74
1.9
1.6
—
—
—
0
0
109
793
1.39
2.72
5.9
7.9
11.13
11.17
mmol/l
0.05
100
708
109
793
1.39
2.72
5.9
7.9
105.14
104.97
mmol/l
0.16
100
709
180
1414
1.29
2.67
1.4
1.4
28.98
32.02
iu/l
0.65
153
1227
97
694
1.41
2.67
2.1
1.9
5330.95
5239.22
u/l
0.01
29
281
71
479
1.49
2.65
1.5
1.4
—
—
—
0
0
259
2132
1.23
2.58
2.3
2.3
12.39
12.62
nmol/l
0.16
238
1906
223
1807
1.25
2.57
4.7
5.3
1.57
1.58
%
0.02
210
1711
204
1638
1.26
2.55
2.0
2.0
2.26
2.39
ug/l
0.06
173
1457
127
960
1.33
2.51
1.9
2.0
13.78
12.00
mg/l
0.21
118
887
27
143
1.89
2.50
1.1
1.2
—
—
—
0
0
71
486
1.47
2.49
1.5
1.4
—
—
—
0
0
96
695
1.39
2.49
1.2
1.3
34.41
31.27
u/l
0.09
83
595
20
95
2.11
2.48
1.0
1.4
107.70
83.50
%
—
10
52
60
397
1.52
2.48
1.9
1.6
—
—
—
0
0
210
1700
1.25
2.45
1.9
2.5
4.29
4.22
g/l
0.66
191
1551
210
1701
1.25
2.44
1.9
2.5
7.44
7.45
g/l
0.04
191
1552
122
921
1.33
2.44
1.3
1.3
—
—
—
0
0
41
249
1.65
2.42
1.3
1.3
—
—
—
0
0
34
196
1.74
2.42
2.5
2.3
590.21
512.06
e6/l
0.31
28
159
695
6247
1.14
2.41
2.3
2.6
2.38
2.31
g/l
2.96
643
5758
49
312
1.58
2.40
1.2
1.2
—
—
—
0
0
170
1346
1.27
2.40
2.6
2.7
—
—
—
0
0
53
344
1.55
2.40
2.2
2.9
—
—
—
0
0
40
243
1.65
2.37
1.3
1.3
—
—
—
0
0
209
1699
1.24
2.36
1.9
2.5
3.66
3.71
g/l
0.17
190
1552
47
298
1.58
2.35
1.2
1.2
—
—
—
0
0
47
298
1.58
2.35
1.2
1.2
—
—
—
0
0
643
5761
1.14
2.34
2.4
2.7
22.46
21.92
%
0.42
597
5342
177
1414
1.26
2.33
3.0
3.6
44.14
61.95
mg/l
0.59
159
1212
177
1415
1.26
2.32
3.0
3.6
41.15
91.87
mg/l
0.73
160
1215
46
293
1.58
2.27
1.2
1.2
—
—
—
0
0
94
692
1.37
2.24
1.9
1.9
5.41
4.80
mmol/24h
0.78
84
601
45
287
1.57
2.22
1.2
1.2
—
—
—
0
0
69
483
1.44
2.20
1.5
1.4
—
—
—
0
0
488
4315
1.15
2.17
3.5
4.2
10.82
24.83
ug/l
1.37
390
3537
142
1118
1.28
2.13
1.5
1.5
0.07
6.35
iu/ml
0.59
19
218
203
1669
1.23
2.10
5.0
5.6
0.93
0.87
%
1.55
191
1577
168
1353
1.25
2.10
2.2
3.1
25.04
24.97
mmol/l
0.10
163
1336
66
463
1.43
2.09
1.6
1.4
—
—
—
0
0
2855
27737
1.10
2.09
24.6
22.7
332.19
331.19
g/l
7.72
2850
27577
195
1599
1.23
2.07
1.8
2.6
2.80
2.94
g/l
1.26
176
1451
73
525
1.40
2.03
1.4
1.6
—
—
—
0
0
64
450
1.43
2.02
1.1
1.1
—
—
—
0
0
14
63
2.23
2.00
2.2
2.1
—
—
—
0
0
65
460
1.42
1.98
1.6
1.4
—
—
—
0
0
121
945
1.29
1.96
2.3
2.3
137.60
127.46
g/l
4.01
88
741
65
462
1.41
1.94
1.6
1.4
—
—
—
0
0
130
1029
1.27
1.91
2.1
2.0
3.23
9.83
iu/l
0.61
44
408
31
188
1.65
1.90
2.1
2.4
—
—
—
0
0
25
143
1.75
1.88
2.1
1.7
—
—
—
0
0
25
143
1.75
1.88
2.2
1.8
—
—
—
0
0
25
143
1.75
1.88
2.1
1.7
—
—
—
0
0
66
474
1.40
1.87
1.4
1.5
33.28
27.98
ng/l
0.29
66
474
65
466
1.40
1.86
1.0
1.1
4.09
3.11
u/ml
0.32
30
233
16
79
2.03
1.85
1.0
1.1
0.77
0.70
umol/24h
—
6
37
16
79
2.03
1.85
1.0
1.1
2.27
12.67
u/ml
—
8
52
39
253
1.55
1.84
1.2
1.3
0.09
1.40
u/ml
1.58
23
146
39
254
1.54
1.81
1.5
1.7
86.49
107.38
ng/l
1.39
39
254
31
191
1.63
1.80
1.0
1.0
1.01
1.16
u/l
1.30
13
100
59
419
1.41
1.79
3.9
3.7
51.60
57.81
%
1.27
50
361
8
29
2.76
1.79
1.3
1.0
—
—
—
0
0
76
565
1.35
1.77
1.2
1.1
1.90
1.74
u/ml
0.05
42
315
6
18
3.34
1.74
1.5
2.2
213.67
194.89
ng/l
—
6
18
21
117
1.80
1.74
1.2
1.2
0.33
0.30
g/l
0.87
16
93
108
848
1.28
1.72
1.2
1.1
3.58
4.44
0.43
12
87
731
6724
1.11
1.71
3.2
3.0
1.08
1.16
e6/l
0.23
430
3615
154
1263
1.23
1.69
1.3
1.3
—
—
—
0
0
601
5477
1.11
1.67
3.3
3.3
0.80
0.78
ug/l
0.12
395
3721
51
359
1.43
1.65
1.1
1.2
—
—
—
0
0
27
165
1.64
1.64
1.3
1.3
—
—
—
0
0
27
165
1.64
1.64
1.3
1.3
—
—
—
0
0
53
377
1.41
1.62
2.0
1.6
—
—
—
0
0
1011
9468
1.09
1.62
3.9
4.1
89.92
89.19
%
0.42
990
9248
41
278
1.48
1.61
1.0
1.0
773.68
734.93
ng/l
0.21
31
178
41
278
1.48
1.61
1.0
1.0
281.85
321.41
ng/l
0.54
33
182
42
287
1.47
1.59
1.2
1.5
—
—
—
0
0
232
1991
1.18
1.59
1.7
1.5
—
—
—
0
0
50
354
1.42
1.58
1.1
1.1
3.74
3.39
u/ml
0.05
21
151
175
1466
1.20
1.57
1.8
2.5
0.94
1.01
g/l
0.08
148
1258
11
50
2.20
1.56
1.1
1.1
—
—
—
0
0
41
280
1.47
1.56
1.0
1.0
38.85
42.84
ng/l
0.26
32
180
27
169
1.60
1.51
1.0
1.1
—
—
—
0
0
214
1835
1.18
1.49
3.3
3.2
25.61
25.31
mmol/l
0.62
206
1769
13
65
2.00
1.48
2.2
2.1
—
—
—
0
0
174
1469
1.19
1.46
1.9
2.5
10.12
10.37
g/l
0.32
154
1307
9
38
2.37
1.45
1.0
1.0
—
—
—
0
0
126
1033
1.23
1.43
1.2
1.2
182.50
93.41
titre
0.53
16
88
52
379
1.38
1.42
1.1
1.1
4.42
2.46
u/ml
0.25
24
183
101
809
1.25
1.42
1.5
1.6
—
—
—
0
0
23
142
1.62
1.38
1.2
1.1
1149.24
384.66
ng/l
—
8
38
190
2209
0.85
1.36
1.7
1.8
3.50
3.47
mmol/l
0.09
122
1557
267
3027
0.87
1.36
2.1
2.0
3.47
3.39
ratio
0.52
198
2367
10
47
2.13
1.33
1.0
1.1
—
—
—
0
0
338
3026
1.13
1.32
2.6
2.7
67.99
63.75
ml/min/173m2
1.29
143
1304
67
515
1.31
1.31
1.3
1.4
—
—
—
0
0
505
4629
1.10
1.29
5.0
7.5
1.15
1.03
mmol/l
0.26
411
3810
34
485
0.70
1.29
3.7
5.2
379.41
352.79
umol/l
0.52
28
431
11
206
0.53
1.29
1.0
1.4
—
—
—
0
0
122
1012
1.21
1.27
1.5
1.5
—
—
—
0
0
27
178
1.52
1.26
1.3
1.7
3.94
1.93
u/field
0.58
18
126
405
3679
1.11
1.24
2.3
2.4
37.01
40.40
u/l
0.39
339
3085
507
4660
1.10
1.24
5.1
7.6
12.38
12.25
kpa
0.19
481
4479
25
163
1.54
1.22
1.2
1.3
134.16
155.77
mmol/24h
0.84
25
163
43
313
1.38
1.22
1.8
1.6
24.31
19.87
u/ml
0.28
13
55
10
49
2.04
1.22
1.1
1.0
—
—
—
0
0
78
620
1.26
1.21
1.3
1.4
—
—
—
0
0
48
357
1.35
1.20
1.3
1.5
—
—
—
0
0
45
332
1.36
1.18
1.7
1.5
—
—
—
0
0
45
332
1.36
1.18
1.7
1.5
—
—
—
0
0
45
332
1.36
1.18
1.7
1.5
—
—
—
0
0
386
3510
1.11
1.17
1.5
1.8
1.46
1.49
%
0.29
337
3052
67
527
1.28
1.14
1.2
1.1
—
0.78
—
0
16
58
448
1.30
1.13
1.1
1.1
1.75
3.47
—
7
60
505
4663
1.10
1.13
5.1
7.6
5.04
5.11
kpa
0.80
480
4481
93
762
1.23
1.12
1.3
1.4
—
—
—
0
0
10
51
1.96
1.11
1.0
1.0
—
—
—
0
0
654
6114
1.08
1.10
3.3
3.1
3.84
2.95
e6/l
0.88
355
2992
56
433
1.30
1.09
1.1
1.1
0.81
1.21
u/ml
0.30
29
221
25
168
1.49
1.09
1.0
1.6
—
—
—
0
0
98
810
1.22
1.09
2.9
2.7
17.58
16.10
%
4.00
93
796
80
647
1.24
1.09
4.5
3.8
1.64
1.65
%
0.00
70
581
108
902
1.20
1.08
3.2
3.4
0.82
0.81
nmol/l
0.05
92
727
36
262
1.38
1.05
1.3
1.8
14.16
8.73
umol/l
0.20
23
192
14
228
0.61
1.03
1.4
1.5
47.52
58.29
ug/l
0.48
14
228
144
1240
1.17
1.03
1.8
2.5
0.03
0.03
g/l
0.11
128
1114
28
196
1.43
1.02
1.2
1.2
—
—
—
0
0
14
83
1.69
1.01
1.1
1.1
—
—
—
0
0
46
351
1.31
1.00
1.1
1.1
—
2.92
—
0
5
13
76
1.71
0.98
1.5
1.5
1.17
1.17
mmol/l
0.07
13
76
9
158
0.57
0.98
12.4
13.4
701.00
8985.99
nmol/l
—
9
153
5
23
2.18
0.98
2.8
1.5
326.40
310.48
umol/24h
—
5
23
58
459
1.27
0.97
1.0
1.1
0.77
1.14
u/ml
0.43
25
190
0
29
0.00
0.97
0.0
1.2
—
—
—
0
0
592
5545
1.08
0.97
1.4
1.4
—
—
—
0
0
7
36
1.95
0.97
1.0
1.4
—
—
—
0
0
277
2508
1.11
0.95
3.0
3.0
128.82
127.76
g/l
0.39
266
2433
14
85
1.65
0.94
1.1
1.3
2.27
1.58
mmol/l
—
7
57
48
374
1.29
0.92
1.2
1.3
7.76
7.56
mmol/l
0.18
41
320
223
1999
1.12
0.92
1.8
1.8
—
—
—
0
0
10
55
1.82
0.92
1.6
1.3
—
0.78
—
0
6
6
28
2.14
0.91
2.7
1.8
—
—
—
0
0
87
729
1.20
0.89
5.7
5.1
184.07
527.86
iu/ml
1.06
15
101
100
850
1.18
0.87
2.0
1.7
298.13
302.95
mu/l
0.05
91
783
24
169
1.42
0.87
1.8
1.7
39.73
39.68
g/l
0.01
24
169
171
1518
1.13
0.84
1.4
1.4
—
—
—
0
0
6
31
1.94
0.84
1.3
1.2
—
—
—
0
0
54
668
0.81
0.84
1.3
1.6
1436.58
1026.88
mu/l
0.42
42
531
54
434
1.25
0.83
6.4
5.6
8.57
7.44
mmol/l
0.49
48
371
114
985
1.16
0.83
1.2
1.2
—
—
—
0
0
6
32
1.88
0.81
1.2
1.1
6.13
6.03
mmol/l
—
6
32
16
237
0.67
0.81
1.4
2.2
7.78
8.52
mmol/l
0.34
16
237
122
1062
1.15
0.81
2.7
3.6
4.94
1.98
index
0.84
71
538
49
391
1.26
0.81
2.8
3.5
11.93
13.03
index
0.40
30
212
8
47
1.70
0.80
1.1
1.1
—
—
—
0
0
24
329
0.73
0.80
1.3
1.6
—
—
—
0
0
9
148
0.61
0.79
3.6
2.2
296.11
916.62
e6/l
—
9
103
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
26
0.00
0.78
0.0
1.3
—
4485.65
—
0
17
0
26
0.00
0.78
0.0
1.4
—
22.70
—
0
15
15
98
1.53
0.78
1.1
1.1
—
—
—
0
0
81
685
1.19
0.77
1.2
1.3
—
—
—
0
0
6
34
1.77
0.76
8.8
4.3
—
—
—
0
0
1650
16054
1.05
0.76
12.6
12.1
0.00
0.00
e9/l
1.42
1387
13056
25
183
1.37
0.75
1.3
1.1
—
—
—
0
0
53
431
1.23
0.75
1.4
1.5
51.17
59.97
%
0.72
30
261
32
244
1.31
0.75
1.1
1.1
12.77
9.48
iu/ml
—
6
70
115
1004
1.15
0.75
1.2
1.2
—
—
—
0
0
89
762
1.17
0.74
3.8
3.5
27.02
28.35
mg/l
0.13
62
525
114
996
1.15
0.74
1.2
1.2
—
—
—
0
0
118
1034
1.15
0.73
1.8
1.5
—
—
—
0
0
7
38
1.84
0.73
1.0
1.0
—
—
—
0
0
7
38
1.84
0.73
1.0
1.2
1.46
1.76
umol/24h
—
7
38
26
193
1.35
0.73
1.2
1.1
19.05
16.11
u/ml
—
10
81
206
1871
1.11
0.72
1.6
1.7
1.63
1.55
g/l
0.53
178
1608
143
1273
1.13
0.71
3.0
3.4
3.85
3.35
ratio
0.07
83
754
21
151
1.39
0.71
5.1
5.2
70.91
61.85
mg/l
0.40
11
108
42
336
1.25
0.70
1.8
1.9
3.39
4.37
mg/l
1.62
42
326
26
195
1.34
0.69
1.2
1.2
132.31
132.98
nmol/l
0.02
26
195
69
583
1.19
0.69
2.4
2.5
276.67
1624.42
u/ml
—
6
33
10
157
0.64
0.68
6.9
13.2
0.54
0.64
mmol/l
—
10
142
63
529
1.19
0.67
1.1
1.1
19.24
22.56
au/ml
0.13
15
107
100
874
1.15
0.66
1.5
1.4
—
—
—
0
0
134
1195
1.13
0.66
1.8
2.5
0.01
0.00
g/l
0.80
115
1049
87
753
1.16
0.66
1.5
1.4
—
—
—
0
0
5
28
1.79
0.66
1.0
1.8
—
—
—
0
0
113
997
1.14
0.66
1.7
1.5
—
—
—
0
0
30
232
1.30
0.66
1.2
1.2
—
—
—
0
0
72
841
0.85
0.65
2.3
2.3
77.66
98.39
ug/min
0.21
46
495
38
304
1.25
0.65
1.1
1.1
—
—
—
0
0
51
422
1.21
0.64
1.1
1.1
1.89
3.81
eliau/ml
0.98
15
170
73
848
0.86
0.63
1.6
1.5
—
—
—
0
0
413
3892
1.07
0.62
3.0
3.6
1.71
1.87
mmol/l
0.46
374
3401
43
351
1.23
0.62
4.3
5.6
15.35
67.04
u/ml
1.89
11
109
49
588
0.83
0.61
1.1
1.2
278.63
282.58
u/ml
0.03
24
361
425
4012
1.07
0.61
2.9
3.5
5.75
5.84
kpa
1.20
416
3904
375
3526
1.07
0.61
5.5
7.1
9.49
10.34
mmol/l
1.69
351
3380
81
703
1.16
0.61
1.9
1.6
—
—
—
0
0
40
326
1.23
0.59
1.1
1.1
0.64
0.22
u/ml
0.30
15
113
31
245
1.27
0.59
2.1
1.9
—
—
—
0
0
11
72
1.53
0.59
1.1
1.4
—
—
—
0
0
239
2213
1.09
0.59
1.9
1.9
—
—
—
0
0
16
114
1.41
0.58
1.4
1.3
1894.24
395.18
ug/l
—
9
51
6
36
1.67
0.56
1.0
1.2
—
—
—
0
0
22
286
0.77
0.56
1.8
1.8
—
—
—
0
0
14
98
1.43
0.56
1.4
1.3
36.25
34.56
%
—
8
64
152
1383
1.10
0.55
1.7
2.2
218.07
700.10
ug/l
2.32
141
1307
124
1116
1.11
0.55
1.8
2.6
0.00
0.00
g/l
-0.00
115
1048
6
37
1.62
0.55
1.2
2.6
0.67
0.84
u/field
—
6
37
32
394
0.81
0.54
1.2
1.5
53.00
60.67
ug/l
0.50
27
317
20
152
1.32
0.52
2.9
2.2
270.25
130.00
umol/l
—
8
87
406
3855
1.06
0.51
5.7
8.3
123.59
120.06
g/l
3.18
395
3769
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
143
1305
1.10
0.51
2.7
3.1
0.37
0.35
iu/ml
0.21
84
731
15
109
1.38
0.50
1.2
1.0
—
—
—
0
0
118
1302
0.90
0.49
1.7
1.6
0.34
0.34
mg/l
0.01
54
571
24
189
1.27
0.49
1.0
1.1
—
—
—
0
0
2826
27962
1.04
0.47
23.3
21.6
13.69
13.75
%
1.64
2804
27570
7
47
1.49
0.47
1.7
1.4
3.63
700006.51
nmol/l
—
7
38
18
137
1.32
0.47
3.3
2.1
19.09
20.40
ug/l
0.16
18
124
433
4133
1.05
0.46
5.2
7.9
95.18
95.51
%
0.35
414
3989
113
1027
1.10
0.45
2.0
1.8
—
—
—
0
0
119
1086
1.10
0.44
1.5
1.7
—
—
—
0
0
16
121
1.32
0.44
1.3
1.4
3.27
3.15
mmol/l
0.07
16
111
63
554
1.14
0.44
5.2
6.5
11.66
12.38
mg/l
0.62
58
520
31
372
0.83
0.43
1.3
1.5
0.87
0.98
ratio
2.15
17
225
31
372
0.83
0.43
1.3
1.5
1.08
1.13
ratio
0.13
17
225
31
372
0.83
0.43
1.3
1.5
1.19
1.22
ratio
0.06
17
225
32
266
1.20
0.43
1.7
1.4
33.33
73.16
titre
—
6
19
29
239
1.21
0.42
5.1
7.0
16.84
97.54
ug/l
0.54
19
144
101
1111
0.91
0.42
1.9
1.7
4.13
4.49
mg/l
0.15
81
846
90
812
1.11
0.42
1.3
1.3
157.38
215.10
miu/ml
1.04
35
350
5
32
1.56
0.42
1.0
1.0
2.52
6.84
u/ml
—
5
32
18
140
1.29
0.42
1.5
1.3
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
351
3347
1.05
0.41
2.9
3.0
4.42
4.50
kpa
0.41
345
3252
31
369
0.84
0.40
1.3
1.4
—
—
—
0
0
19
150
1.27
0.40
1.7
2.0
73.19
56.68
ug/l
0.30
19
145
0
18
0.00
0.40
0.0
1.2
—
2.61
—
0
18
33
278
1.19
0.40
1.2
1.0
283.24
292.09
mg/l
0.37
33
253
7
105
0.67
0.39
1.1
1.1
—
—
—
0
0
108
989
1.09
0.39
1.5
1.6
10111.32
12663.46
e6/l
0.29
80
683
10
71
1.41
0.39
1.7
1.5
—
—
—
0
0
10
137
0.73
0.39
1.1
1.2
—
—
—
0
0
51
447
1.14
0.38
1.3
1.4
85248.94
72467.26
e6/l
0.10
31
249
11
80
1.38
0.38
1.2
1.4
—
—
—
0
0
5
37
1.35
0.37
1.2
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
171
1.23
0.35
1.1
1.1
—
—
—
0
0
50
565
0.88
0.35
1.3
1.4
177.83
152.90
au/ml
—
6
159
57
509
1.12
0.34
1.3
1.5
2029.02
3868.97
e6/l
0.52
45
361
211
1997
1.06
0.34
4.2
3.6
1.02
1.02
ratio
0.52
192
1799
228
2402
0.95
0.34
5.1
9.1
24.45
24.33
mmol/l
0.23
219
2354
135
1259
1.07
0.34
2.1
1.8
—
—
—
0
0
30
350
0.86
0.33
1.3
1.2
—
—
—
0
0
19
155
1.23
0.32
1.3
1.5
2.35
2.01
umol/l
1.09
19
140
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
44
497
0.88
0.32
1.8
1.5
—
—
—
0
0
27
229
1.18
0.32
1.4
1.5
76.89
81.69
umol/l
0.39
27
229
17
137
1.24
0.32
1.1
1.2
17.00
10.56
mm/h
0.63
17
137
36
314
1.15
0.31
1.4
2.0
3.50
1.55
u/field
0.57
18
168
19
156
1.22
0.31
1.3
1.5
34.63
30.17
umol/l
1.01
19
145
7
53
1.32
0.30
1.0
1.2
—
—
—
0
0
43
381
1.13
0.30
4.0
3.9
—
—
—
0
0
18
148
1.22
0.29
1.3
1.4
176.73
213.15
pmol/l
0.22
18
148
26
223
1.17
0.28
1.5
1.7
2.48
4.36
ug/l
0.68
19
177
396
3831
1.04
0.28
2.0
2.2
0.22
0.21
g/l
1.93
367
3576
43
384
1.12
0.27
1.3
1.4
330.95
327.72
u/l
0.02
43
370
9
116
0.78
0.27
1.7
2.8
11.89
10.20
kpa
—
9
116
91
978
0.93
0.27
1.3
1.3
—
—
—
0
0
24
279
0.86
0.27
1.1
1.2
—
113.75
—
0
8
13
104
1.25
0.26
1.2
1.1
—
—
—
0
0
12
95
1.26
0.26
1.1
1.3
—
—
—
0
0
47
424
1.11
0.26
1.7
1.5
0.26
0.32
nmol/l
0.55
31
310
20
169
1.18
0.25
5.1
3.3
1.65
1.05
%
0.70
20
169
403
3910
1.03
0.25
3.6
3.6
—
—
—
0
0
234
2246
1.04
0.25
6.8
10.2
16.10
15.81
%
0.76
222
2172
9
75
1.20
0.25
1.1
1.1
—
14.60
u/ml
—
0
5
114
1074
1.06
0.24
2.2
2.9
1.48
1.62
mg/l
1.39
104
961
22
189
1.16
0.24
1.6
1.8
1.89
7.87
nmol/l
1.52
17
156
6
82
0.73
0.24
1.2
1.4
30.97
31.42
nmol/l
—
6
61
6
85
0.71
0.24
1.0
1.1
—
—
—
0
0
5
38
1.32
0.23
1.0
1.8
—
—
—
0
0
81
756
1.07
0.23
1.3
1.3
—
—
—
0
0
81
756
1.07
0.23
1.3
1.3
—
—
—
0
0
26
228
1.14
0.22
1.5
1.8
—
—
—
0
0
110
1040
1.06
0.22
1.3
1.4
—
—
—
0
0
13
107
1.22
0.21
1.3
1.6
8.77
9.34
ug/l
0.31
13
107
0
11
0.00
0.21
0.0
6.4
—
385.82
—
0
11
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
1.74
—
0
12
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
15
126
1.19
0.21
2.1
1.3
—
—
—
0
0
28
249
1.13
0.20
1.3
1.4
1.21
1.11
promille
0.13
20
195
9
115
0.78
0.20
1.7
2.8
4.41
5.03
kpa
—
9
115
31
279
1.11
0.19
1.1
1.3
—
—
—
0
0
6
52
1.15
0.19
3.8
7.6
9.97
10.47
%
—
6
52
104
988
1.05
0.19
2.8
2.4
188.67
195.37
%
0.32
97
936
103
979
1.05
0.18
1.6
1.6
—
—
—
0
0
23
204
1.13
0.18
1.4
1.4
—
—
—
0
0
23
204
1.13
0.18
1.4
1.4
—
—
—
0
0
32
291
1.10
0.17
2.3
2.8
17.51
29.43
mg/l
2.30
25
208
15
129
1.16
0.17
1.1
1.2
—
—
—
0
0
47
505
0.93
0.16
1.8
1.5
—
—
—
0
0
84
883
0.95
0.16
1.2
1.1
0.54
0.63
ratio
—
7
139
328
3205
1.03
0.16
4.2
4.0
1.23
1.23
mmol/l
0.43
277
2756
6
78
0.77
0.15
1.3
1.5
—
—
—
0
0
30
328
0.91
0.15
1.1
1.2
125.67
107.35
pmol/l
1.97
30
328
22
197
1.12
0.15
2.1
2.1
—
143.00
—
0
46
29
265
1.10
0.14
1.6
1.7
—
—
—
0
0
57
537
1.06
0.14
1.2
1.1
1.11
1327.08
iu/ml
—
9
99
47
440
1.07
0.14
1.5
1.4
271.97
274.61
mosm/kgh2o
0.34
37
332
349
3561
0.98
0.14
4.5
7.2
1.34
1.34
mmol/l
0.01
338
3496
17
151
1.13
0.13
1.0
1.1
1645.94
1560.98
miu/ml
0.10
17
151
28
257
1.09
0.13
1.3
1.5
5.77
6.68
u/l
0.24
22
212
13
113
1.15
0.13
1.2
1.1
—
—
—
0
0
21
190
1.11
0.12
3.4
2.6
729.67
1071.35
u/ml
0.89
21
190
50
528
0.95
0.12
1.2
1.2
1.64
3.89
u/ml
1.91
22
178
46
434
1.06
0.12
1.5
1.4
—
—
—
0
0
554
5467
1.02
0.12
5.1
6.9
104.11
104.17
mmol/l
0.10
554
5462
51
483
1.06
0.12
1.1
1.1
—
—
—
0
0
244
2492
0.98
0.11
5.1
7.9
24.85
24.93
mmol/l
0.11
239
2478
28
302
0.93
0.11
2.5
1.5
—
—
—
0
0
12
105
1.14
0.11
1.3
1.6
—
—
—
0
0
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
13
145
0.90
0.09
1.5
1.6
72.08
67.29
%
0.25
13
117
39
370
1.05
0.09
1.3
1.4
43179.47
92910.46
e6/l
0.68
19
255
49
511
0.96
0.08
1.1
1.1
—
—
—
0
0
7
67
1.04
0.08
3.6
7.7
4.93
5.36
kpa
—
7
67
7
68
1.03
0.07
1.4
1.2
—
—
—
0
0
6
71
0.84
0.07
1.0
1.0
14.88
34.68
iu/ml
—
6
71
105
1024
1.03
0.07
2.3
2.4
3.66
3.62
g/l
0.10
100
971
25
266
0.94
0.07
1.5
1.5
—
—
—
0
0
93
954
0.97
0.07
1.3
1.2
1.54
1.57
g/l
0.49
93
954
8
95
0.84
0.06
1.0
1.1
—
—
—
0
0
33
346
0.95
0.06
1.3
1.5
27.18
30.08
%
0.17
17
209
90
878
1.03
0.06
2.6
3.4
979.51
859.26
u/ml
0.05
81
805
11
99
1.11
0.06
1.0
1.1
—
—
—
0
0
32
305
1.05
0.06
1.1
1.0
—
—
—
0
0
11
101
1.09
0.04
1.0
1.1
—
—
—
0
0
11
101
1.09
0.04
1.1
2.1
—
—
—
0
0
124
1223
1.01
0.04
1.3
1.4
—
—
—
0
0
23
240
0.96
0.03
1.5
1.5
—
—
—
0
0
14
132
1.06
0.02
1.8
1.5
66.86
334.95
nmol/24h
0.67
14
132
13
138
0.94
0.02
1.0
1.1
—
—
—
0
0
17
162
1.05
0.02
1.0
1.2
—
—
—
0
0
33
321
1.03
0.02
1.5
1.6
—
—
—
0
0
153
1518
1.01
0.02
2.9
3.4
93.12
3029.68
u/ml
0.96
134
1291
14
133
1.05
0.01
1.8
2.6
0.64
0.61
mmol/l
0.87
14
133
20
198
1.01
0.00
3.1
4.2
—
—
—
0
0
25
248
1.01
0.00
1.5
1.5
—
—
—
0
0
44
442
1.00
0.00
3.4
3.0
11.88
10.69
mmol/l
0.61
44
434
28
275
1.02
0.00
2.0
2.2
723.61
637.11
ml
0.33
18
178
79
792
1.00
0.00
2.3
2.6
34.03
34.98
umol/l
0.15
73
711
71
709
1.00
0.00
1.5
1.8
1.06
0.85
nmol/l
0.58
58
591
10
104
0.96
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
9
91
0.99
-0.00
1.4
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.4
2.2
8.42
17.80
umol/l
—
5
51
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
52
520
1.00
-0.00
1.2
1.2
2.55
4.80
u/ml
1.43
29
222
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
63
0.95
-0.00
1.0
1.2
—
—
—
0
0
8
82
0.98
-0.00
3.3
2.4
13.50
422.57
ug/l
—
8
82
8
86
0.93
-0.00
1.1
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.2
45.28
48.04
mg/l
—
5
44
Mortality – FinRegistry
↥Association
Association between endpoint H8_MENIERE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_MENIERE | 0.876 [0.8, 0.96] | 0.006 |
| Birth year | 0.991 [0.98, 1.0] | 0.033 |
During the follow-up period (1.1.1998 — 31.12.2019), 1902 out of 13148 females with H8_MENIERE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_MENIERE | 0.777 [0.71, 0.85] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 1269 out of 7015 males with H8_MENIERE died.
Mortality risk
Mortality risk for people of age
years, who have H8_MENIERE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.092% | 0.158% |
| 5 | 0.431% | 0.937% |
| 10 | 1.069% | 2.318% |
| 15 | 2.118% | 4.412% |
| 20 | 3.919% | 7.457% |
Relationships between endpoints
↥Index endpoint: H8_MENIERE – Ménière disease
GWS hits: 5
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data